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Abstract
The stilbene based CD [2]-rotaxanes 2.12 and 2.13 have been synthesised using 
trinitrophenyl blocking groups. Using 2D NMR spectroscopy it was determined that the 
[2]-rotaxanes 2.12 and 2.13 are orientational isomers. The [2]-rotaxanes 2.12 and 2.13 
possess ditopic axles and have the potential to act as molecular shuttles upon 
isomerisation of the stilbene unit from the trans conformation to the cA-isomer.
Irradiation with UV light failed to isomerise the stilbene units of the [2]-rotaxanes 2.12 
and 2.13. It appears that the trinitrophenyl blocking groups disrupt the isomerisation 
pathway between the trans conformations and the ds-isomers. The addition of acid and 
base and consequent deprotonation and neutralisation of the secondary amines of the [2]- 
rotaxane 2.12 also failed to cause the CD to move along the axle. Thus the [2j-rotaxanes 
2.12 and 2.13 failed to fulfil their roles as molecular shuttles.
Mesityl nitrile oxide (4.3) was used in attempts to form the [2]-rotaxanes 4.4 and 4.9 by 
cycloaddition with the acrylamides 4.2 and 4.7. Instead cycloaddition of the acrylamide 
4.2 with mesityl nitrile oxide (4.3) and only formed the 2-isoxazoline 4.5. Treatment of 
the acrylamide 4.7 with mesityl nitrile oxide (4.3) also failed to give the hermaphroditic 
[2]-rotaxane 4.9.
An hermaphroditic CD molecular switch was constructed that is powered through 
photochemical energy. The acetamide 5.5(E) is converted to the cA-isomer 5.5(Z) by 
irradiation with light of wavelength 350 nm. The reaction is reversible by irradiation of 
the cfs-isomer 5.5(Z) with light of wavelength 254 nm. The acetamides 5.5(E) and 5.5(Z) 
can act as molecular transports for the carriage of methyl orange (5.8) along an HPLC 
column. The trans-isomer 5.5(E) was revealed to have a transport coefficient (K) of 2800 
dm3 m o l1, the cA-isomer 5.5(Z) had a value of 30300 dm3 mol'1 and aCD (1.15) a value 
of 7900 dm mol . It was determined that the acetamide 5.5(E) forms the dimeric 
inclusion complex 5.7 to hinder the transport of the dye 5.8 while the cis-isomer 5.5(Z) 
allows the dye 5.8 to include facilitating its transport.
vii
The [2]-rotaxanes 6.7, 6.8 and 6.10 were synthesised using triazine blocking groups. The 
synthesis provides a means to produce a [2]-rotaxane with an alternative blocking group 
to the trinitrophenyl systems. The structures were assigned using 2D NMR spectroscopy.
The ditopic [2]-rotaxanes 7.1, 7.2, 7.6 and 7.7 were synthesised using the triazine 
blocking reagent 6.9. Using 2D NMR spectroscopy, the [2]-rotaxanes 7.1 and 7.2 along 
with the [2]-rotaxanes 7.6 and 7.7 were determined to be pairs of orientational isomers 
with the CD situated on the stilbene unit of the axle. Each of the [2]-rotaxanes 7.1, 7.2, 
7.6 and 7.7 was then determined to be a molecular shuttle. Irradiation with light of the 
wavelength 350 nm or 370 nm produced their ds-isomers. Irradiation with 254 nm light 
reformed the [2]-rotaxanes 7.1, 7.2, 7.6 and 7.7. The [2]-rotaxanes 7.1 (Z) and 7.2(Z) 
were able to be isolated and 2D NMR spectroscopy was used to determine that the 
isomerisation of the stilbene unit caused the CD to shuttle to a different part of the axle.
The hermaphroditic [2]-rotaxane 8.5(E,E) was successfully synthesised using the triazine 
based blocking reagent 6.9. The structural assignment of the hermaphroditic [2]-rotaxane 
8.5(E,E) was conducted using 2D NMR spectroscopy. Irradiation of the hermaphroditic 
[2]-rotaxane 8.5(E,E) with light of wavelength 350 nm formed the trans,cis-isomer 
8.5(E,Z). Irradiation for a longer period of time formed the cis,cis-isomer 8.5(Z,Z). The 
irradiation of the isomer mixture with 254 nm light reformed the hermaphroditic [2]- 
rotaxane 8.5(E,E). The system can therefore be considered a molecular muscle.
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Introduction
Chapter 1: Introduction
The association of molecules has been studied since the mid 1930s when the 
association of higher order entities was given the name “Übermoleküle”, which literally 
means supermolecule.13 Supramolecular chemistry was born out of the receptor concept 
conceived by Paul Ehlrich 4,5 This concept stated that in the relationship of biological 
receptors for their substrates, the molecules would not act to perform their function unless 
bound.4 Alfred Werner’s coordination theory and Emil Fischer’s lock and key image 
were also important in the development of the supramolecular chemistry concept.5
Molecular chemistry is a term that can be put to the mastering of rules associated 
with the properties of covalent bonds and their transformation.4,6 In the same sense, 
supramolecular chemistry may be associated with the desire to master the rules governing 
intermolecular bonds.5,6 Supramolecular chemistry has therefore been defined as 
“chemistry beyond the molecule” and is concerned with intermolecular interactions like 
electrostatic interactions, hydrogen bonding and van der Waals forces within a definite 
molecular structure.4
The field of supramolecular chemistry is now undergoing a change from structure 
towards the development of the function of assemblies.7 This development is due to an 
awareness of the approaching impracticality of the scaling down of devices beyond a 
lower limit of 1 pm.8 A “bottom up” approach manipulating systems at the molecular 
level to formulate devices is seen to be the bridge between these limits.8 The molecular 
recognition of a substrate to its receptor with reactive functions forms a supermolecule 
that may act as a supramolecular reagent or catalyst.4 Increasing the binding units creates 
more complex functions in what could be seen as molecular devices.4 Research into this 
area has lead to new applications in the development of molecular electronics, artificial 
photosynthesis, construction of ion channels and the control of molecular motion.7
[2]-Rotaxanes 1.3 are considered ideal for the potential construction of molecular 
devices.9 [2]-Rotaxanes 1.3 are a series of species consisting of a macrocycle threaded on 
an axle that has end groups that prevent the disassociation of the components.911 The 
structure of a [2]-rotaxane 1.3 is shown on the right hand side of Figure 1.1 along with its 
components, the dumbbell 1.2 and macrocycle 1. 1, on the left. The name [2]-rotaxane
1
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was suggested by Schill and Zollenkopf.12 and is derived from the Latin terms, rota for 
wheel and axis for axle. Even before the first synthesis of a [2]-rotaxane, the possibility 
for its formation was pointed out in the discussion on chemical topology by Frisch and 
Wasserman13 in 1961. Topology is concerned with interlocked structures that remain 
linked despite the distortion of bond lengths or angles. In this paper, it was pointed out 
that [2]-rotaxanes could not be strictly classified as topological isomers. Their existence 
is indebted to the “ ...limited flexibility, extension and compression possible with 
molecular entities.” The expansion of the macrocycle of the [2]-rotaxane 1.3 would 
allow the disassociation of the molecule. A [2]-rotaxane, however, has much in common 
with topological isomers as their synthesis requires the specific arrangement of their 
components.10
(a) (b)
Figure 1.1. (a) The components of a [2]-rotaxane, and (b) a [2]-rotaxane 1.3.
It is accepted that the construction of a [2]-rotaxane can proceed via the three 
different methods of “clipping”, “threading” and “slippage” These are illustrated in 
Scheme 1.1. The “clipping” method requires the open ended macrocycle 1.4 to enclose a 
dumbbell 1.2. The clipping of the open ended macrocycle 1.4 then affords the [2]- 
rotaxane 1.3. The “threading” method firstly involves the encapsulation of an axle 1.6 by 
a macrocycle 1.1. The addition of large blocking groups 1.8 to the ends of the 
encapsulated axle 1.7 gives rise to the [2]-rotaxane 1.3. The final method is the 
“slippage” method and involves the slipping of a macrocycle 1.1 over a blocking group 
of a dumbbell 1.2 using an external energy source to form a [2]-rotaxane 1.3.
2
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“clipping” “ threading’ “slippage”
>■
1.2 1.6
f
1.4
0 €=?(
1.5
1.3
[2]-Rotaxane
Scheme 1.1. Strategies for the synthesis of [2]-rotaxanes: “clipping”, “threading” and 
“slippage”.
The formation of the first [2]-rotaxane was reported by Harrison and Harrison,17 
in 1967. Using a statistical approach, a resin bound alkyl macrocycle was treated with the 
axle decane- 1,10-diol and the blocking group triphenylmethyl chloride. The treatment 
was repeated 70 times after which a [2]-rotaxane was hydrolysed from the resin in 6% 
yield. To improve the yield of the formation of a [2]-rotaxane it was suggested that the 
components had to be “...positioned to each other in some way.”]0 Schill and 
Zollenkopf12 used a directed synthesis to position the building blocks for the formation of 
a [2]-rotaxane. Covalent bonds were used to bind a macrocycle to a dumbbell which 
improved the yield of the [2]-rotaxane forming reaction to 81%. The synthesis, 
however, was long and required 15 steps for the preparation and cleavage of the ring to 
produce the final product.12 A non-covalently bound method therefore seemed necessary 
to template the formation of a [2]-rotaxane in high yields.10
3
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Macrocycles, depending on the make-up of the ring structure are able to bind a 
wide variety of molecules using non-covalent bonds. Sauvage et al., ' used the co-
ordination of copper(I) with specifically designed terpyridine macrocyclic ligands to 
produce [2]-rotaxanes with yields of up to 59%. Electrostatic interactions like 7t-
stacking between electron rich and electron poor groups have been used by Stoddart and
22 26
co-workers ' to form [2]-rotaxanes. A variety of [2]-rotaxanes were able to be formed 
using the templating interaction between Tt-acceptor cyclophanes and n-donating
22  26  27  22
tetrathiafulvalene or various aromatic ethers. ' Leigh et al. ‘ has in the past used 
hydrogen bonding interactions to form various [2]-rotaxanes by a clipping method. The 
templation of an aromatic diacid chloride and benzylic diamines with dipeptide dumbells 
followed by their condensation formed [2]-rotaxanes in up to 97% yield. Cyclodextrins 
(CDs) have also been used to template the synthesis of [2]-rotaxanes. The process for the 
formation of CD [2]-rotaxanes is commented on later in this chapter.
Macrocycles that are functionalised with directly attached binding groups are able 
to form another set of [2]-rotaxanes. These macrocycles are also known as 
hermaphrodites 1.9 as they possess both a host and guest component.34 The products able 
to be synthesised upon capping the hermaphrodite 1.9 with a suitable blocking reagent
1.8 are summarised in Scheme 1.2. If the linker between the binding group and the
26
macrocycle is flexible, a cyclic [l]-rotaxane 1.10 may result from the capping.' ’ 
Depending on the size and geometry of the binding group acyclic [n]-rotaxanes 1.11 can 
form. These molecules can also be viewed as supramolecular daisy chains.37 It is also 
possible for a daisy chain to “...bite its own tail...“' to form cyclic [n]-rotaxanes 1.12. 
The cyclic [2]-rotaxane where n = 1 has been synthesised and is also known as an 
hermaphroditic [2]-rotaxane.
4
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Hermaphrodite 1.9
Cyclic [n]-rotaxane
1.12
Cyclic
[1]-rotaxane 1.10
Acyclic
[n]-rotaxane 1.11
Scheme 1.2. Strategies for the synthesis of a cyclic [l]-rotaxane 1.10, an acyclic [n]- 
rotaxane 1.11 and acyclic [n]-rotaxane 1. 12.
An example of an hermaphroditic [2]-rotaxane, synthesised by Sauvage et a/.,40 is 
shown in Scheme 1.3. The [2]-rotaxane 1.13 was synthesised using copper(I) co-
ordination of the terpyridine macrocyclic ligands of two hermaphrodites. As mentioned 
above, [2]-rotaxanes are considered ideal for the potential construction of molecular 
devices.9 A molecular device is a chemical structure that upon the appropriate stimuli 
performs a mechanical movement.41 The hermaphroditic [2]-rotaxane synthesised by 
Sauvage et al.,40 can also be considered a molecular device. The removal of the copper(I) 
ions followed by the addition of zinc(II) causes complexation between a terpyridine and a 
phenanthroline unit to form the [2]-rotaxane 1.14. This causes the length of the molecule 
to contract. Addition of copper(I) ions displaces the zinc(II) ions to reform the [2]- 
rotaxane 1.13. By analogy, the contraction and expansion of the [2]-rotaxane 1.13 can be 
viewed as a molecular muscle. This process is a mimic of what occurs in the sarcomere 
where the myosin containing thick filament moves forwards and backwards along the 
actin polymer to induce contraction or relaxation of a muscle fibre.42
5
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Scheme 1.3. A  molecular muscle synthesised by Sauvage et al.40
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Introduction
In this project CDs were used as the macrocycles to construct similar molecular 
devices as that synthesised by Sau vage et al.40 CDs, as they are known today, were 
discovered in the late nineteenth century by Villiers43 through the digestion of starch with 
Bacillus amylobacter. It was not until 1936, however, that the structure of the CDs was 
postulated by Fruendenburg44 and co-workers to be cyclic, comprising of a - 1,4- 
glycosidic linkages. Extensive X-ray crystallography has since been conducted on the 
CDs to determine their precise structures 43 47
The structure and atom numbering of a CD can be represented as shown in Figure 
I.2.48’49 CDs are comprised of multiple a - 1,4-glucopyranose units with the most 
commonly occurring aCD (1.15), ßCD (1.16) and yCD (1.17) made up of 6, 7 and 8 units 
respectively. One face of the CD is slightly larger than the other which is why the 
structure is often represented as a truncated cone as shown on the right in Figure 1.2. 
Each of the glucopyranose units is aligned in a 4C, chair configuration which structures 
the CD so that each of the primary hydroxyls lines the smaller face while the secondary 
hydroxy groups line the larger face of the CD. The peripheral hydroxy groups render the 
CD soluble in water. The CD-H3, CD-H5 and CD-H6 hydrophobic protons line the 
cavity of the CD giving the annulus a hydrophobic nature48’49
Secondary 
face ^
Primary
face
a-cyclodextrin n = 1,1.15  
ß-cyclodextrin n = 2,1.16
y-cyclodextrin n = 3, 1.17
Figure 1.2. Illustration of a cyclodextrin (left) and its schematic representation as a 
truncated cone (right).
Even before the exact structure of the CDs had been resolved, the properties of 
CDs were studied which showed their ability to complex many organic compounds.50'51
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The ability of CDs to complex organic molecules rests with the unique attributes of their 
structure. The hydrophobic nature of the annulus favours the inclusion of non-polar guest 
molecules in an aqueous solution. The complexation is favoured by the removal of non-
polar guest molecules from a polar aqueous solution and the expulsion from the non-polar 
cavity of polar water molecules.49'52
The modification of natural CDs is also possible and allows the shape, size and 
other physical properties of CDs to be altered.49 This modification has been performed 
for a variety of reasons which include improving their solubility or for the catalysis of 
reactions.53 Modifications of CDs at their primary (CD-OH6) and secondary (CD-OH2 
and CD-OH3) hydroxy groups are the most straightforward. The CD-OH6 groups are the 
most nucleophilic of the hydroxy groups and are able to be selectively modified with 
electrophilic species like p-toluenesulfonyl chloride (1.18)49 The synthesis of the 
sulfonate 1.19, shown in Scheme 1.4, has been extensively studied and provides a 
platform for further modification by nucleophilic substitution.54 57 In Scheme 1.4, the 
synthetic procedure to form the amine 1.21 via the azide 1.20 is shown.54’55 57
C l-S
Pyridine, rt, 2.5 h
NaN3
H20, 80 °C 
5.5 h
V
PPh3, NH4OH
DMF, rt, 4 h
1.21 1.20
Scheme 1.4. Formation of the amine 1.21 according to the experimental conditions of 
Onagi.57
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The complexation of guest molecules by CDs has been used in the formation of 
many [2]-rotaxanes. Of the three conceivable methods for the formation of a [2]-rotaxane 
described above, only the “threading” method has been utilised for the formation of CD 
[2]-rotaxanes. The “clipping” method is not realistic in the formation of a [2]-rotaxane of
this type as this would negate the driving force of a CD’s ability to form complexes.16 An
8^
example of the utilisation of the slippage method with CDs was reported by Macartney' 
and is illustrated in Figure 1.3. The size of the rm-butylpyridinium groups is similar to 
the cavity of aCD (1.15). The rate constant for the inclusion is faster than the rate 
constant for the disassociation which extends the lifetime of the included species 1.22. 
However, the included species 1.22 could not be considered a [2]-rotaxane as the tert- 
butylpyridinium groups do not prevent the disassociation of the CD. Such included 
species are called [2]-pseudorotaxanes as they are not mechanically interlocked.59
Figure 1.3. A cyclodextrin [2]-pseudorotaxane 1.22 reported by Macartney.
The first record of the formation of a CD [2]-rotaxane using the “threading” 
method was reported by Ogino.60,61 Transition metal complexes were used as blocking 
groups to form the [2]-rotaxanes 1.26 and 1.27 as shown in Scheme 1.5.
9
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+
1.23
DMSO
1.15 or 1.16
1.24 or 1.25
NH2 1.24 = ocCD
1.25 = ßCD
CoCI2(en)2
DMSO
en =  H2N n h 2
(en)2CICoH2N
NH2CoCI(en)2
1.26 = aCD
1.27 = ßCD
Scheme 1.5. Formation of the first cyclodextrin [2]-rotaxanes 1.26 and 1.27 reported by 
Ogino.60
Since then, the synthesis o f [2]-rotaxanes using covalently linked blocking groups 
has been developed. Some examples are shown in Figure 1.4. The [2]-rotaxane 1.28
fO
synthesised by Harada et al. used covalently linked trinitrophenyl groups to block the 
CD from disassociating from the alkyl chain. Wenz et al. ' used covalently linked 
triphenylmethyl groups in the synthesis o f the [2]-rotaxane 1.29. Recently, a review by 
Wenz et a lM detailed the synthesis of a range of new CD [2]-rotaxanes. Many of these 
possess the ability to act as molecular devices.
10
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Figure 1.4. Examples of cyclodextrin [2]-rotaxanes reported by Harada et al., and Wenz 
et al.6?
Stilbenes were chosen in this research project to form [2]-rotaxanes as various 
stilbene-CD [2]-rotaxanes had been previously synthesised. Illustrated in Scheme 1.6 is 
the stilbene based [2]-rotaxane 1.32 that was synthesised by Easton et al.65 The synthesis 
uses 4,4’-diaminostilbene (1.30) as the non-polar guest to complex with aCD (1.15) in 
carbonate buffer at pH 10. This pH is used to maintain the stilbene 1.30 as the free amine 
for reaction with the blocking reagent 2,4,6-trinitrobenzene-1-sulfonic acid sodium salt 
(1.31). A nucleophilic aromatic substitution occurs to give the [2]-rotaxane 1.32.
Hermaphroditic [2]-rotaxanes have also been formed using stilbenes and CDs. 
The reaction scheme for the formation of the hermaphroditic [2]-rotaxane 1.34 by Onagi 
et al.; is shown in Scheme 1.7. Sulfonation of the CD-OH6 groups of aCD (1.15) as 
described above provides an avenue for CD modification. Addition of the stilbene 1.30 
through nucleophilic substitution of the sulfonate group enables the formation of the 
hermaphroditic CD 1.33. The hermaphroditic [2]-rotaxane 1.34 was isolated from the 
reaction of the hermaphroditic CD 1.33 with the trinitrophenyl blocking reagent 1.31.
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Carbonate Buffer 
pH 10
NH NO.
Scheme 1.6. Formation of the stilbene-based cyclodextrin [2]-rotaxane 1.32 by Easton et 
a lm
Carbonate 
Buffer 
pH 10
NH NO
Scheme 1.7. Formation of the stilbene and cyclodextrin-based hermaphroditic [2]-
39rotaxane 1.34 by Onagi et al:
The photochemistry of stilbenes was another important factor in the selection of 
them as the guests for the formation of CD [2]-rotaxanes. The photochemistry of the 
stilbene 1.35 is summarised in Scheme 1.8. The stilbene 1.35 which contains a trans-
12
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olefinic bond can be isomerised to its ds-isomer 1.36 upon excitation with light. This 
isomerisation process is reversible to reform the trans-isomer 1.35. There are also several 
competing reactions that can occur during the photoisomerisation process. One reaction is 
a cyclodimerisation reaction of two trans-stilbenes to form the isomeric cyclic dimers 
1.37 and 1.38. The ds-stilbene 1.36 can also undergo a cyclisation reaction to form the 
dihydrophenanthrene 1.39. Further oxidation leads to the phenanthrene 1.40.66 It is the 
change in conformation of the stilbene unit upon isomerisation that is of interest for the 
formation of molecular shuttles and muscles.
1.36 1.39 1.40
Scheme 1.8. Photochemistry of the stilbene 1.35: (a) isomerisation, (b) cyclodimerisation, 
and (c) cyclisation.66
One stilbene based CD-[2]-rotaxane that can be viewed as a molecular shuttle is 
that synthesised by Stainer et al., shown in Scheme 1.9. Irradiation of the trans-isomer 
1.41 at a wavelength of 347 nm produces the ds-isomer 1.42 and causes the CD to shuttle 
along the axle from the double bond at the centre to one side. The reverse reaction occurs 
when the ds-isomer 1.42 is irradiated at a wavelength of 265 nm. One perceived flaw in 
the molecular shuttle shown in Scheme 1.9 is the lack of a defined second CD binding 
unit. Consequently the CD does not move entirely off the stilbene unit when it is in its cis 
form.
13
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340 nm265 nm
Scheme 1.9. A molecular shuttle synthesised by Stainer et al.
The aim of this project was therefore to use the stable complex formed between 
stilbenes and CDs, to form alternative [2]-rotaxanes. A different [2]-rotaxane was sought 
with a second CD binding unit that would allow the CD to move completely off the 
stilbene unit after isomerisation. The construction of hermaphroditic [2]-rotaxanes using 
stilbenes and CDs that would act as molecular muscles like that synthesised by Sauvage 
et al., 40 was also sought.
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Chapter 2: Synthesis and Conformational Analysis of a- 
Cyclodextrin [2]-Rotaxanes with Trinitrophenyl Blocking Groups
In the previous chapter, it was described how the formation of a [2]-rotaxane 
could be undertaken using various means. The “threading” method has been used 
extensively in our research group and was selected to synthesise the [2]-rotaxanes in this 
work.
As shown in Scheme 2.1, a suitable sized non-polar guest 2.2 and CD 2.1 when 
placed in water are in equilibrium with the CD-guest complex 2.3 . The use of a suitable 
reagent 2.4 to add a bulky group to either end of the guest molecule 2.2 prevents the guest 
2.2 from dissociating from the CD 2.1 thus forming the [2]-rotaxane 2.5 .
Scheme 2.1. Schematic diagram of the formation of the cyclodextrin [2]-rotaxane 2.5 
using the “threading” method.
As described in Chapter 1, stilbenes have been used to form [2]-rotaxanes with 
CDs. Shown in Scheme 1.6 is the stilbene based [2]-rotaxane 1.32 that was previously 
synthesised by Easton et a lb5 Stilbenes also have the ability to photochemically 
interconvert between their cis- and trans-isomers. It has been previously reported that 
trans-stilbenes have higher affinity for aCD (1.15) than c/s-stilbenes.68 Therefore if a
15
Chapter 2
second CD binding unit was selected that had a stronger binding with aCD (1.15) than a 
cA-stilbene, but weaker than with its trans counterpart, it could be attached to the stilbene 
and capped with a suitable blocking reagent to form a [2]-rotaxane with the potential to 
act as a molecular shuttle. This is shown in Scheme 2.2 where the isomerisation of the 
stilbene from the trans form 2.6 to the cis 2.7 would cause the CD to shuttle along the 
axle towards the second CD binding unit.
trans [2]-rotaxane 
2.6
encapsulated trans-stilbene
Scheme 2.2. Expected photochemical isomerisation of the stilbene unit of a frans-stilbene 
based [2]-rotaxane 2.6 to produce a ds-[2]-rotaxane 2.7 that would cause the cyclodextrin 
to shuttle to the second cyclodextrin binding unit.
As described in Chapter 1, a species that can be viewed as a molecular shuttle is 
that synthesised by Stainer et a/.,67 shown in Scheme 1.9. One perceived flaw in the 
molecular shuttle, however, is the lack of a defined second CD binding unit. 
Consequently the CD does not move entirely off the stilbene unit when it is in its cis 
form. A different [2]-rotaxane was sought with a second CD binding unit that would 
allow the CD to move completely off the stilbene unit after isomerisation.
In the synthesis of an alternative [2]-rotaxane molecular shuttle, 4- 
aminophenylacetic acid (2.8) was chosen as the source of a second CD binding unit. This 
was thought to be a suitable reagent as it could be coupled to the stilbene 1.30 through an 
amide bond. It was believed that the amide bond would provide suitable separation to
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allow the CD to move completely away from the stilbene when isomerised. Phenyl 
groups are also rigid and were thought likely to provide a good linear axle for the 
formation of a [2]-rotaxane. In the synthesis shown in Scheme 2.3, the amine 2.8 was 
protected using BOC-ON under anhydrous conditions in DMF and TEA to form the 
carbamate 2.9 as had been previously reported in the literature. ' Excess of the stilbene 
1.30 was then coupled to the carbamate 2.9 using the amide coupling agent BOP in DMF 
with TEA. The crude product was purified by preparative HPLC to give the amide 2.10 in 
44% yield. This was followed by deprotection of the amino group by dissolving in DCM 
for the addition of TFA to afford the diamine 2.11 in a yield of 87%. The diamine 2.11 
was equilibrated in carbonate buffer of pH 10 with aCD (1.15) for 24 hours and then 
allowed to react with the sulfonate 1.31. TLC showed the existence of a species with an 
Rf different to any starting material that absorbed UV light and on exposure to 
naphthalene-1,3-diol gave a pink colouration characteristic of a CD as was expected for a 
[2]-rotaxane.65 The material was applied to a Diaion HP-20 column and the excess aCD 
(1.15) was eluted with MQ H2O before the product of interest was removed with MeOH. 
It was then subjected to reverse phase HPLC where two components were revealed and 
isolated. The formation of two [2]-rotaxanes was confirmed by ESI mass spectrometry 
which gave an M ion of m/z 1736.4 for the first [2]-rotaxane 2.12, and a HI-RES M+Na+ 
ion of m/z 1760.4464 for the second [2]-rotaxane 2.13. These species were found to be in 
a ratio of about 1:1 from the HPLC analysis and they were isolated in yields of 2.2% for 
the [2]-rotaxane 2.12 and 2.1% for the [2]-rotaxane 2.13.
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BOC-ONI R = H (2-8) 
TEA
DMF U- R = BOC (2.9)
TFA
DCM
—  R = BOC(2.10)
R = H (2.11)
1. Carbonate 
Buffer 
pH 10 j NO; 
S 0 3Na
1.31
(2.2 eq)
OpN HN
OpN HN
Scheme 2.3. Formation of the [2]-rotaxanes 2.12 and 2.13.
The two apparently different [2]-rotaxanes 2.12 and 2.13 are formed due to the 
asymmetric nature of both aCD (1.15) and the axle species 2.11 creating two different 
possible orientations for the CD to reside over the axle. The formation of isomeric [2]-
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rotaxanes has been identified on a number of previous occasions. Isnin and Kaifer were
the first to encounter this phenomenon. Upon reaction of the acid 2.14 and the amine 2.15
with the aqueous-stable amide coupling agent EDC in water in the presence of ocCD
(1.15), a mixture of the isomeric [2]-rotaxanes 2.16 and 2.17 was obtained as seen in
Scheme 2.4. These [2]-rotaxanes were observed for an alkyl chain length of 7 and 11 and
was verified by NOESY 2D NMR spectroscopy. The 'H NMR spectrum showed two
different amide proton signals that correlated through space with the CD primary and 
for the l”T And 3-lb
secondary hydroxyl groups,^respectively. This indicated that the CD had two different 
orientations on the axle.
n = 7,11
Scheme 2.4. Formation of the isomeric [2]-rotaxanes 2.16 and 2.17 reported by Isnin and 
Kaifer.73
Buston et a/.74 also encountered this phenomenon. In their approach to synthesise 
[2]-rotaxanes based on cyanine dyes they allowed the aldehyde 2.18 to react with the 
pyridinium chloride 2.19 and aCD (1.15) in aqueous sodium hydroxide as shown in 
Scheme 2.5. The isomeric [2]-rotaxanes 2.20 and 2.21 were formed in a 1:2 mixture as 
measured by 'H NMR spectroscopy and were isolated and characterised along with the 
free dye 2.22. NOESY 2D NMR spectroscopy was used to identify the position of the CD 
in each case. For the [2]-rotaxane 2.20 there were interactions between the CD-H3 
protons and the julolidine stopper and between the CD-H5 protons and the adamantyl 
group. The reverse interactions were observed for the isomer 2.21.
In another case, isomeric CD [2]-rotaxanes were synthesised by Park and Song.75 
Upon reaction of the bromide 2.24 with an equilibrated mixture of the aliphatic chain- 
linked carbazole viologen 2.23 and aCD (1.15), a mixture of the two isomers 2.25 and
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2.26 was isolated in a yield of 27%. Fractional precipitation was used to separate the 
isomers and 2D NMR spectroscopy to verify that they were isomeric [2]-rotaxanes. From 
the ROESY spectra the isomer 2.25 showed NOE interactions between the CD-H3 and 
carbazole protons. The isomer 2.26 had NOE interactions between the CD-H6 and 
carbazole protons. Thus the orientation of the CD was as shown in Scheme 2.6.
NaOH aq 
95°C
Scheme 2.5. Formation of the isomeric [2]-rotaxanes 2.20 and 2.21 reported by Buston et 
al.14
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With the knowledge of the previous examples of isomeric CD [2]-rotaxanes it was 
then the objective to determine the exact orientation and positioning of the CD in the [2]- 
rotaxanes obtained in the present work (Scheme 2.3). This was mapped using a 
combination of *H DQCOSY and 'H ROESY NMR techniques. From the 'H DQCOSY 
spectrum each of the CD proton signals was firstly assigned to sets of protons within the 
[2]-rotaxane structure. The CD-H1 proton signals characteristically appear furthest 
downfield near 5 ppm. From this signal the CD-H2, CD-H3, CD-H4 and CD-H5 signals 
were assigned from their sequential DQCOSY interactions as shown in Figure 2.1. The 
remaining signals were allotted to the CD-H6A and CD-H6B protons that have a strong 
DQCOSY interaction with each other.
DQCOSY DQCOSY
DQCOSY
DQCOSY
Figure 2.1. DQCOSY interactions of the cyclodextrin protons in a glucose sub-unit.
In looking at the CD region of the DQCOSY spectrum of the [2]-rotaxane 2.12 as 
shown in Figure 2.2, the CD-H1 proton signals are found at 4.92 ppm as they are the 
furthest downfield. The CD-H1 proton signals have one interaction with a set of signals at 
3.42 ppm that can be concluded to be due to the CD-H2 protons. These in turn show an 
interaction with a signal at 3.90 ppm corresponding to the CD-H3 protons. The CD-H3 
protons show an interaction with the CD-H4 protons for which signals are found at 3.57 
ppm which in turn show an interaction with the CD-H5 protons with signals at 3.89 ppm. 
The two final strong crosspeaks of the CD-H6 and CD-H6 signals are found at 3.53 
and 3.74 ppm.
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Figure 2.2. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 2.12 in ^4- 
methanol at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals.
For the purpose of assignment of the axle proton signals of the [2]-rotaxanes 2.12 
and 2.13, the designations shown in Figure 2.3 were used.
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Figure 2.3. Proton designations of the axle of the [2]-rotaxanes 2.12 and 2.13.
To assign signals to the axle protons, a combination of 'H ROESY and ’H 
DQCOSY NMR spectra was used as shown in Figure 2.4. In the stilbene moiety, the 
signals of the olefinic protons E and F are easily assigned due to their larger coupling. 
These signals should also show DQCOSY crosspeaks with each other. The signal due to 
protons D should have a stronger NOE ROESY interaction, and hence a larger crosspeak, 
with the signal of the olefinic proton F than that of E. This is because proton F would be 
closer in space than proton E. The larger crosspeak is due to the inverse relationship of 
the distance between two protons and the strength of their NOE interaction. Protons D 
should also have a DQCOSY and NOE interaction with C placing them next to D in the 
axle. Protons G should also show an interaction with the olefinic protons with a stronger 
NOE interaction with E than F as again E is closer in space.
R(Wk)
C = DQCOSY 
R = ROESY 
Str = STRONG 
Wk = WEAK
R(Wk)
Figure 2.4. Method for assignment of the stilbene proton signals due to likely DQCOSY 
and ROESY interactions.
The 'H DQCOSY NMR spectrum of the aromatic region for the [2]-rotaxane 2.12 
is shown in Figure 2.5. The signals for the olefinic protons E and F at 7.01 and 7.12 ppm,
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which were assigned on the basis of their large coupling constant, show a strong 
DQCOSY interaction. This coupling was calculated to be 16 Hz, consistent with that of a 
rra/w-olefinic bond.76 The other aromatic proton signals also show DQCOSY 
interactions. The signal due to protons C at 7.66 ppm shows an interaction with the signal 
at 7.35 ppm corresponding to protons D. The signal due to protons G at 7.84 ppm shows 
an interaction with that of protons H at 7.11 ppm. In addition the protons K signal at 7.33 
ppm shows an interaction with the protons L signal at 7.07 ppm. From this information, 
the signals due to the protons of the three para-substituted aromatic rings and the trans- 
olefinic bond from the product 2.12 were identified.
C D  F G H K L
fi 'i KD"-! HIH
7 . 2 -
< 7 . 5 -
F1 (ppm)
Figure 2.5. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 2.12 in <7*- 
methanol at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
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The 'H ROESY NMR spectrum of the same aromatic region was next to be 
examined. The contour plot of interest is shown in Figure 2.6. From the spectrum all 
proton resonance assignments of the stilbene unit can be deduced. An NOE interaction is 
seen between the signals of aromatic protons D and G and those of the rrans-olefinic 
bond. It is not possible to measure the relative strengths of the interactions because of the 
overlap between the interactions of protons G and H and those of K and F so the 
assignments for protons E and F could be the reverse of that shown. This is of no 
consequence, however, in the following analysis of the position of the CD on the axle. As 
in the previous DQCOSY spectrum, crosspeaks are observable between the C and D 
aromatic protons signals. As the protons K and L show no interactions with the olefinic 
protons, they are not part of the stilbene unit and must make up the para-substituted 
phenyl group of the second CD binding unit.
The section of the 'H ROESY contour plot that shows crosspeaks between the 
axle and proton signals can be seen in Figure 2.7. On the y-axis the signals corresponding 
to the protons of the axle can be found while the x-axis shows those of the protons of the 
CD. The signal of protons C shows crosspeaks with the CD-H6A and CD-H6B proton 
signals and a very minor interaction with the CD-H5 proton signal placing them at the 
primary face of the CD. The signal of protons D shows both strong interactions with the 
CD-H6a and CD-H6B proton signals and either or both of the CD-H5 and CD-H3 proton 
signals. This fits with them residing next to C in the axle and towards the primary face of 
the CD. The olefinic signal at 7.02 ppm has strong crosspeaks with either or both those of 
the CD-H3 and CD-H5 annular protons and must sit centrally within the CD. The olefinic 
proton signal at 7.12 ppm is part of a multiplet that results from the overlapping signal of 
aromatic protons H. Due to the multiplet, it can only be deduced that either one or both of 
these axle proton types interacts with either or both of the CD-H3 and CD-H5 protons. 
The signal due to protons G shows NOE interactions with both the CD-H3 and CD-H5 
proton signals and therefore protons G must be centrally located inside the CD annulus. 
The aromatic proton K shows no interactions with any of the CD annular protons. There 
is only a crosspeak with the signal due to the alkyl protons J. The K and J proton 
interaction is only seen through 2D ROESY NOE interactions. The signal of aromatic 
protons L shows no NOE interactions with the CD. This shows that the phenyl subunit of
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the axle is not encapsulated by the CD. Therefore in its trans form, the CD is located on 
the stilbene of the axle in the [2]-rotaxane 2.12.
K>rCH K>i
H ^
j  7 .6 -
F1 (ppm)
Figure 2.6. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 2.12 in d r  
methanol at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
While this confirms the formation of a [2]-rotaxane, from the information 
gathered the exact orientation of the CD on the axle has not been deciphered. Before 
explaining how this was accomplished, the procedures used to determine the location of 
the CD on the axle of the second isomeric [2]-rotaxane 2.13 are described. This 
procedure was followed because if the CD had been positioned differently it may have
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been possible that NOE interactions would indicate the orientation in that case and 
therefore also for the isomer 2.12.
____
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Figure 2.7. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 2.12 in d 4-  
methanol at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
The first step again in the process to delineate the structure of the [2]-rotaxane 
2.13 was to assign the CD region of the DQCOSY spectrum. From the contour plot,
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shown in Figure 2.8, the signal of the CD-H1 protons is the furthest downfield and can be 
found at 4.91 ppm. The CD-H1 signal has one crosspeak with a signal at 3.43 ppm 
belonging to the CD-H2 protons. The CD-H2 signal shows a correlation with a signal at 
3.85 ppm corresponding to the CD-H3 protons which interact with the CD-H4 protons for 
which the signal is at 3.57 ppm. The CD-H4 proton signal correlates with that of the CD- 
H5 protons at 3.88 ppm. The CD-H6A and CD-H6B proton signals show strong 
crosspeaks with each other and are found at 3.63 and 3.76 ppm.
D Ü  6
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Figure 2.8. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 2.13 in (I4- 
methanol at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals.
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The 'H DQCOSY NMR spectrum of the aromatic region was used to determine 
which resonances of the axle were coupled and is shown in Figure 2.9. The signals of the 
olefinic protons F and E at 6.98 and 7.17 ppm show a strong DQCOSY correlation. The 
signals were determined to be due to olefinic protons due to their large coupling of 16 Hz, 
consistent with that of a frans-alkene.76 The other six aromatic signals also reflect 
DQCOSY interactions. The signal due to protons C at 7.67 ppm shows an interaction 
with that of protons D at 7.90 ppm. The signal due to protons G at 7.31 ppm shows an 
interaction with the signal at 7.06 ppm corresponding to protons H. The signal of protons 
K at 7.38 ppm shows a crosspeak with the signal of the aromatic protons L at 7.11 ppm. 
This information allows the assignment of the resonances of the three para-substituted 
aromatic rings and the trans-olefinic bond as shown in Figure 2.9.
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Figure 2.9. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 2.13 in d4- 
methanol at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
29
Chapter 2
To assign the proton resonances of the stilbene subunit, the H ROESY NMR 
spectrum of the same axle region was examined. From the contour plot, shown in Figure 
2.10, it is evident that both the signals of the aromatic protons D and G show NOE 
crosspeaks with the signals of the olefinic protons E and F. As there is no apparent 
difference in the relative strengths of the interactions, it is not clear which olefinic proton 
is closer to which aromatic proton in terms of space. Again this exact assignment is not 
crucial in the following analysis of the position of the CD on the axle. Multiple NOE 
interactions between the signals of aromatic protons C and D, G and H, and K with L are 
also observable. The para-substituted aromatic of the phenyl second unit is comprised of 
the signals of the aromatic protons K and L as they are not a part of the stilbene unit.
p m  I .1 . . . . .  I . . . . . .  . . , i i  | -n j-n | i . i | "  ' ' | ‘ "  ' | ' ' ' [
8 . 0  7 . 9  7 . 8  7 . 7  7 . 6  7 . 5  7 . 4  7 . 3  7 . 2  7 . 1  7 . 0  6 . 9  6 . 8  
F I  (ppm)
Figure 2.10. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 2.13 in d4- 
methanol at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
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The contour plot of the 'H ROESY spectrum of the [2]-rotaxane 2.13 that shows 
NOE interactions between the CD and axle can be seen in Figure 2.11. The y-axis 
contains the signals corresponding to the protons of the axle while on the x-axis the 
signals corresponding to the protons of the CD can be found. Again moving along the 
axle resonances, the position of the CD was established. The signal of protons C from the 
stilbene shows NOE interactions with the CD-H3 signal while the signal of protons D 
interacts with the CD-H3 and CD-H5 proton signals. This positions these aromatic 
stilbene protons at the secondary face of the CD. The signals of the olefinic protons E and 
F both show strong interactions with the signal of the CD-H5 protons positioning them 
centrally within the CD annulus. The signal of the stilbene protons G shows NOE 
crosspeaks with the signals of the CD-H5, CD-H6A and CD-H6B protons. Protons G are 
therefore situated at the primary face of the CD. The signal of the H protons shows no 
such interactions with any of the signals of the CD protons. This means that the H proton 
must be found outside the CD cavity far enough away to prevent any NOE interactions 
from being measured. The aromatic protons K and L also show no interaction with any of 
the CD protons placing them outside the CD cavity. One crosspeak does arise due to a 
NOE interaction between the signal of the alkyl protons J and the signal of the aromatic 
protons K. That means there are no interactions between the signals of the phenyl subunit 
and CD annulus. Therefore in its trans form, the CD is situated solely on the stilbene of 
the axle for the [2]-rotaxane 2.13.
Again it is therefore confirmed that a [2]-rotaxane has been formed, but the exact 
orientation of the CD of each of the [2]-rotaxanes 2.12 and 2.13 was still yet to be 
determined. In each case the CD could be facing either way on the axle. Therefore a 
different means to decipher the orientation in each case had to be found.
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Figure 2.11. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 2.13 in (I4- 
methanol at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
Many approaches were considered to determine the orientation of the CD for each 
of the [2]-rotaxanes 2.12 and 2.13 with some of them expected to be more problematic 
than others. One was to selectively modify the primary or secondary face of the CD with 
a group that would interact with the non-CD-bonded parts of the [2]-rotaxane. However,
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because of the low yields often associated with CD modification, this method was 
deemed too difficult and a simpler idea was sought. A more straightforward solution 
would be to isomerise the [2]-rotaxane to its c/s-isomer. If the CD then shifted onto the 
phenyl group, the direction of the CD might then be determined and hence the orientation 
of the parent trans-isomer would be known. This was attempted but the results were all 
but simple as is reported in the next chapter. The final strategy was the simplest of the
- j ' l
three and proved to be the most effective. In the study by Isnin and Kaifer, ' they were 
able to determine the orientation of their isomeric CD [2]-rotaxanes 2.16 and 2.17 by 
observing through space interactions between the signals of the amide protons of the axle 
and the alcohols of either the primary or secondary face of the CD. Because the previous 
conformational analysis of the isomeric [2]-rotaxanes 2.12 and 2.13 was carried out in d r  
methanol, their amine, amide and hydroxyl protons underwent deuterium exchange with 
the solvent. This removed their signals from the 'H NMR spectrum. Therefore if a non-
exchangeable solvent such as df>-DMSO was used, it was anticipated that deuterium 
exchange would not occur enabling further NOE interactions in the ROESY spectrum to 
be seen that would identify the orientation of the CD in the [2]-rotaxane isomers 2.12 and 
2. 13.
Looking firstly at the [2]-rotaxane 2.12 it can be seen that there are changes in the 
spectra resulting from the use of the non-exchangeable solvent d6-DMSO. The DQCOSY 
spectrum of the CD region is shown in Figure 2.12. According to the review by Schneider 
et al.,11 the CD-H1 proton signal in d6-DMSO is found at 4.75 ppm. It has an interaction 
with the signal at 3.22 ppm due to the protons of CD-H2. This signal shows interactions 
with the signals of two sets of protons. The downfield signal at 5.44 ppm belongs to the 
CD-OH2 protons while the upfield signal is due to the CD-H3 protons located at 3.63 
ppm. The signal of the CD-H3 protons show a further two interactions. Again the 
downfield signal is the result of the hydroxyl protons of CD-OH3 at 5.27 ppm while the 
upfield signal is from the CD-H4 protons at 3.45 ppm. The signal of the CD-H4 protons 
in turn shows a DQCOSY interaction with that of protons CD-H5 at 3.65 ppm. The 
characteristic strongly coupled CD-H6A and CD-H68 signals are found at 3.34 and 3.57 
ppm. They both have an additional interaction with the downfield signal of the CD-OH6 
protons at 4.34 ppm.
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Figure 2.12. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 2.12 in d ^ -  
DMSO at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals.
As in the previous assignments, the next step was to identify the aromatic signals 
of the axle protons. The DQCOSY and ROESY contour plots for the aromatic region of 
the spectrum of the [2]-rotaxane 2.12 are found in Figure 2.13 and Figure 2.14. From the
34
Synthesis and Conformational Analysis of a-Cyclodextrin [2]-Rotaxanes with Trinitrophenyl
Blocking Groups
DQCOSY spectrum, no new crosspeaks arose due to the non-exchangeable solvent. The 
pairing of aromatic protons was undertaken as previously through the interactions of their 
signals. Interactions between the signals of the olefinic E and F protons are identifiable 
along with those of the aromatic G and H, and K and L protons. The multiplet over the 
region of 6.90-7.15 ppm has an integration of 7 H in comparison with the other sets of 
resonances. It can therefore be assumed that both the C and D signals are also found in 
the broad multiplet along with the L and F signals.
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Figure 2.13. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 2.12 in d ö -  
DMSO at 25 °C of the region where crosspeaks are observed between axle protons.
From the ’H ROESY NMR spectrum of the same axle region, shown in Figure 
2.14, the emergence of a new peak led to the orientation of the stilbene unit in the axle
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being determined. The new signal is found at 10.22 ppm and must be due to a nitrogen 
coupled proton from either of the secondary amines B or M or the amide proton I. This 
signal has NOE interactions with both the signals of the H and K aromatic protons and 
must therefore be the result of the amide proton I. Because the protons of the amines B 
and M are at the extremities of the axle, they could only interact with one coupled set of 
aromatic protons. In fact the secondary amine proton signals were not detected in the 'H 
NMR spectrum. This is presumably because the corresponding protons rapidly exchange 
on the NMR time scale and cannot be observed. From the assignment of the H and K 
aromatic protons, the rest of the axle was assigned. The signal of the H protons shows 
both a DQCOSY and NOE interaction with that of the G protons. Further NOE 
interactions with the signals of the olefinic protons E and F established the relationships 
of the stilbene unit in the axle as shown in Figure 2.14. As the H aromatic protons belong 
to the stilbene, the K and hence the L aromatic protons must be found in the second 
binding unit. Unlike the previous conformational analyses, the arrangement of the 
stilbene in relation to the second binding unit was thus identified. This enabled the 
orientation of the CD in the [2]-rotaxane 2.12 to be determined, as follows.
To determine the CD orientation, the ROESY NOE interactions between the axle 
and CD signals were then investigated with the contour plot shown in Figure 2.15. The 
signals corresponding to the CD protons are found on the x-axis while the signals of the 
axle protons are on the y-axis. It was established from the assignment of the [2]-rotaxane 
2.12 in ^-methanol that the K and L protons were not included in the CD. Therefore 
from Figure 2.15, the signals of the stilbene protons C or D and not that of the L protons 
show an interaction with the signals of the CD-H6 protons. This places the primary face 
of the CD on the stilbene unit near the trinitrophenyl blocking group. The signals of the 
protons G and H both show interactions with those of the CD-H3 and CD-H5 protons. 
This places the secondary face of the CD on the stilbene unit near the central amide bond 
of the axle. The CD of the [2]-rotaxane 2.12 is therefore positioned on the stilbene unit of 
the axle as its protons only show interactions with those of the stilbene unit. It is 
orientated as shown by the structure in Figure 2.15 where the secondary face of the CD is 
directed towards the secondary binding unit.
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Figure 2.14. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 2.12 in d ^ -  
DMSO at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
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Figure 2.15. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 2.12 in d 
DMSO at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
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With the orientation of the CD on the axle of the [2]-rotaxane isomer 2.12 
deciphered, the [2]-rotaxane 2.13 was also subjected to the 2D NMR study in d^-DMSO. 
This was to ascertain whether the CD faced the opposite direction to confirm the two [2]- 
rotaxanes 2.12 and 2.13 were orientational isomers. The assignment again started with the 
DQCOSY spectrum of the CD region which is found in Figure 2.16. As before, 
DQCOSY interactions originating through the downfield signal of the protons CD-H1 
were used to completely assign each of the CD protons.
The axle was next assigned using the ROESY contour plot of the aromatic region 
shown in Figure 2.17. The key interactions that determined the axle assignments of the 
[2]-rotaxane 2.12 were also seen for the [2]-rotaxane 2. 13. The signal of the amide proton 
I is again shown, registering at 10.24 ppm. It shows NOE interactions with the signal of 
the stilbene protons H and the long range interaction with the signal of the K aromatic 
protons of the second binding unit. Further NOE interactions of the signals of the H 
stilbene and K aromatic protons enable all axle assignments to be determined as shown in 
Figure 2.17.
The ROESY 2D NMR contour plot that shows NOE interactions between the CD 
and axle proton signals is shown in Figure 2.18. The signals on the y-axis are attributed to 
the aromatic protons while those of the CD protons can be found on the x-axis. The 
orientation and location of the CD for the [2]-rotaxane 2.13 was determined through the 
interactions of the stilbene protons E, F and H. The signal of the protons H shows clear 
NOE interactions with the CD-H6A and CD-H6B signals while the signals of the E and F 
protons only show interactions with those of the CD-H3 or CD-H5 signals. As the signal 
of the H aromatic proton has previously shown a NOE interaction with the amide proton 
signal of I in Figure 2.17, the primary face of the CD is therefore situated near the amide 
bond centrally over the axle with the secondary face pointing towards the rest of the 
stilbene unit. This structure is shown and is confirmed by the remaining NOE interactions 
shown in the ROESY contour plot in Figure 2.18.
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Figure 2.16. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 2.13 in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals.
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Figure 2.17. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 2.13 in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
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Figure 2.18. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 2.13 in d 
DMSO at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
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In summary, the isolated two [2]-rotaxanes 2.12 and 2.13 are orientational 
isomers. In both cases the CD resides on the stilbene unit of the axle due to its stronger 
binding affinity in comparison to the phenyl based second binding unit. The structures of 
the isomeric [2]-rotaxanes after 2D NMR assignment are shown in Figure 2.19. The 
isomer 2.12 has the secondary face of the CD pointing towards the second binding unit 
while the isomer 2.13 has the primary face of the CD pointed towards the second binding 
unit. While the orientation was not able to be deciphered by NMR spectroscopy using d 4-  
methanol, the use of the solvent ^-DM SO prevented exchange of the amide proton I 
allowing the full axle assignment and hence the conformational analysis to be completed.
Figure 2.19. Structures of the [2]-rotaxanes 2.12 and 2.13 determined through ’H 2D 
NMR assignment.
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Chapter 3: Investigating the Potential of a-Cyclodextrin [2]- 
Rotaxanes as Molecular Shuttles
In the work described in the previous chapter the CD [2]-rotaxanes 2.12 and 2.13 
were successfully synthesised using trinitrophenyl blocking groups. The conformations of 
these molecules were determined using 2D NMR spectroscopy and confirmed to be 
orientational isomers. With the conformational analysis completed, the photochemistry of 
the stilbene units was investigated to determine whether the isomers would act as 
molecular shuttles. This study was first carried out on the [2]-rotaxane 2.12 as shown in 
Scheme 3.1, but before the study could be undertaken, the wavelengths for irradiation had 
to be determined.
H NO
Scheme 3.1. Proposed behaviour of the [2]-rotaxane 2.12 as a molecular shuttle.
Isomerisation of a /rans-stilbene proceeds by the selective excitation of the 
compound near its ?imax at a wavelength of light that is away from the >.max of the cis- 
isomer. The reverse can be performed to reproduce the trans-isomer. In the isomerisation
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of the trans-[2]-rotaxane 1.41 by Stainer et a lbl as shown in Scheme 1.9 to produce the 
ds-isomer 1.42, 340 nm light was used. This wavelength is near the A,max of the trans [2]- 
rotaxane 1.41 where the ds-isomer 1.42 has very little absorbance. The reverse reaction 
used 265 nm light where the ds-isomer 1.42 had an increased absorbance while the 
absorbance of the trans-isomer 1.41 was diminished.
To determine the wavelengths required for the investigation into the isomerisation 
of the [2]-rotaxane 2.12, its UV/visible spectrum was examined and interpreted. It is 
shown as the black line in Figure 3.1 for a 2.42 x 10'5 M solution in MQ H2O. From the
spectrum the Xmax at 338 nm is attributed to the /rans-stilbene unit while the
trinitrophenyl blocking group unit is responsible for the Ä,max at 393 nm. For the
isomerisation the three available sources of light were 254 nm, 300 nm and 350 nm
fluorescent lamps. It was expected that the ds-isomer 3.1 would have a UV/visible 
spectrum similar to that of the [2]-rotaxane 1.42 where the maximum absorbance would 
be at around 265 nm. The 350 nm source was used as it was closest to the maximum 
absorbance of the /rans-stilbene and was thought to be a wavelength where the expected 
ds-isomer 3.1 would not absorb so intensely. Because the [2]-rotaxane 2.12 has a 
diminished absorbance at about 280 nm in the UV/visible spectrum, the 254 nm source of 
light was used to attempt the reversal of the isomerisation to reform the trans-isomer 
2.12.
The attempted isomerisation was monitored using a combination of UV/visible 
spectroscopy and reverse phase analytical HPLC. A 3 cm sample of the [2]-rotaxane 
2.12 solution in MQ fUO was irradiated with ten 350 nm lamps for a period of 24 hours 
in a sealed 10 mm i.d. quartz tube. At time intervals within this period the sample was 
analysed by UV/visible spectroscopy which spectra are seen as the red, orange, green and 
blue lines in Figure 3.1. The solution was then subjected to HPLC as shown in Figure 3.2. 
An attempt to reform the [2]-rotaxane 2.12 was undertaken by irradiation of the solution 
with ten 254 nm lamps for 15 minutes with an aliquot of the solution again subjected to 
HPLC.
Despite the long length of the irradiation with 350 nm light there was very little 
change in the UV/visible spectra shown in Figure 3.1. At the maximum absorbance of the 
rrans-stilbene unit at 338 nm there was no change. From the HPLC traces shown in
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Figure 3.2 it was determined that 52% of the starting material had been consumed after 
24 hours irradiation. No significant new peaks arose as a consequence. After the 
irradiation with the 254 nm light the amount of the [2]-rotaxane 2.12 detected by HPLC 
decreased further to 41% of the original starting material as shown by the purple line in 
Figure 3.2.
It can therefore be concluded that the [2]-rotaxane 2.12, upon irradiation near the 
A.max of the rrans-stilbene, did not form any of the c/s-isomer 3.1. After the irradiation, the 
A.max at 338 nm, characteristic of the /rans-stilbene unit, was largely unchanged. This 
means the rrans-stilbene unit still existed. The decrease in the amount of the [2]-rotaxane 
2.12 recorded by HPLC must therefore be due to the formation of other products 
containing the frans-stilbene unit. This is supported by the inability to reform the [2]- 
rotaxane 2.12, as measured by HPLC, after irradiation with 254 nm light where the A.max 
of the m-isomer 3.1 was expected to be.
—  2.12
-----1 h 350 nm
3 h 350 nm
-----8  h 350 nm
-----24 h 350 nm
Wavelength (nm)
Figure 3.1. UV/visible spectra of a solution of the [2]-rotaxane 2.12 [2.42 x 10‘5 M] in 
MQ H2O and after exposure to 350 nm light.
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Figure 3.2. Reverse-phase HPLC chromatograms of the [2]-rotaxane 2.12 [2.42 x 105 M] 
in MQ H2 O before and after exposure to 350 and 254 nm light.
An attempt was also made to isomerise the [2]-rotaxane 2.13 to determine if the 
change in orientation of the CD had any affect on the isomerisation of the stilbene unit. 
For the photolytic study, the UV/visible spectrum of a 2.27 x 105 M solution of the [2]- 
rotaxane 2.13 in MQ H2 O was recorded and is shown as the black line in Figure 3.3. 
Because the spectrum appeared essentially the same as that of the [2]-rotaxane 2.12, the 
same wavelengths of light and time lengths were used to study the isomerisation 
capabilities of the [2]-rotaxane 2.13.
Upon irradiation of the [2]-rotaxane 2.13 over the 24 hour period at 350 nm, there 
was no significant change at the maximum absorbance of the rra/is-stilbene unit at 338 
nm of the UV/visible spectrum as shown in Figure 3.3. From the HPLC trace of the 
irradiated material shown in Figure 3.4, it was determined that 60% of the [2]-rotaxane
2.13 was consumed in the reaction. The irradiation of the sample with 254 nm light for 15 
minutes in an attempt to reform the [2]-rotaxane 2.13 is shown by the purple HPLC trace 
in Figure 3.4. The irradiation caused a further decrease in the amount of the [2]-rotaxane
2.13 to 35% of the original amount as determined through HPLC.
In similar results to the photolysis of the [2]-rotaxane 2.12, the irradiation of the 
[2]-rotaxane 2.13 at 350 nm did not result in the formation of any cis material. This was 
indicated by the unchanged ?imax of the irradiated [2]-rotaxane 2.13 solution by
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UV/visible spectroscopy. As was the case for the [2]-rotaxane 2.12, the decrease in the
amount of the [2]-rotaxane 2.13 as determined through HPLC indicated the formation of
other unknown trrms-stilbene containing products. This reaction was unable to be
reversed by the irradiation of the solution with 254 nm light.
The stilbene units of each of the [2]-rotaxanes 2.12 and 2.13 were therefore
unable to reversibly isomerise. The [2]-rotaxanes 2.12 and 2.13 were instead presumably
converted to other fra/is-stilbene containing products. The desired formation of molecular
shuttles powered by the isomerisation of a stilbene unit therefore failed in these cases. In
the work of Stainer et a l bl the stilbene unit of the [2]-rotaxane 1.41 was able to be
isomerised to form the cis-isomer 1.42 to shuttle the CD to a different part of the
molecule. The main difference between the [2]-rotaxane 1.41 and the [2]-rotaxanes 2.12
Preferential reactions o f
and 2.13 is the type of blocking group. The trinitrophenyl blocking group used for the
^ l*e vent's
[2]-rotaxanes 2.12 and 2.13 therefore probably interrupts the Irans to cis isomerisation 
pathway to form other trans-stilbene containing products.
-----2.13
-----1 h 350 nm
3  h 350 nm
-----7  h 350 nm
-----24 h 350 nm
190 240 290 340 390 440 490 540 590
Wavelength (nrrj)
Figure 3.3. UV/visible spectra of a solution of the [2]-rotaxane 2.13 [2.27 x 105 M] in 
MQ H2O and after exposure to 350 nm light.
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Figure 3.4. Reverse-phase HPLC chromatograms of the [2]-rotaxane 2.13 [2.27 x 105 M] 
in MQ H2O before and after exposure to 350 and 254 nm light.
Alternative methods were therefore sought to utilise the [2]-rotaxanes 2.12 and 
2.13 as potential molecular shuttles. One possibility that was considered was an acid-base 
control as used by Ashton et al. and shown in Scheme 3.2. By adding either of the bases 
/-PnNEt or BU3N, before subsequent addition of the acids CF3CO2H or TfOH, they were 
able to neutralise the secondary amine of the [2]-rotaxane 3.2 or protonate that of 3.3 to 
shift the dibenzo[24]crown-8 macrocycle to or from the 4,4’-bipyridinium binding group. 
In this case they altered the hydrogen bonding between the protonated amine and the 
ether oxygens to direct where the macrocycle was situated on the [2]-rotaxane. It was 
therefore considered what affect deprotonation of the secondary amines in each of the
[2]-rotaxanes 2.12 and 2.13 would have on the location of the CD. The question was
effecf
posed whether deprotonation of the amines would provide an attractive or repulsive affect 
with the CD causing it to move from the stilbene unit.
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CF3C 02H or TfOH
*70
Scheme 3.2. An acid-base controlled molecular shuttle synthesised by Ashton et al.
In the study by Easton et al.,b5 the secondary amines of the [2]-rotaxane 1.32 were 
determined to have pA^s of 9.3 and 9.6 through potentiometric titration. Their acidic 
nature is due to the electron withdrawing effects of the trinitrophenyl groups. With that 
system it was resolved that the deprotonation had no affect on the position of the CD. 
This was thought to be because the bulky trinitrophenyl groups at either end of the [2]- 
rotaxane 1.32 are close in space to the CD. The deprotonation of the secondary amines 
could have no affect as the CD would be prevented from moving due to the nearby 
blocking groups. As the [2]-rotaxanes 2.12 and 2.13 have a much greater distance 
between the blocking groups it was thought the deprotonation of the amines may enable 
attractive or repulsive forces to alter the CD location. The amines of the [2]-rotaxanes 
2.12 and 2.13 were expected to have similar pA'aS to those of the [2]-rotaxane 1.32 
because they also have trinitrophenyl groups creating an electron withdrawing effect. 
Nevertheless a variable pH study was undertaken to examine this. The study was carried 
out on the isomer 2.12 by dissolving the compound in ^-methanol to increase its 
solubility. As a consequence the measurements can only be considered as a rough guide 
to the actual pD as a true measurement requires an aqueous solution. The pD of the 
solution was then recorded with a micro combination pH electrode in an NMR tube
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before a !H NMR experiment on the solution was performed. The pD was then adjusted 
with either NaOD or DC1 solution and the 'H NMR spectrum recorded again over the pD 
range of 3.6 to 11.4.
The 'H NMR spectra of the aromatic region for the [2]-rotaxane 2.12 with 
changing pD are shown in Figure 3.5. Between a pD of 3.6 and 8.1 there is little change 
in the chemical shift of the signals of the aromatic protons. When the pD is elevated 
above 8.1 there are several upfield movements of the aromatic signals. The signals with 
the largest change in chemical shift are those belonging to the A and N protons with 0.47 
ppm and 0.54 ppm upfield movements. The signals of the L and H protons also have 
large upfield movements of chemical shift. These movements have values of 0.40 and 
0.39 ppm for the signals of the L and H protons respectively.
The upfield shift of the L and N signals is consistent with the loss of the amine 
proton M causing a shielding effect on the L and N protons through resonance. Loss of 
the amine proton B would also cause the upfield shift of the signal of the A protons, but it 
would also be expected to affect the signal of the protons C which are substantially 
unaffected. It may be that the CD twists the trinitrophenyl and amino groups out of 
coplanarity preventing the affect from the deprotonation registering on the aromatic 
protons C. The large shift of the signal of the protons H is also difficult to explain. The 
protons H are nearest to the amide proton I which would be expected to have a very large 
pA'a, based on the similar molecule phenylacetanilide, where the amide has a p/fa of 
20.6.79 The amide I should therefore not deprotonate even at the highest pD used for this 
study. The two inconsistencies are not due to an error in the assignment of the signals of 
the protons C and H, as a thorough re-examination established the assignments are 
correct.
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Figure 3.5. 'H NMR spectra of the [2]-rotaxane 2.12 over the region of 6.6 ppm to 9.2 
ppm in ^-methanol with varying pD.
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From the pD study of the [2]-rotaxane 2. 12, the secondary amines deprotonate at 
pD above 8.1. This conclusion is based on the similarity of the NMR signals in the pD 
range 3.6 to 8.1, before a large upfield shift of the signals of the A, L and N protons when 
the pD is raised above 8.1. To determine if the deprotonation of the secondary amines of 
the [2]-rotaxane 2.12 has any affect on the position of the CD, ROESY NMR 
spectroscopy was conducted on the [2]-rotaxane 2.12 at a pD of 7.8 and at 11.0. The pD 
of 7.8 was chosen as from the pD study the neutral species was expected to be present. 
The pD of 11.0 was chosen as from the pD study it was expected that the doubly 
deprotonated axle would be present. Also as the CD secondary alcohols have a pKa of 
12.33,49 a pD lower than 12 was used to prevent their deprotonation complicating the 
study.
The 2D NMR spectra for the [2]-rotaxane 2.12 were first analysed at a pD of 7.8 
to determine the conformation of the neutral species. The DQCOSY spectrum of the CD 
region is shown in Figure 3.6. The signals of the CD protons were assigned as in Chapter 
2 from the DQCOSY interactions between the signals of the CD protons. The signals of 
the axle protons were then assigned using both the DQCOSY and ROESY 2D NMR 
contour plots of the region from 6.7 to 8.0 ppm found in Figures 3.7 and 3.8. The stilbene 
unit signals were assigned as described in Chapter 2. The 'H ROESY contour plot shown 
in Figure 3.9 shows crosspeaks between the signals of the axle and CD annular protons 
which enables the location of the CD to be determined for the [2]-rotaxane 2.12 at a pD 
of 7.8. The plot gives clear evidence that the CD is situated on the stilbene unit of the 
axle with the signals of the C to H protons all showing interactions with those of the CD 
annular protons. The CD is therefore in the same location on the axle of the [2]-rotaxane 
2.12 at a pD of 7.8 as it was when the pD was unadjusted in the work described in 
Chapter 2.
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Figure 3.6. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 2.12 in pD 
7.8 ^-methanol at 25 °C of the region where crosspeaks are observed between the 
cyclodextrin proton signals.
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Figure 3.7. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 2.12 in pD 
7.8 ^-methanol at 25 °C of the region where crosspeaks are observed between axle 
proton signals.
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Figure 3.8. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 2.12 in pD 
7.8 ^-methanol at 25 °C of the region where crosspeaks are observed between the axle 
proton signals.
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Figure 3.9. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 2.12 in pD 
7.8 «^-methanol at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
The [2]-rotaxane 2.12 was next analysed at a pD of 11.0 to determine if the 
deprotonation of the secondary amines altered the position of the CD. The signals of the 
CD protons were firstly assigned using the DQCOSY spectrum of the CD region shown 
in Figure 3.10. The signals of the aromatic protons of the axle were again assigned using 
both DQCOSY and ROESY 2D NMR with their contour plots found in Figures 3.11 and 
3.12. The 'H ROESY contour plot found in Figure 3.13 shows crosspeaks between the
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signals of the axle and CD annular protons of the [2]-rotaxane 2.12. From the contour 
plot the signals of the D, E, F, G and H stilbene protons all show NOE interactions with 
those of the CD protons. From the NOE interactions the CD is positioned on the stilbene 
as shown in Figure 3.13. It follows that the deprotonation of the secondary amines by 
elevating the pD of the solution to 11.0 does not change the position of the CD from that 
determined for the neutral species at a pD of 7.8.
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Figure 3.10. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 2.12 in 
pD 11.0 ^-methanol at 25 °C of the region where crosspeaks are observed between the 
cyclodextrin proton signals.
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Figure 3.11. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 2.12 in 
pD 11.0 ^-methanol at 25 °C of the region where crosspeaks are observed between axle 
proton signals.
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Figure 3.12. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 2.12 in pD 
11.0 ^-methanol at 25 °C of the region where crosspeaks are observed between the axle 
proton signals.
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Figure 3.13. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 2.12 in pD 
11.0 ä^-methanol at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
Since the CD does not move as a result of adjusting the pD the [2]-rotaxane 2.12 
is not an acid-base controlled molecular shuttle. A pD study on the [2]-rotaxane 2.13 was 
not conducted as it was anticipated that this [2]-rotaxane would show analogous
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behaviour. Thus it was concluded that neither of the [2]-rotaxanes 2.12 nor 2.13 is 
suitable for use as either a photochemical or pH dependent molecular shuttle.
The difficulties with the photochemical isomerisation appear to stem from the use 
of the trinitrophenyl blocking groups. This conclusion is supported by the work of
on
Cieslinski, who reported the hermaphroditic [2]-rotaxane 3.4 as the basis of a molecular 
muscle, but found that upon irradiation it decomposed in preference to interconversion to 
and from the cis,cis form 3.5 (Scheme 3.3).
350 nm 254 nm
Scheme 3.3. Attempted isomerisation between the rrarcs,rrarc.s-hermaphroditic [2]- 
rotaxane 3.4 and its cis,cis form 3.5.
In light of these observations the use of the trinitrophenyl blocking group was 
abandoned. A related attempt to synthesise the hermaphroditic [2]-rotaxane 3.9, as shown 
in Scheme 3.4, was also abandoned when difficulties were encountered with the 
synthesis. The succinic acid 3.6 had been made according to the procedure by Onagi,57 
which had been coupled to the amine 1.30 using DMT-MM to give the hermaphroditic 
CD 3.7. Subsequent treatment with the blocking reagent 1.31 had resulted in the
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formation of two products which were tentatively identified using MALDI mass 
spectrometry as the hermaphroditic CD 3.8 and the hermaphroditic [2]-rotaxane 3.9. The 
dimer 3.9, however, was only formed in a trace amount. The attempt to complete the 
synthesis and undertake photolysis studies was therefore stopped.
Scheme 3.4. Attempted synthesis of the hermaphroditic [2]-rotaxane 3.9.
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In summary trinitrophenyl blocked [2]-rotaxanes were found to be unsuitable as 
photochemical molecular devices. Alternative blocking groups were therefore sought to 
produce CD [2]-rotaxanes as molecular shuttles and muscles.
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Chapter 4: 1,3-D ip o la r  Nitrile Oxide Cycloaddition in Attempted 
Synthesis of Hermaphroditic [2]-Rotaxanes
From the previous chapter, when the isomeric [2]-rotaxanes 2.12 and 2.13 were 
irradiated with light of various wavelengths, they did not undergo reversible 
isomerisation. It is thought that the trinitrophenyl groups interfere with the 
photochemistry of the stilbene unit. To overcome this problem, it was decided that 
alternative blocking groups would be investigated to attempt to synthesise a [2]-rotaxane 
with the ability to act as a molecular shuttle. One possibility that arose was the use of 
nitrile oxides in the capping of the [2]-rotaxanes.
When dipolarophiles in the form of alkenes or alkynes react with nitrile oxides 
they undergo [3+2] cycloadditions to form isoxazoles or 2-isoxazolines. ’ To construct 
a [2]-rotaxane using nitrile oxide cycloaddition chemistry a dipolarophile had to be 
attached to a CD binding group. Acryloyl chloride (4.1) was chosen to react with the 
diamine 1.30 to form a suitable substrate to undergo a cycloaddition reaction. After 
inclusion within aCD (1.15), the dipolarophile was expected to react with a nitrile oxide 
to form a [2]-rotaxane. The mesityl nitrile oxide 4.3 had previously been synthesised.*3’*4 
As a [2]-rotaxane had been synthesised using a 2,6-dimethylaniline blocking group, the 
orr/m-methyl groups of the mesityl group were expected to be sufficiently bulky to 
prevent dissociation of the CD from the cycloaddition product.
The diacrylamide 4.2 was synthesised by allowing the diamine 1.30 to react with 
the acid chloride 4.1 in DMF and TEA as shown in Scheme 4.1. The product was isolated 
in a yield of 71%. It was suspended in a solution of aCD (1.15) saturated MQ H2O and 
the mixture was stirred for a period of 24 hours to allow an inclusion complex to form. 
The nitrile oxide 4.3 was then added and the mixture was stirred for three days. However, 
none of the desired [2]-rotaxane 4.4 was detected. Only the 2-isoxazoline 4.5 was 
isolated.
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Scheme 4.1. Attempted synthesis of the [2]-rotaxane 4.4 using nitrile oxide cycloaddition 
chemistry.
To determine why the [2]-rotaxane 4.4 was not obtained, a !H NMR experiment 
was carried out on a 1:1 mixture of the diacrylamide 4.2 with aCD (1.15) in D2O. There 
were no signals belonging to the acrylamide 4.2 or its inclusion complex with ocCD (1.15) 
indicating that neither are present in solution to an appreciable extent. Various remedies 
were attempted to dissolve the acrylamide 4.2. The use of sonication in water and mixed 
solvent systems, however, both failed to produce the desired [2]-rotaxane 4.4.
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Despite these setbacks, the plan to use nitrile oxide cycloadddition to synthesise 
[2]-rotaxanes was not abandoned completely. The direct attachment of the stilbene and 
acrylamide units to the CD was considered, whereby the acid chloride 4.1 would be 
allowed to react with the hermaphroditic CD 4.6 to form the acrylamide 4.7. It was hoped 
that an hermaphroditic [2]-rotaxane would form when the activated alkene of the 
dimerically complexed hermaphroditic CD 4.7 underwent a cycloaddition reaction with 
the nitrile oxide 4.3. This hermaphroditic [2]-rotaxane would have the ability to act as a 
molecular muscle with the 2-isoxazoline unit acting as a secondary binding unit upon 
isomerisation of the stilbene units. This method was thought to be sound as the solubility 
of the acrylamide unit in water was expected to be increased by the attachment to a 
hydrophilic CD. This theory is supported by the work of Meyer et al., ’ who were able 
to synthesise 2-isoxazolines in water using an hermaphroditic CD acrylamide and phenyl 
based nitrile oxides. The likelihood of the acrylamide 4.7 forming a dimeric inclusion 
complex was supported by the work of Cieslinski et al. The hermaphroditic CD 4.6 had 
been previously synthesised and shown to form an hermaphroditic [2]-rotaxane upon 
reaction with the trinitrophenyl blocking reagent 1.31.
In the formation of the hermaphroditic CD 4.7, the free amine 4.6 was firstly 
synthesised according to the method of Cieslinski et a l m The hermaphroditic CD 4.6 was 
then dissolved in MQ fEO and allowed to react with the acid chloride 4.1 in the presence 
of TEA, to give the desired product 4.7 in 83% yield. To form an hermaphroditic [2]- 
rotaxane the dipolarophile 4.7 first had to form a dimeric inclusion complex. 2D 'l l  NMR 
experiments on a sample of the hermaphroditic CD 4.7 in D2O revealed that the dimeric 
inclusion complex 4.8 was formed as shown in Scheme 4.2.
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Scheme 4.2. Formation of the hermaphroditic cyclodextrin 4.7 and its dimeric inclusion 
complex 4.8 .
Formation of the inclusion complex 4.8 was established by firstly consulting the 
gHMQC NMR spectrum of the CD region of the contour plot shown in Figure 4.1. From 
the carbon resonances, the signal of the CD-C6-A carbon attached to the stilbene unit is 
distinguished from the signals belonging to the CD-C6-B to CD-C6-F carbons. The B to 
F carbon signals appear in the region 61.0 to 64.0 ppm, while the CD-C6-A signal 
appears downfield at 69.4 ppm. The stilbene is therefore connected to the CD with an 
ether linkage as an amine linkage, which might conceivably have resulted as an 
alternative product from reaction of the corresponding tosylate 1.19 with 4-amino-4’- 
hydroxystilbene, would be expected to shift the signal upfield to around 46.0 ppm. 
Crosspeaks are observable between the signal of the CD-C6-A carbon and the signals of 
the CD-H6-A protons. The identification of the signals of the CD-H6-A protons allows 
the signal of the aromatic stilbene protons closest to the CD to be assigned through
70
1,3-Dipolar Nitrile Oxide Cycloaddition in Attempted Synthesis of Hermaphroditic [2]-Rotaxanes
ROESY 2D NMR spectroscopy. The ROESY contour plot for the acrylamide 4.7 shown 
in Figure 4.3 shows NOE interactions between the signals of CD-H6-A and the stilbene 
protons A placing the A protons closest to the CD. This enables the signals of the stilbene 
unit to be fully assigned.
Figure 4.1. A section of the 500 MHz gHMQC spectrum of the hermaphroditic 
cyclodextrin 4.7 in D2O at 25 °C of the region where crosspeaks are observed between 
cyclodextrin proton and carbon signals.
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With the aromatic protons A signal assigned, the rest of the stilbene and 
acrylamide proton signals were distinguished using the ROESY contour plot shown in 
Figure 4.2, except that the E and F signals could not be distinguished as they both show 
interactions with the signals of the olefinic protons C and D.
The ROESY contour plot of the hermaphroditic CD 4.7 was used to establish the 
formation of a dimeric inclusion complex. The area that shows NOE interactions between 
the signals of the CD and those of the aromatic protons is shown in Figure 4.3. From the 
contour plot each of the signals of the stilbene protons A to F displays NOE interactions 
with signals that belong to the CD protons. An inclusion complex therefore forms 
between the CD and the stilbene unit. This inclusion complex exhibits symmetrical 
characteristics through the sharpness of the !H NMR signals. The complex can therefore 
be concluded to be dimeric as a non-dimeric binding mode would be non-symmetrical 
and result in a more complex spectrum. There are, however, no interactions between the 
signals of the vinyl protons and those of the CD. The vinyl group must therefore protrude 
from the secondary face of the CD. Therefore it was hoped that the protruding vinyl 
group would undergo a [3+2] cycloaddition reaction with the nitrile oxide 4.3 to form the 
hermaphroditic [2]-rotaxane 4 .9 .
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Figure 4.2. A section of the 500 MHz ROESY spectrum of the hermaphroditic 
cyclodextrin 4.7 in D2O at 25 °C of the region where crosspeaks are observed between 
axle proton signals.
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Figure 4.3. A section of the 500 MHz ROESY spectrum of the hermaphroditic 
cyclodextrin 4.7 in D2 O at 25 °C of the region where crosspeaks are observed between 
axle and cyclodextrin proton signals.
The formation of the hermaphroditic [2]-rotaxane 4 .9 , however, was not 
successful (Scheme 4.3). The hermaphroditic CD 4.7 was stirred in MQ H2 O to form the
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previously studied inclusion complex 4 .8 . Into the mixture, 1.1 equivalents of the nitrile 
oxide 4.3 dissolved in minimal DMF were then added drop-wise. After seven days there 
appeared to be none of the nitrile oxide 4.3 left in solution so a further 0.9 equivalents of 
the nitrile oxide 4.3 dissolved in DMF was added. After ten days the reaction was deemed 
complete when none of the dipolarophile 4.7 was observable by TLC. Work up of the 
mixture including using reverse phase HPLC gave two compounds 4.10 and 4.11. Each 
produced ESI mass spectra with ions of m/z 1230.4 and 1265.4. Neither of these 
corresponds to the mass expected for the hermaphroditic [2]-rotaxane 4.9 .
DMF/HoO
4.10 + 4.11
O HN NH Ck,
Scheme 4.3. Attempted synthesis of the hermaphroditic [2]-rotaxane 4.9 which instead 
resulted in the products 4.10 and 4.11.
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The ‘H NMR spectra of the products 4.10 and 4.11 in D2 O are shown in Figure 
4.4. These do not show signals of vinyl protons. New signals arise in the region 2.5 to 3.5 
ppm. One notable absence is any signal attributable to aromatic mesityl protons that 
would have been expected to appear in the vicinity of 7 ppm.
CD Proton Signals
No Aromatic Mesityl 
Proton Signals
New
Signals
No Vinyl Proton Signals
New
Signals
No Aromatic Mesityl 
Proton Signals
No Vinyl Proton Signals
8 7 6 5 4 3 ppm
Figure 4.4. 500 MHz 'H NMR spectra of the hermaphroditic cyclodextrin 4.7 and the 
cycloaddition products 4.10 and 4.11 in D2 O at 25 °C.
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The absence of signals of vinyl protons and appearance of new signals upfield 
implies the hermaphroditic [2]-rotaxane 4.7 has undergone reaction. However, the 
absence of any signal of mesityl aromatic protons along with the mass spectral data 
indicates that neither of the products contains the mesityl group. The ion of m/z 1265.4 
for each of the products 4.10 and 4.11 can be explained as the M+H+ ion formed by the 
addition of CO2 to the hermaphroditic CD 4.7. The products 4.10 and 4.11 therefore may 
be regioisomers formed by cycloaddition followed by retro-cycloaddition or 
decomposition but the exact structures have not been determined. In any event it is clear 
that an hermaphroditic [2]-rotaxane was not formed.
Despite the exact structures not being able to be determined, through 2D NMR 
spectroscopy it was established that the products 4.10 and 4.11 are some form of 
hermaphroditic CD. Both the products contain stilbene units that form dimeric inclusion 
complexes in D2O but not in ^-methanol or d6-DMSO.
In conclusion, the expected hermaphroditic [2]-rotaxane 4.9 was not formed by 
the [3+2] cycloaddition of the dipolarophile 4.7 with the nitrile oxide 4.3. The !H NMR 
spectra of the products 4.10 or 4.11 did not contain signals of aromatic mesityl protons 
which, along with their respective mass spectral data and 2D NMR spectra pointed 
towards an undesired decomposition or retro-cyclisation to form regioisomeric 
hermaphroditic CD by-products. The attempted synthesis of an hermaphroditic [2]- 
rotaxane using 1,3-dipolar nitrile oxide cycloaddition chemistry was therefore abandoned. 
Alternative methods were explored to produce a [2]-rotaxane.
77
Chapter 4
78
A Photochemically Activated Hermaphroditic Cyclodextrin Switch for the Transport of Methyl
Orange
Chapter 5: A Photochemically Activated Hermaphroditic
Cyclodextrin Switch for the Transport of Methyl Orange
From the work in Chapter 4 the attempted synthesis of the hermaphroditic [2]- 
rotaxane 4.9 proved unsuccessful using cycloaddition chemistry. The hermaphroditic [2]- 
rotaxane 4.9 would have had the potential to act as a molecular device in the form of a 
muscle. It has been previously shown that hermaphroditic CDs have other uses. In work 
by Coulston,87 hermaphroditic CDs were used in the transport of methyl orange (5.8) 
along an HPLC column. In the work described in this chapter the possibility of an 
hermaphroditic CD based on the previously synthesised hermaphroditic CD 4.6 was 
explored for use as a similar molecular transport.
Previously, Coulston used pCD (1.16) to produce the cinnamide 5.1(E). Upon 
irradiation with light of wavelength 300 nm, the trans-olefinic bond isomerised to give 
the ds-cinnamide 5.1(Z) as shown in Scheme 5.1. This reaction was reversed by 
irradiation with 254 nm light, a deuterium arc lamp (190 nm -  600 nm), or addition of 
iodine with a sunlight lamp. Using the Hummel and Dryer method88 described below, as 
exploited by Croft el a/.,89 each of the isomers 5.1(E) and 5.1(Z), along with natural ßCD 
(1.16), was tested for their association constant (A'a) with the dye 5.8 using HPLC. 
Because in the HPLC study, the dye 5.8 is bound to the CD and carried through the 
column faster than normally would be the case, the association constant can be viewed as 
a molecular transport coefficient (K). Different values of the transport coefficient then 
depict different hosts’ abilities to transport the dye 5.8 through the HPLC column. From 
the study by Coulston,87 the trans-isomer 5.1(E) was revealed to have a transport 
coefficient of 2385 ± 169 dm3 mol'1, the ds-isomer 5.1(Z) had a value of 618 ± 46 dm3 
m of1 and ßCD (1.16) a value of 3790 ± 228 dm3 m ol1. While the fra/w-isomer 5.1(E) 
had a lower transport coefficient than the natural ßCD (1.16), the value for the cis-isomer 
5.1(Z) was much lower, which was suggested to be due to self inclusion of the cinnamoyl 
group. The isomerisation between the trans-isomer 5.1(E) and the ds-isomer 5.1(Z) 
acted as a molecular switch for the transport of the dye 5.8.
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Scheme 5.1. Reversible isomerisation of the /rarcs-cinnamide 5.1(E) and the cis-isomer 
5.1(Z) reported by Coulston.87
In the present work stilbene-substituted CDs were investigated for the transport of
orv
the dye 5.8. Cieslinski, had prepared the stilbene based hermaphroditic CDs 5.2(E) and 
5.2(Z) and shown their interconversion upon photolysis as illustrated in Scheme 5.2. The 
rra/is-isomer 5.2(E) formed the dimeric inclusion complex 5.3 while the cis-isomer 
5.2(Z) did not form an inclusion complex leaving the CD annulus free to potentially 
complex a guest. Systems of this type were thought to be good candidates for new 
molecular transport devices. It was expected that the c/s-isomers would have transport 
coefficients for the dye 5.8 similar to that of aCD (1.15) while the tra/rs-isomers would 
have significantly lower coefficients due to the dimeric inclusion.
The specific system chosen was based on the hermaphroditic CD 4.6 described in 
Chapter 4. The hermaphroditic CD 4.6 was acylated to avoid ionisation of the amino 
group which might have affected guest binding. The reaction scheme is found in Scheme 
5.3. The acetamide 5.5(E) was isolated in a yield of 53% and its ESI mass spectrum 
showed an M+H+ ion at m/z 1208.0.
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INCLUSION
COMPLEX
Scheme 5.2. Reversible isomerisation of the mms-stilbene-based hermaphroditic 
cyclodextrin 5.2(E) and the cis-isomer 5.2(Z) where the trans-'isomev 5.2(E) forms the 
dimeric inclusion complex 5.3 while the ds-isomer 5.2(Z) does not form a complex.
Scheme 5.3. Formation of the acetamide 5.5(E).
2D NMR spectroscopy showed that the acetamide 5.5(E) formed a dimeric 
inclusion complex in D2O. The assignment of the signals of the stilbene unit only 
required the ROESY contour plot shown in Figure 5.1. From the ROESY contour plot in 
Figure 5.2, crosspeaks between each of the signals of the stilbene protons with those of
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the CD protons established the formation of an inclusion complex. The inclusion complex 
is assumed to be a symmetrical dimer for a variety of reasons. The stilbene cannot be 
self-included as its long rigid structure would prevent this. Any non-symmetrical 
complex would result in a more complicated !H NMR spectrum, and the dimer is likely 
to be the most favoured symmetrical complex in entropy terms. Finally, the 
hermaphroditic CD 4.6, upon which the synthesis of the acetamide 5.5(E) is based, has 
been previously shown by Cieslinski to form an hermaphroditic [2]-rotaxane upon 
reaction with the trinitrophenyl blocking reagent 1.31.
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Figure 5.1. A section of the 500 MHz ROESY spectrum of the acetamide 5.5(E) in D2O 
at 25 °C of the region where crosspeaks are observed between stilbene proton signals.
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Figure 5.2. A section of the 500 MHz ROESY spectrum of the acetamide 5.5(E) in D2O 
at 25 °C of the region where crosspeaks are observed between stilbene and cyclodextrin 
proton signals.
The acetamide 5.5(Z) was then formed by the photoisomerisation of the 
acetamide 5.5(E) using light of wavelength 350 nm as shown in Scheme 5.4. The 
irradiation wavelength was determined from the UV/visible spectrum of the trans-isomer
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5.5(E) as illustrated in Figure 5.5. As noted previously, photoexcitation of a trans- 
stilbene at a wavelength at or near its maximum absorbance results in the formation of the 
ds-isomer. A 350 nm light source was used as it was the closest available wavelength to 
the ^max of the trans-isomer 5.5(E) at 338 nm. At 350 nm absorption of light by the cis- 
isomer 5.5(Z) and its isomerisation was expected to be limited. Initially irradiation of a 
3.55 x 102 M solution of the acetamide 5.5(E) gave the ds-isomer 5.5(Z) which was 
isolated in a yield of 19%. The HI-RES ESI mass spectrum of another product showed a 
peak that corresponds to the M+Na+ ion of m/z 2438.8257 of the dimer 5.6. It is assumed 
that a [2+2] photocyclisation of the olefinic bonds of two separate stilbene units forms a 
mixture of isomers of the dimer 5.6. It was thought that the formation of the dimer 5.6 
was due to the concentrated solution allowing two molecules to come into contact. The 
irradiation of the acetamide 5.5(E) with 350 nm light was therefore repeated at a lower 
concentration of 2.51 x 105 M. Under these conditions the ds-isomer 5.5(Z) was then 
isolated in a yield of 40%.
5.5(Z)
i) 3 h 350 nm, 25% aq MeCN, 3.55 x 10'2 M
Scheme 5.4. Isomerisation of the acetamide 5.5(E) with 350 nm light to form the cis- 
isomer 5.5(Z) and the dimeric by-product 5.6.
The complexation characteristics of the acetamide 5.5(Z) were then determined 
using 2D NMR spectroscopy. The 2D NMR ROESY contour plot in Figure 5.3 was
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firstly used to assign the signals of the stilbene unit. From the ROESY contour plot in 
Figure 5.4, crosspeaks between the signals of the CD and stilbene protons were used to 
determine if the acetamide 5.5(Z) formed an inclusion complex. The only crosspeaks 
visible were between the signal of the stilbene protons A and the signals of the CD 
protons. The ROESY interactions arise due to the vicinity of the CD-H6 protons to the 
stilbene unit as a result of their ether connection. The cA-isomer 5.5(Z) therefore does not 
form a CD inclusion complex.
A B
E, F
( p p m ) -
6 . 4 -
6 . 5 -
6 . 6 -
6 . 7 -
6 . 8 -
6 . 9 -
7 . 0 -
" 7 . 3 - :
7 . 4 -
7 . 5 t
7 . 6 -
Figure 5.3. A section of the 500 MHz ROESY spectrum of the acetamide 5.5(Z) in D2O 
at 25 °C of the region where crosspeaks are observed between stilbene proton signals.
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Figure 5.4. A  section o f the 500 MHz ROESY spectrum of the acetamide 5.5(Z) in D2O 
at 25 °C o f the region where crosspeaks are observed between stilbene and cyclodextrin 
proton signals.
The complexation characteristics o f the acetamides 5.5(E) and 5.5(Z) are 
summarised in Scheme 5.5. The trans-isomer 5.5(E) forms a dimeric inclusion complex. 
The conformation o f the stilbene unit o f the c/s-isomer 5.5(Z) prevents any inclusion 
complex from forming. Before the isomerisation between the acetamide 5.5(E) and the
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ds-isomer 5.5(Z) could be labelled a switch and each of the isomers tested for their 
ability to act as a molecular transport, the reversibility of the interconversion between the 
isomers had to be measured.
350 nm
INCLUSION
COMPLEX
Scheme 5.5. Isomerisation of the fra/is-stilbene-based hermaphroditic cyclodextrin 
5.5(E), which forms the dimeric inclusion complex 5.7, to the ds-isomer 5.5(Z) which 
does not form a complex.
The reversibility of the interconversion between the acetamides 5.5(E) and 5.5(Z) 
was measured using reverse-phase HPLC and UV/visible spectroscopy. Firstly the 
irradiation wavelengths were determined for each of the isomers. The frans-isomer 5.5(E) 
was irradiated at wavelength 350 nm to produce the ds-isomer 5.5(Z) as discussed above. 
To determine the irradiation wavelength to use with the ds-isomer 5.5(Z), its UV/visible 
spectrum was examined and is shown as the black line in Figure 5.7. The spectrum shows 
a 7,max at 298 nm. The wavelengths of light available closest to this ?imax were 254 nm and 
350 nm. The light of wavelength 254 nm was used to irradiate the ds-isomer 5.5(Z). At 
254 nm, the absorption of light by the frans-isomer 5.5(E) and its isomerisation was 
expected to be less than that for the ds-isomer 5.5(Z).
The UV/visible spectra and HPLC traces of a 2.48 x 105 mol dm 3 solution of the 
acetamide 5.5(E) before and after irradiation with light of wavelengths 350 nm and 254
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nm are found in Figures 5.5 and 5.6 respectively. From its HPLC trace, the peak 
corresponding to the acetamide 5.5(E) has a retention time of 17.7 minutes. The c/s- 
isomer 5.5(Z) was made up to a concentration of 1.65 x 103 mol dm 3 in MQ H20  and its 
UV/visible spectra and HPLC traces before and after irradiation with light of wavelengths 
254 nm and 350 nm were recorded and are shown in Figures 5.7 and 5.8 respectively. 
From its HPLC trace, the peak corresponding to the acetamide 5.5(Z) has a retention time 
of 20.5 minutes.
From the study it was apparent that the irradiation of the acetamide 5.5(E) with 
light of wavelength 350 nm produced the c/s-isomer 5.5(Z). In the UV/visible spectra, the 
absorbance at 338 nm corresponding to the trans-isomer 5.5(E) decreases after the 
irradiation. The irradiated solution has a maximum absorbance at 298 nm corresponding 
to the cfs-isomer 5.5(Z). The irradiation of the c/s-isomer 5.5(Z) with light of wavelength 
254 nm produced the trans-isomer 5.5(E). From the UV/visible spectra, upon irradiation, 
the absorbance at 338 nm increased corresponding to the formation of the /rans-isomer 
5.5(E). Thus it was established that the interconversion between the acetamides 5.5(E) 
and 5.5(Z) is reversible. The basis of a photochemical switch mechanism had therefore 
been established. The next step was to investigate whether the change in the 
conformation of the stilbene unit between the acetamide 5.5(E) and the c/s-isomer 5.5(Z) 
was able to fulfil the purpose of a machine to do work on a guest for the transport of the 
dye 5.8 through a HPLC column.
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-----2 m 350 nm
-----2 m 254 nm
Wavelength (nm)
Figure 5.5. UV/visible spectra of the acetamide 5.5(E) [2.48 x 105 M l in MQ H2O and 
after subsequent exposure to 350 and 254 nm light after periods o f time as indicated in 
the graph.
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Figure 5.6. Reverse-phase HPLC chromatograms of the acetamide 5.5(E) [2.48 x 105 M] 
in MQ FPO and after subsequent exposure to 350 and 254 nm light after periods o f time 
as indicated in the graph. The spectra in the insert are offset horizontally by 0.5 minutes 
and vertically by 0.005 AU for clarity.
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Figure 5.7. UV/visible spectra o f the acetamide 5.5(Z) [1.65 x 105 M ] in MQ H 2O and 
after subsequent exposure to 254 and 350 nm light after periods o f time as indicated in 
the graph.
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Figure 5.8. Reverse-phase HPLC chromatograms of the acetamide 5.5(Z) [1.65 x 105 M ] 
in MQ FFO and after subsequent exposure to 254 and 350 nm light after periods of time 
as indicated in the graph. The spectra in the insert are offset horizontally by 0.5 minutes 
and vertically by 0.002 AU for clarity.
0.004-
0 .000 -
J I |
L__________ A ....
^  A  _______J L
18.00 20.00
Minutes
22.00
—  5.5(Z)
—  1 m  254 nm
—  1 m  350 nm
90
A Photochemically Activated Hermaphroditic Cyclodextrin Switch for the Transport of Methyl
Orange
To test their ability to act as molecular transports, the transport coefficients of 
each of the acetamides 5.5(E) and 5.5(Z) along with otCD (1.15) for the dye 5.8 were 
calculated. The transport coefficients were obtained using the Hummel and Dryer 
method,88 as adapted by Croft et a/.89 In the method, a solution of the dye 5.8 of a known 
concentration is pumped through an HPLC column. A solution of one of the CDs 1.15, 
5.5(E) or 5.5(Z) is then injected through the same HPLC column. As seen in the HPLC 
trace in Figure 5.9, binding of the dye 5.8 with the CDs 1.15, 5.5(E) or 5.5(Z) results in a 
positive peak. The CDs 1.15, 5.5(E) and 5.5(Z) have shorter retention times than the dye
5.8 under the conditions of the HPLC run and cause the bound dye 5.8 to be carried at a 
faster rate through the HPLC column than the unbound dye 5.8. When the CD bound dye
5.8 passes off the HPLC column there is an increased local amount of the UV active dye
5.8 and a positive peak in the HPLC trace. Due to the binding of the dye 5.8 to the CD a 
void of the dye 5.8 is left on the column which results in a negative peak later in the 
HPLC trace. The molar amount of the dye 5.8 transported by the CD is then determined 
by comparing with a blank injection of borate buffer. Plotting the molar ratio (F) of guest 
bound to host injected against r/[guest] in a Scatchard plot90 enabled the transport 
coefficient (K) for each of the CDs 1.15, 5.5(E) and 5.5(Z) for the dye 5.8 to be 
determined.
0.12 •
0 . 1 0 -
Positive Peak 
(Host-Guest Complex)
0.08 •
0.06 •
0.04 •
0.02
- 0 . 02 -
Negative Peak 
(Guest Void)
- 0 .04 -
- 0 . 06 -
- 0 .08 -
9.00 10.00
M inutes
Figure 5.9. Example of a reverse-phase HPLC chromatogram at 450 nm of a cyclodextrin 
in a solution of the dye 5.8.
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The Scatchard plots for aCD (1.15) and the acetamides 5.5(E) and 5.5(Z) are
represented in a combined graph in Figure 5.10. The transport coefficients of each of the
CDs 1.15, 5.5(E) and 5.5(Z) for the dye 5.8 are extrapolated from the y-intercepts of the
plots and are summarised in Table 5.1. In the Scatchard plots, there are variations of the
points at lower concentrations of the dye 5.8 (closest to the y-axis) from the lines of best
fit. These errors are due to fluctuations created by the limited sensitivity for the detection
of the dye 5.8 at low concentrations by the diode array detector of the HPLC. The
transport coefficient of aCD (1,15) for the dye 5.8, however, was calculated as 7900 dm3
mof which is comparable to literature values ranging from 6200 to 11700 dm mof
determined using other methods.9195 Before the study was undertaken it was anticipated
that due to the dimeric complex observed in the 2D NMR study of the acetamide 5.5(E),
its ability to bind the dye 5.8 would be diminished in comparison to aCD (1.15). The
transport coefficient of the acetamide 5.5(E) was calculated at 2800 dm3 m of1 which is
almost three times lower than that of unmodified aCD (1.15). As the acetamide 5.5(Z)
seK -
was shown to not form a inclusion complex, it was expected that the ability to bind the
A
dye 5.8 would be larger in comparison to the /rans-isomer 5.5(E). Due to the substitution 
of the CD, however, the transport coefficient of the c/s-isomer 5.5(Z) was expected to be 
comparable but lower than the unhindered aCD (1.15). The result obtained was very 
surprising with the transport coefficient of the acetamide 5.5(Z) for the dye 5.8 calculated 
to be 30300 dm3 m o l1 which is approximately four times greater than for aCD (1.15). 
The conformations of the stilbene units of the acetamides 5.5(E) and 5.5(Z) therefore 
have a large bearing on the ability to transport of the dye 5.8 along the HPLC column. 
Further investigation was needed to explain why the binding of the acetamide 5.5(Z) for 
the dye 5.8 was so strong.
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Figure 5.10. Scatchard plots for the dye 5.8 with aCD (1.15) and the acetamides 5.5(E) 
and 5.5(Z).
Cyclodextrin Transport Coefficient (K )  (drn^ m o l1)
otCD (1.15) 7900
5.5(E) 2800
5.5(Z) 30300
Table 5.1. Transport coefficients of the dye 5.8 by otCD (1.15), the acetamides 5.5(E) and 
5.5(Z) from the Scatchard plots in Figure 5.10.
To investigate the increased binding of the dye 5.8 by the acetamide 5.5(Z), 
ROESY 2D NMR spectroscopy was conducted on an equimolar solution of the acetamide 
5.5(Z) and the dye 5.8 to identify any possible reasons for the unusual result. The 
ROESY contour plot of the aromatic region is shown in Figure 5.11. From the ten signals 
resulting from both the stilbene (A-F) and azobenene (AZO) proton signals, only those of
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the c/s-stilbene were assigned. The signals of the stilbene unit were assigned through 
interactions with the signals of the olefinic protons C and D which arise as one singlet at 
6.33 ppm. The remaining signals are a result of the protons of the azobenzene of the dye 
5.8. From the ROESY contour plot in Figure 5.11 there are no identifiable NOE 
interactions between the signals of the stilbene and azobenzene protons that would 
signify a reason for the increased binding of the dye 5.8 for the acetamide 5.5(Z).
The ROESY contour plot in Figure 5.12 shows interactions between the signals of 
the CD protons and those of the aromatic protons. It was determined above that the 
stilbene of the acetamide 5.5(Z) is not included. With no stilbene inclusion within the 
CD, the crosspeaks observed between the signals of the CD protons and the signals of the 
azobenzene protons of the dye 5.8 were anticipated. Interestingly, there are interactions 
observable between the signals of the N-methyl protons of the dye 5.8 and each of the 
signals of the c/s-stilbene protons. The proximity of the TV-methyl protons with the 
stilbene unit may arise as a result of a secondary binding interaction between the units. 
Presumably the secondary interactions create a cooperative binding effect to stabilise the 
inclusion complex and increase the transport coefficient.
The ROESY 2D NMR spectrum of the acetamide 5.5(E) in DiO with an added 
equivalent of the dye 5.8 was then studied. It had previously been determined from the 
HPLC transport assay that the dye 5.8 was limited in including within the CD due to the 
acetamide 5.5(E) favouring a much stronger dimeric inclusion complex. From the 
ROESY contour plot shown in Figure 5.13, only NOE crosspeaks between the signals of 
the stilbene protons and those of the CD protons arise, confirming that the dye 5.8 does 
not displace the stilbene from the CD. The dimeric inclusion complex of the acetamide 
5.5(E) is therefore much stronger than its binding for the dye 5.8. This strong dimeric 
inclusion complex would result in a reduced transport coefficient for the dye 5.8 by the 
acetamide 5.5(E).
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Figure 5.11. A section of the 500 MHz ROESY spectrum of the acetamide 5.5(Z) with 
the dye 5.8 in D2O at 25 °C of the region where crosspeaks are observed between 
aromatic proton signals.
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Figure 5.12. A section of the 500 MHz ROESY spectrum of the acetamide 5.5(Z) with 
the dye 5.8 in D2O at 25 °C of the region where crosspeaks are observed between 
aromatic proton signals and cyclodextrin or /V-methyl proton signals.
96
A Photochemically Activated Hermaphroditic Cyclodextrin Switch for the Transport of Methyl
Orange
CD-H2 - CD-H6
6 . 4 - j
6 . 6 -;
6 . 8 -
O  o  O
7. 4- :
7 . 6 i
< ^ 2 >^ — -  -
8 . 0 i
4 . 2  4 . 0  3 . 8  3 . 6  3 . 4  3 . 2  3 . 0  2 . 8  2 . 6  2 . 4  2 . 2  2 . 0
P I  (ppm)
Figure 5.13. A section of the 500 MHz ROESY spectrum of the acetamide 5.5(E) with 
the dye 5.8 in D2O at 25 °C of the region where crosspeaks are observed between 
aromatic proton signals and cyclodextrin or A-methyl proton signals.
The conditions, however, for each of the NMR experiments differ from the HPLC 
study in terms of the concentrations at which they are able to be undertaken. An increased 
concentration is required for NMR spectroscopy that may result in exaggerated binding
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effects. Inclusion complex formation is concentration dependent which would increase 
the likelihood of the acetamide 5.5(E) forming a dimeric inclusion complex in the NMR 
spectroscopy study than at the lower concentration of the HPLC study. Nevertheless, the 
NMR study can be used as a strong guide to the behaviour of the acetamide 5.5(E) as a 
dimeric inclusion complex is likely to have formed in the HPLC study to reduce its 
transport coefficient with the dye 5.8.
An hermaphroditic CD molecular switch has therefore been constructed which 
can be powered through photochemical energy. The binding characteristics for the 
acetamides 5.5(E) and 5.5(Z) for the dye 5.8 are summarised in Scheme 5.6. Light of 
wavelength 350 nm has been shown using UV/visible spectroscopy, NMR spectroscopy 
and HPLC to convert the acetamide 5.5(E) to the ds-isomer 5.5(Z). This reaction is 
reversible through irradiation with light of wavelength 254 nm. The acetamide 5.5(E) 
forms the dimeric inclusion complex 5.7 to hinder the transport of the dye 5.8 while the 
ds-isomer 5.5(Z) allows the dye 5.8 to include facilitating its transport. The ROESY 2D 
NMR spectrum of the acetamide 5.5(Z) with the dye 5.8 also shows NOE interactions 
between the signals of the A-methyl protons of the dye 5.8 and those of the ds-stilbene 
unit that may be the result of a secondary interaction that increases the transport 
coefficient of the ds-isomer 5.5(Z) for the dye 5.8.
254 nm 350 nm
5.5(Z) + 5.8
Scheme 5.6. Operation of a photochemically switchable device for the transport of 
methyl orange (5.8).
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Chapter 6: Synthesis of a-Cyclodextrin [2]-Rotaxanes Using 
Methoxytriazine Blocking Groups
In the work described in Chapter 2 it was shown that [2]-rotaxanes with ditopic 
axles containing stilbenes are able to be made using trinitrophenyl blocking groups. 
These molecules are unable to photochemically interconvert been their trans- and cis- 
isomers to act as molecular shuttles due to interference of the trinitrophenyl blocking 
groups. In an attempt to find alternative blocking groups to construct a [2]-rotaxane 
molecular shuttle, nitrile oxide cycloaddition chemistry was used but proved 
unsuccessful. A different approach was therefore sought using a triazine as a blocking 
reagent to form [2]-rotaxanes.
In the related synthesis conducted by Kunitake et al.,96 shown in Scheme 6.1, 
2,4,6-trichloro-l,3,5-triazine (6.1) was substituted with the naphthalene 6.2 to produce 
the triazine 6.3 . Upon addition to a solution of the HC1 salt of the stilbene 1.30 and ßCD 
(1.16), followed by the addition of aniline (6.4), the triazinyl [2]-rotaxane 6.5 was 
formed. Due to the success of this strategy, tests were undertaken to see if this could be 
applied in the synthesis of [21-rotaxanes and hermaphroditic [2]-rotaxanes that would act 
as molecular shuttles and muscles. Small modifications were made to adapt the synthesis 
to install some preferred features. The CD was changed from ßCD (1.16) to ocCD (1.15) 
as aCD (1.15) has a much larger affinity for stilbenes.68 The methoxy-substituted 
triazines 6.6 and 6.9 were commercially available and used in the reactions.
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NaHCO
1. NaHCO
Scheme 6.1. Formation of the triazine capped [2]-rotaxane 6.5 as reported by Kunitake et 
a l96
The methoxytriazine 6.6 was used first as shown in Scheme 6.2. To a stirred 
suspension of the stilbene 1.30 and aCD (1.15) in MQ H2O, the triazine 6.6 was added. 
The triazinyl [2]-rotaxane 6.7 was isolated from the reaction mixture in a yield of 20% 
and its HI-RES ESI mass spectrum showed an M+Na+ ion of m/z 1491.3960.
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1.H20, TEA, rt, 2 h 
2. 6.6, rt, 16 h
Scheme 6.2. Formation of the [2]-rotaxane 6.8.
With the [2]-rotaxane 6.7 in hand, 2D NMR spectroscopy was used to determine 
the position of the CD on the axle. The CD proton signals were firstly assigned from the 
DQCOSY contour plot found in Figure 6.1. The signals of the stilbene unit of the [2]- 
rotaxane 6.7 were then assigned using both the DQCOSY and ROESY 2D NMR spectra 
shown in Figures 6.2 and 6.3.
Crosspeaks between the signals of the CD and stilbene protons were then sought 
in the ROESY contour plot shown in Figure 6.4. As the study was conducted in d<j-
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DMSO which does not favour CD inclusion complexes, any crosspeaks between the 
signals would indicate the formation of a [2]-rotaxane. In the plot, NOE interactions are 
visible between each of the signals of the stilbene protons with the signals of the CD 
protons. The signal of the aromatic protons C shows interactions with those of the CD-H6 
protons indicating the aromatic protons reside at the primary face of the CD. The signals 
of the protons G and H show interactions with those of the CD-H3 and CD-H5 protons 
indicating the protons G and H reside at the secondary face of the CD. The structure of 
the [2]-rotaxane 6.7 can therefore be drawn as shown in Figure 6.4.
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Figure 6.1. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 6.7 in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals.
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Figure 6.2. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 6.7 in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between stilbene proton 
signals.
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Figure 6.3. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 6.7 in d(,~ 
DMSO at 25 °C of the region where crosspeaks are observed between stilbene proton 
signals.
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Figure 6.4. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 6.7 in d ^  
DMSO at 25 °C of the region where crosspeaks are observed between stilbene and 
cyclodextrin proton signals.
While the triazinyl [2]-rotaxane 6.7 was formed it appeared it was not entirely 
stable. This was evident by the formation of a decomposition product as noted by extra 
signals appearing in the 'H NMR spectrum. Over the course of several days the signals 
resulting from the protons of the [2]-rotaxane 6.7 disappeared. Assuming this was due to 
the reactivity of the chlorotriazine moiety a final substitution was therefore performed on
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the [2]-rotaxane 6.7 with aniline (6.4) to form the aniline substituted [2]-rotaxane 6.8 as 
detailed in Scheme 6.2. The [2]-rotaxane 6.8 was isolated in a yield of 33% and its HI-
RES ESI mass spectrum showed an M+H+ ion of m/z 1583.3780.
2D NMR spectroscopy was then conducted on the [2]-rotaxane 6.8 to assign its 
signals. Using the DQCOSY contour plot shown in Figure 6.5, the signals of the CD 
protons were assigned as depicted.
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Figure 6.5. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 6.8 in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals.
106
Synthesis of a-Cyclodextrin [2]-Rotaxanes Using Methoxy triazine Blocking Groups
The axle proton signals were then assigned from a combination of both the 
DQCOSY and ROESY contour plots shown in Figures 6.6 and 6.7. The signals of the 
aniline protons A, B, C, P, Q and R at either end of the [2]-rotaxane 6.8 were able to be 
assigned through their integration and DQCOSY interactions. The remaining signals of 
the stilbene protons were assigned through their DQCOSY and ROESY interactions.
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Figure 6.6. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 6.8 in d(,~ 
DMSO at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
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Figure 6.7. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 6.8 in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
The ROESY contour plot in Figure 6.8 shows crosspeaks between the signals of 
the CD protons and those of the stilbene protons. The signals of the aniline protons show 
no interaction with the CD. Their three relatively sharp signals are due to their chemical
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equivalence in not being associated with the CD. The signal of the aromatic protons H 
shows an interaction with the signal of the CD-H6 protons while the signals of the 
olefinic protons I and J do not. This places the CD on the axle as shown in Figure 6.8. 
From the plot there is therefore no change in the CD binding as a result of the final 
substitution of the triazine ring with the amine 6 .4 .
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Figure 6.8. A section of the 600 MHz DQCOSY spectrum of the [2]-rotaxane 6.8 in d<r 
DMSO at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
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An alternative one step procedure was investigated to form a triazinyl [2]- 
rotaxane, in which the dimethoxytriazine 6.9 was used as the blocking reagent. The 
reaction scheme is illustrated in Scheme 6.3. The [2]-rotaxane 6.10 was isolated in 4.8% 
yield and its HI-RES ESI mass spectrum showed an M+Na+ ion of m/z 1461.5141.
HoN
1.30
1.H20 , TEA, rt, 2 h 
2. 6.9, rt, 16 h
OMe
N=<
Cl^  /7N
OMe
6.9
Scheme 6.3. Formation of the dimethoxytriazinyl [2]-rotaxane 6.10.
The 'l l  NMR assignment using 2D NMR spectroscopy on the [2]-rotaxane 6.10 
was carried out by firstly assigning the signals of the CD protons from the DQCOSY 
contour plot shown in Figure 6.9.
Next examining the aromatic region of the ROESY contour plot in Figure 6.10, 
the signals of the stilbene protons were assigned. In previous assignments the DQCOSY 
spectrum was also consulted but in this case it was not required.
From the ROESY NMR contour plot shown in Figure 6.11, the position of the CD 
on the stilbene unit of the [2]-rotaxane 6.10 was assigned. The signals of the olefinic 
protons E and F show strong interactions with the signals of the CD-H5 protons and weak 
interactions with the signals of the CD-H3 protons. This places the olefinic protons 
centrally within the CD annulus. The signal of the aromatic protons D shows interactions 
with the signals of the CD-H5, CD-H6A and CD-H6B protons. This places this part of the
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stilbene at the primary face of the CD. Therefore the structure of the [2]-rotaxane 6.10 
can be drawn as shown in Figure 6.11.
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Figure 6.9. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 6.10 in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals.
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Figure 6.10. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 6.10 in df,- 
DMSO at 25 °C of the region where crosspeaks are observed between stilbene proton 
signals.
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Figure 6.11. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 6.10 in d$- 
DMSO at 25 °C of the region where crosspeaks are observed between stilbene and 
cyclodextrin proton signals.
In summary, the synthesis of the [2]-rotaxanes 6.7 , 6.8 and 6.10 provides a means 
to produce a [2]-rotaxane with an alternative blocking group to the trinitrophenyl 
systems. The structures as a result of their 2D NMR assignment are shown in Figure 6.12.
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6.8
J
6.10
Figure 6.12. Structures of the [2]-rotaxanes 6.7, 6.8 and 6.10 determined through 2D 'H 
NMR spectral assignment.
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Chapter 7: Isomeric Dimethoxytriazine Blocked [2]-Rotaxanes that 
Act as Molecular Shuttles
The synthesis of the new triazine blocked [2]-rotaxanes 6.7 , 6.8 and 6.10 provides 
alternatives to the use of the trinitrophenyl blocking reagent 1.31 used previously. 
Triazine blocking groups were therefore used in the synthesis of potential molecular 
shuttles and muscles. From the previous chapter it was observed that the stability of the 
dichloro-[2]-rotaxane 6.7 came into question. A further substitution with the amine 6.4 
was required to form the [2]-rotaxane 6.8 to prevent any decomposition. The synthesis of 
the [2]-rotaxane 6.10 was completed in one step with no such complications. Despite the 
lower yield for the reaction using the triazine blocking reagent 6.9 to form the [2]- 
rotaxane 6.10, as the product of the reaction was more stable the triazine 6.9 was used in 
the syntheses detailed in this chapter.
An axle suitable for the synthesis of a simple shuttle system was therefore 
required. The ditopic diamine 2.11, whose synthesis was described in Chapter 2, was 
deemed ideal to produce a [2]-rotaxane with the potential to act as a simple molecular 
shuttle. The synthetic scheme for the formation of the [2]-rotaxanes 7.1 and 7.2 is shown 
in Scheme 7.1. The diamine 2.11 was stirred in MQ FEO with aCD (1.15) before the 
triazine blocking reagent 6.9 was added. The [2]-rotaxanes 7.1 and 7.2 were determined 
to be formed in a ratio of 69:31, using HPLC, and were isolated in yields of 3.4% and 
1.3% respectively. The formation of the [2]-rotaxanes 7.1 and 7.2 was confirmed by ESI 
mass spectroscopy where they each produced M+H+ ions of m/z 1594.5 in their mass 
spectra.
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Scheme 7.1. Formation of the [2]-rotaxanes 7.1 and 7.2 .
The isomeric [2]-rotaxanes 2.12 and 2.13 differ in the orientation of the CD on the 
axle. The orientation of the CD was determined using ROESY 2D NMR spectroscopy 
where NOE interactions between the signals of the CD annular protons and the signals of 
the axle protons arise as crosspeaks in the contour plot. 2D NMR spectroscopy was 
conducted on each of the [2]-rotaxanes 7.1 and 7.2 to confirm that they were also 
orientational isomers.
Firstly, in the assignment of the signals of the [2]-rotaxane 7.1, those of the CD 
protons were assigned as in the previous chapters. The DQCOSY spectrum was used with 
the contour plot of the CD region shown in Figure 7.1. The initial assignment of the 
signal of the CD-H1 protons located at 4.75 ppm was made according to the literature
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review by Schneider et al.11 DQCOSY interactions between the signals of neighbouring 
protons of the CD enable the signals to be assigned as shown in Figure 7.1.
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Figure 7.1. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 7.1 in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals.
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Using both DQCOSY and ROESY NMR spectroscopy, the signals of the axle of 
the [2]-rotaxane 7.1 were then assigned. A section of the DQCOSY contour plot of the 
[2]-rotaxane 7.1 is shown in Figure 7.2. The signals of the E and F protons show 
DQCOSY interactions with each other. These signals are therefore the result of a trans- 
olefin as they each have a coupling of 16 Hz. The rest of the signals show DQCOSY 
interactions and they can be assigned as illustrated in Figure 7.2. At this point in the 
assignment it can only be determined that there are three para-substituted aromatic rings. 
Through the ROESY contour plot shown in Figure 7.3, the axle was fully assigned. The 
signal of the protons D exhibits an NOE interaction with the signals of the olefinic 
protons E and F. The signals of the olefinic protons also show an interaction with the 
multiplet caused by the signals of the C and G protons. As the signal of the protons C 
already interacts with that of the protons D which is close to the olefin, the protons G 
must be close in space to the olefinic bond. With the signals of the stilbene assigned, the 
rest of the axle was deciphered by assigning the interactions of the signal of the amide 
proton I. The signal of the proton I shows an interaction with both of those of the protons 
H and K. The overall assignment of the axle can therefore be drawn as shown in Figure 
7.3.
The ROESY contour plot of the [2]-rotaxane 7.1 found in Figure 7.4 shows NOE 
interactions between the signals of the CD and stilbene protons. The CD is therefore 
positioned on the stilbene unit of the axle. The signal of the protons D shows an NOE 
interaction with both the signals of the protons CD-H5 and CD-H6. The protons D are 
therefore found at the primary face of the CD. As the signals of the olefinic protons E and 
F only have interactions with the signal of the CD-H5 protons, the olefinic bond must 
reside closer towards the secondary face than the D proton. The CD is therefore 
orientated in such a way that its secondary face is closest to the phenyl moiety as 
illustrated in Figure 7.4.
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Figure 7.2. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 7.1 in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
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Figure 7.3. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 7.1 in d 6-  
DMSO at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
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Figure 7.4. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 7.1 in da- 
DMSO at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
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2D NMR spectroscopy was then conducted on the [2]-rotaxane 7.2 to confirm 
whether the orientation of the CD on the axle was the opposite to that of the [2]-rotaxane
7.1. This would re-affirm that the [2]-rotaxanes 7.1 and 7.2 were orientational isomers. 
The assignment again started with the DQCOSY spectrum of the CD region shown in 
Figure 7.5. As before, DQCOSY interactions originating through the signal of the CD-H1 
protons at 4.74 ppm were used to completely assign each of the signals of the CD 
protons.
For the assignment of the axle signals of the [2]-rotaxane 7.2, only ROESY 2D 
NMR spectroscopy was required. The aromatic region of the ROESY contour plot is 
shown in Figure 7.6. The signals E and F are the result of /rarcs-olefinic protons as they 
have a coupling of 16 Hz. NOE interactions between the signals of the olefinic protons E 
and F and the signals of the aromatic protons enabled the signals of the stilbene to be 
assigned as shown in Figure 7.6. From the contour plot in Figure 7.6, it is impossible to 
tell which of the stilbene protons are closest to the aromatic protons K. Neither of the 
signals of the protons B or I show any interactions with the aromatic protons K. The full 
assignment of the axle protons, however, was able to be completed using the ROESY 
contour plot in Figure 7.7. The signal of the alkyl protons J shows interactions with the 
signal of the nitrogen coupled proton I and the signal of the aromatic protons K. This 
results in the axle assignment as shown in Figure 7.7.
The ROESY NMR contour plot of the [2]-rotaxane 7.2 shown in Figure 7.7 shows 
interactions between the signals of the stilbene protons C to H and those of the CD 
protons. The CD is therefore situated on the stilbene unit of the axle of the [2]-rotaxane
7.2 . The signal of the protons H shows interactions with the signal of the CD-H6 protons 
while the signal of the aromatic protons G shows interactions with the signals of the CD- 
H5 and CD-H6 annular protons. The primary face of the CD is therefore near the centre 
of the axle. The signals of the C, D, E and F protons all show interactions with the signals 
of the CD-H3 and CD-H5 protons. The secondary face of the CD is therefore closest to 
the triazine blocking group. Therefore the structure of the [2]-rotaxane 7.2 can be 
represented as shown in Figure 7.7.
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Figure 7.5. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 7.2 in da- 
DMSO at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals.
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Figure 7.6. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 7.2 in d <$- 
DMSO at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
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Figure 7.7. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 7.2 in d(,~ 
DMSO at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
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The [2]-rotaxanes 7.1 and 7.2 are therefore orientational isomers of each other and 
were formed in a ratio of 69:31. From the 2D NMR assignment of each of the [2]- 
rotaxanes 7.1 and 7.2, the CD resides on the stilbene unit of the axle. The isomer 7.1 has 
the secondary face of the CD facing the phenyl unit while the isomer 7.2 has the primary 
face of the CD pointed towards the phenyl unit.
A second variety of [2]-rotaxane was also sought to provide a comparison in both 
the synthesis and the eventual photoisomerisation studies. The type of second CD binding 
group was changed to a short alkyl chain. An alkyl chain was thought to be sufficient to 
allow the CD to move from the stilbene unit when it was isomerised from the favoured 
trans conformation to the less favoured cis form. The BOC protected amino acid 7.3 was 
commercially available and was ideal to be coupled to the stilbene 1.30. The amine 1.30 
and the protected amino acid 7.3 were dissolved in DMF with the amide coupling agent 
BOP under anhydrous conditions with TEA as the activating base. The product 7.4 was 
isolated in 70% yield. The diamine 7.5 was formed in 80% yield by deprotecting the 
carbamate 7.4 using TFA. The diamine 7.5 was then stirred in a solution of excess of 
aCD (1.15) in NaHCOß before the triazine 6.9 was added. From the HPLC of the reaction 
filtrate, two peaks were observed in a ratio of 22:78. The ESI mass spectra of the two 
separated products both contained M+H+ ions corresponding to a [2]-rotaxane. The [2]- 
rotaxane 7.6 was isolated in a yield of 0.4% and gave a HI-RES M+H+ ion of tn/z 
1532.5528 while the [2]-rotaxane 7.7 was isolated in a yield of 1.7% and gave an M+H+ 
ion of tn/z 1532.6.
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Scheme 7.2. Formation of the [2]-rotaxanes 7.6 and 7.7.
2D NMR spectroscopy was undertaken on each of the [2]-rotaxanes 7.6 and 7.7 to 
determine where the CD resides on the axle and the orientation of the CD in each case. In 
Figure 7.8, the DQCOSY NMR contour plot was able to be used to assign the signals of 
the CD protons of the [2]-rotaxane 7.6. From the assignment of the signal of the CD-H1 
proton from the literature at 4.74 ppm,77 DQCOSY interactions between the respective 
signals enabled the other assignments as shown in Figure 7.8. In the same plot the signals
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of the alkyl protons J and K could also be assigned. The triplet signal of the alkyl protons 
J at 2.64 ppm shows an interaction with the signal of the protons K that is hidden by the 
CD region of the spectrum. The signal of the alkyl protons K shows an interaction with 
the triplet of the proton L at 7.96 ppm which must be the secondary amino group of the ß- 
alanine second binding unit. Therefore the amine proton L must be furthest proton away 
from the stilbene as shown in Figure 7.10.
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Figure 7.8. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 7.6 in d(,~ 
DMSO at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals and between alkyl proton signals.
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The remainder of the axle of the [2]-rotaxane 7.6 was assigned from the ROESY 
2D NMR spectrum. The contour plot of the aromatic region of the ROESY spectrum is 
shown in Figure 7.9. The signals of the olefinic protons E and F were assigned from their 
larger coupling of 16 Hz. From their NOE interactions, the signals of the protons C, D, G 
and H were assigned as part of the stilbene unit as shown in Figure 7.9. It was not 
possible, however, from this contour plot to determine if the C or H protons were closest 
to the protons J. From the ROESY contour plot in Figure 7.9, it is obvious that the signal 
of the proton I shows an NOE interaction with the signal of the stilbene protons H. In the 
ROESY contour plot in Figure 7.10 the signal of the proton I also shows a small 
interaction with the signal of the alkyl protons J. The signal I is therefore the result of an 
amide proton. The stilbene protons H are therefore closer to the alkyl protons J than the 
stilbene protons C. The axle structure of the [2]-rotaxane 7.6 can therefore be represented 
as shown in Figure 7.10.
The ROESY contour plot shown in Figure 7.10 shows NOE interactions between 
the signals of the stilbene protons and those of the CD. The CD therefore is situated on 
the stilbene unit of the [2]-rotaxane 7.6. The orientation of the CD with respect to the axle 
can also be determined. The contour plot shows interactions between the signals of the 
stilbene protons G and H with both of the signals of the protons CD-H6A and CD-H6B. 
This places the primary face of the CD at the centre of the axle. The overlapping signals 
of the aromatic protons C and D show NOE interactions with the signals of the protons 
CD-H3 and CD-H5. Therefore the secondary face of the CD must be further away from 
the centre of the axle. The structure of the [2]-rotaxane 7.6 as a result of the 2D NMR 
assignment can be represented as shown in Figure 7.10.
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Figure 7.9. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 7.6 in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
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Figure 7.10. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 7.6 in df>- 
DMSO at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
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The [2]-rotaxane 7.7 was also studied by 2D NMR spectroscopy to confirm if the 
products 7.6 and 7.7 were isomeric. The DQCOSY spectrum of the [2]-rotaxane 7.6 
enables the CD signals to be assigned as shown in Figure 7.11. Also, the signal of the 
alkyl protons K which is embedded within the CD region of the 'H NMR spectrum shows 
an interaction with the signal of the alkyl protons J which in turn shows an interaction 
with the signal of the amino proton L. This enables the assignment of the ß-alanine as 
shown in Figure 7.12.
The signals of the stilbene protons were assigned from the aromatic region of the 
ROESY contour plot in Figure 7.12. The signals of the olefinic protons E and F of the 
stilbene unit were assigned by their large coupling of 16 Hz. The stilbene assignment was 
completed as shown in the figure from the NOE interactions between the signals of the 
olefinic protons E and F and those of the aromatic protons. Again the complete 
assignment of the axle could not be completed from the contour plot in Figure 7.12. The 
signal of the aromatic protons H shows an interaction with the signal of the proton I. In 
Figure 7.13, the signal of the proton I shows a small interaction with the signals of the 
alkyl protons J. The signal I is therefore a result of an amide proton and the axle 
assignment can be represented as shown in Figure 7.13.
The ROESY contour plot in Figure 7.13 shows NOE interactions between the 
signals of the stilbene protons and those of the CD. The CD therefore is situated on the 
stilbene unit of the [2]-rotaxane 7.7 . The orientation of the CD with respect to the axle 
can also be determined. The signal of the aromatic protons D shows interactions with the 
signals of protons CD-H5 and CD-H6. The primary face of the CD must reside on the 
stilbene unit closest to the triazine group. The signal of the protons H shows an 
interaction with the signal of the protons CD-H3. The secondary face of the CD must 
therefore reside over the stilbene unit near the centre of the axle. The structure of the [2]- 
rotaxane 7.7 as a result of the 2D NMR assignment may be represented as shown in 
Figure 7.13.
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Figure 7.11. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 7.7 in d f )-  
DMSO at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals and between alkyl proton signals.
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Figure 7.12. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 7.7 in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
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Figure 7.13. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 7.7 in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
135
Chapter 7
With the [2]-rotaxanes 7. 1, 7.2 , 7.6 and 7.7 in hand, UV/visible spectroscopy and 
reverse phase HPLC was used to measure the ability of each of them to photoisomerise to 
and from their c/s-counterparts. A change in conformation of the stilbene was envisioned 
to be enough of a stimulus to cause the CD to move to the second CD binding unit. 
Firstly the irradiation wavelengths were determined for each of the [2]-rotaxanes 7. 1, 7.2 , 
7.6 and 7.7 in attempts to form the cA-isomers. Two irradiation wavelengths were chosen 
at 350 nm and 370 nm as the Xmax of each of the [2]-rotaxanes 7. 1, 7 .2 , 7.6 and 7.7 was 
determined to be in the range of 345 nm to 350 nm as shown below. At 350 nm or 370 
nm, absorption of light by the corresponding c/s-isomers and their isomerisations were 
expected to be limited. The maximum absorbance of the new products formed as a result 
of the irradiation of each of the [2]-rotaxanes 7. 1, 7.2 , 7.6 and 7.7 was in the region of 
265 nm. The wavelengths of light available closest to this maximum absorbance were 
254 nm and 300 nm. The wavelength used for the reverse isomerisation was 254 nm as at 
this wavelength the absorption of light by the [2]-rotaxanes 7. 1, 7 .2 , 7.6 and 7.7 and their 
isomerisation was expected to be less than that for the new products.
The isomerisation towards the cfs-isomer and then back to the trans-isomer was 
designated to be one cycle. For a molecular machine to be utilised it would have to 
perform the same task a multitude of times. For this reason the isomerisation cycle was 
conducted three times to establish a trend for the reversibility of the shuttles. The 
reversibility of the isomerisations is depicted in graphs of the percentage amount of the 
[2]-rotaxanes 7. 1, 7.2, 7.6 or 7.7 determined by HPLC.
The UV/visible spectra of a 1.51 x 105 M solution of the [2]-rotaxane 7.1 before 
and after irradiation with light of wavelengths 350 nm or 370 nm and 254 nm are found 
in Figures 7.14 and 7.15 respectively. The graph of the percentage amount of the [2]- 
rotaxane 7.1 before and after irradiation is shown in Figure 7.16.
Upon irradiation of the sample with light of wavelength 370 nm or 350 nm, there 
is a decrease in absorbance at 350 nm and a slight increase in absorbance at about 265 
nm. Irradiation with 254 nm light causes a decrease at 265 nm and an increase at 345 nm. 
In each case the maximum absorbance does not reach its original level after the 254 nm 
irradiation. The degree of change is much greater for the irradiation with 370 nm light 
than for 350 nm light. From the HPLC study, the percentage amount of the [2]-rotaxane
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7.1 decreased by 9% upon irradiation with 350 nm light. The percentage amount of the 
[2]-rotaxane 7.1 decreased by 28% upon irradiation with 370 nm light. In each case 
irradiation with 254 nm light increased the amount of the [2]-rotaxane 7.1 to within 98% 
of the original amount. The loss of material is presumably due to decomposition of the 
[2]-rotaxane 7.1 upon photolysis.
The irradiation with 350 nm or 370 nm light before irradiation with light of 
wavelength 254 nm therefore reversibly isomerised the [2]-rotaxane 7. 1. There was an 
increase in the absorbance at 265 nm of the solution irradiated with 350 nm or 370 nm 
light. From the HPLC traces a new peak emerged corresponding to a product that had a 
maximum absorbance at 265 nm, characteristic of the ds-isomer of the [2]-rotaxane 7 . 1.
----- 7.1
----- 30 s 350 nm 1
30 s 254 nm 1
30 s 350 nm 2
----- 30 s 254 nm 2
----- 30 s 350 nm 3
----- 30 s 254 nm 3
300 320 340220 240 260 280
Wavelength (nrp)
Figure 7.14. UV/visible spectra of the [2]-rotaxane 7.1 [1.51 x 10'5 M] in MQ H2O and 
after subsequent exposure to 350 and 254 nm light after periods of time as indicated in 
the graph.
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2 m 254 nm 1 
45 m 370 nm 2 
2 m 254 nm 2
-----45 m 370 nm 3
-----2 m 254 nm 3
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Figure 7.15. UV/visible spectra of the [2]-rotaxane 7.1 [1.51 x 10  ^ M] in MQ H2O and 
after subsequent exposure to 370 and 254 nm light after periods of time as indicated in 
the graph.
30 s  350 nm 30 s  254 nm 
45 m 370 nm 2 m 254 nm
Cycles
Figure 7.16. Percentage amount of the [2]-rotaxane 7.1 from the reverse-phase HPLC 
chromatograms monitored at a wavelength of 347 nm. One cycle as indicated on the 
graph denotes irradiation with 350 nm or 370 nm light before irradiation with 254 nm 
light.
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For the photoisomerisation study on the [2]-rotaxane 7.2 , a 1.88 x 10 s M solution 
was made up in MQ FFO and subjected to the same irradiation conditions as used with 
the [2]-rotaxane 7. 1. The UV/visible spectra recorded after the 350 nm or 370 nm 
irradiations followed by the 254 nm irradiations are shown in Figures 7.17 and 7.18 
respectively. The graph of the percentage amount of the [2]-rotaxane 7.2 before and after 
irradiation is shown in Figure 7.19.
The irradiation of the [2]-rotaxane 7.2 with 350 nm or 370 nm light caused a 
decrease in the maximum absorbance at 347 nm in the UV/visible spectra. There was also 
an increase at 265 nm corresponding to the formation of the ds-isomer. The reverse 
isomerisation with the 254 nm light caused the absorbance at 347 nm to increase and the 
absorbance at 265 nm to decrease. The irradiation with 370 nm light caused the greatest 
change in the absorbance just as was the case for the [2]-rotaxane 7 . 1. From the HPLC 
data, irradiation at 350 nm consumed 35% of the starting material. Using light of the 
higher wavelength of 370 nm produced an even better conversion. From the HPLC study 
in Figure 7.19 it was apparent that the amount of the [2]-rotaxane 7.2 converted to its cis- 
isomer after irradiation with 370 nm light was 57%. After one cycle employing the 350 
nm irradiation the reversibility was 94% while for the 370 nm irradiation the reversibility 
was 98%.
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----- 7.2
----- 30 s 350 nm 1
30 s 254 nm 1
30 s 350 nm2
30 s 254 nm2
----- 30 s 350 nm3
----- 30 s 254 nm3
220 240 260 280 300 320 340 360 380 400 420
Wavelength (nm)
Figure 7.17. UV/visible spectra o f the [2]-rotaxane 7.2 [1.88 x 10'5 M ] in MQ H20  and 
after subsequent exposure to 350 and 254 nm light after periods o f time as indicated in 
the graph.
—  7.2
----- 20 m 370 nm 1
1 m 254 nm 1 
20 m 370 nm 2
----- 1 m 254 nm 2
----- 20 m 370 nm 3
----- 1 m 254 nm 3
220 240 260 340 360
Wavelength (nm)
Figure 7.18. UV/visible spectra o f the [2]-rotaxane 7.2 [1.88 x 105 M ] in MQ H20  and 
after subsequent exposure to 370 and 254 nm light after periods o f time as indicated in 
the graph.
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30 s  350 nm, 30 s  254 nm 
20 m 370 nm, 1 m 254 nm
0 0.5 1 1.5 2 2.5 3
Cycles
Figure 7.19. Percentage amount of the [2]-rotaxane 7.2 from the reverse-phase HPLC 
chromatograms monitored at a wavelength of 347 nm. One cycle as indicated on the 
graph denotes irradiation with 350 nm or 370 nm light before irradiation with 254 nm 
light.
For the [2]-rotaxanes 7.6 and 7 .7 , the same methods for the isomerisation and 
monitoring were used. The UV/visible spectra of a 2.22 x IO5 M solution of the [2]- 
rotaxane 7.6 before and after irradiation with light of wavelength 350 nm or 370 nm 
followed by light of wavelength 254 nm are shown in Figures 7.20 and 7.21 respectively. 
The UV/visible spectra of a 1.96 x 105 M solution of the [2]-rotaxane 7.7 before and 
after irradiation with light of wavelength 350 nm or 370 nm followed by light of 
wavelength 254 nm are shown in Figures 7.23 and 7.24 respectively. The graphs of the 
percentage amounts of the [2]-rotaxanes 7.6 and 7.7 before and after irradiation are 
shown in Figures 7.22 and 7.25 respectively.
From the UV/visible spectra of the isomerisation of the [2]-rotaxanes 7.6 and 7.7 
it is apparent that there is a decrease in the maximum absorbance at 348 nm along with an 
increase in the absorbance at 265 nm upon irradiation with the 350 nm and 370 nm light. 
The changes are reversed with irradiation of light of wavelength 254 nm. The 
reversibility for each of the irradiations is very high, in the region of 97-99%. Irradiation
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of the isomeric [2]-rotaxanes 7.6 and 7.7 with 350 nm light enabled 24% and 10% of the 
starting materials to be converted to their corresponding ds-isomers respectively. The 
amount o f the ds-isomers formed was increased substantially to 44% and 30% upon 
irradiation with 370 nm light. The increased formation of the ds-isomers was reflected in 
increased amounts o f the peaks corresponding to the ds-isomers from the HPLC traces 
post irradiation.
—  7.6
----- 30 s 350 nm 1
30 s 254 nm 1 
30 s 350 nm 2 
30 s 254 nm 2
----- 30 s 350 nm 3
----- 30 s 254 nm 3
260 280
Wavelength (nm)
Figure 7.20. UV/visible spectra o f the [2]-rotaxane 7.6 [2.22 x 105 M ] in MQ H 20  and 
after subsequent exposure to 350 and 254 nm light after periods o f time as indicated in 
the graph.
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-----7.6
-----30 m 370 nm 1
1 m 254 nm 1 
30 m 370 nm 2 
1 m 254 nm 2
-----30 m 370 nm 3
-----1 m 254 nm 3
240 260 300 320 380 400
Wavelength (nm)
Figure 7.21. UV/visible spectra of the [2]-rotaxane 7.6 [2.22 x 10° M] in MQ H20  and 
after subsequent exposure to 370 and 254 nm light after periods of time as indicated in 
the graph.
30 s  350 nm  30 s  254 nm 
30 m 370 nm  1 m 254 nm
0 0.5 1 1.5 2 2.5 3
Cycles
Figure 7.22. Percentage amount of the [2]-rotaxane 7.6 from the reverse-phase HPLC 
chromatograms monitored at a wavelength of 347 nm. One cycle as indicated on the 
graph denotes irradiation with 350 nm or 370 nm light before irradiation with 254 nm 
light.
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----- 7.7
----- 30 s 350 nm 1
30 s 254 nm 1
30 s 350 nm 2
30 s 254 nm 2
30 s 350 nm 3
30 s 254 nm 3
400 420
Wavelength (nm)
Figure 7.23. UV/visible spectra o f the [2]-rotaxane 7.7 [1.96 x 105 M] in MQ H 2O and 
after subsequent exposure to 350 and 254 nm light after periods o f time as indicated in 
the graph.
—  7.7
----- 30 m 370 nm 1
1 m 254 nm 1 
30 m 370 nm 2 
1 m 254 nm 2
----- 30 m 370 nm 3
----- 1 m 254 nm 3
Wavelength (nmj
Figure 7.24. UV/visible spectra o f the [2]-rotaxane 7.7 [1.96 x 105 M] in MQ FFO and 
after subsequent exposure to 370 and 254 nm light after periods of time as indicated in 
the graph.
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30 s  350 nm, 30 s  254 nm 
30 m 370 nm, 1 m 254 nm
Figure 7.25. Percentage amount of the [2]-rotaxane 7.7 from the reverse-phase HPLC 
chromatograms monitored at a wavelength of 347 nm. One cycle as indicated on the 
graph denotes irradiation with 350 nm or 370 nm light before irradiation with 254 nm 
light.
In each case 370 nm light isomerises a greater percentage of the [2]-rotaxanes 7. 1, 
7.2 , 7.6 and 7.7 than does 350 nm light. It appears that one orientational isomer of each 
pair also isomerises more effectively. Of the isomeric [2]-rotaxanes 7.1 and 7.2, the latter 
is more effectively transformed. At 370 nm, 57% of the [2]-rotaxane 7.2 isomerises, 
while only 28% of the [2]-rotaxane 7.1 isomerises. As shown in Figure 7.7, the CD in the 
[2]-rotaxane 7.2 is situated on the stilbene unit with its primary face pointing towards the 
second CD binding unit. As the only difference between the [2]-rotaxanes 7.1 and 7.2 is 
the CD orientation, the structure described must be more favourable for the isomerisation 
and presumably the CDs movement along the axle. In the isomerisation of the [2]- 
rotaxanes 7.6 and 7.7 at 370 nm, 44% of the [2]-rotaxane 7.6 is converted to its cis- 
isomer in comparison to 30% for the [2]-rotaxane 7.7 . As it is shown in Figure 7.10, the 
structure of the [2]-rotaxane 7.6 has the CD situated on the stilbene with its primary face 
pointed towards the second CD binding unit, as is the case with the analogue 7.2 .
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To confirm that the [2]-rotaxanes 7.1, 7.2, 7.6 and 7.7 isomerise to their 
corresponding ds-isomers, as indicated by the changes in their UV/visible spectra and 
HPLC traces after irradiation with UV light, and to determine the conformations of those 
ds-isomers, 2D NMR spectroscopy was undertaken. Samples of the ds-isomers 7.1(Z) 
and 7.2(Z) were isolated by preparative HPLC from irradiated solutions of the [2]- 
rotaxanes 7.1 and 7.2, respectively. The samples each contain starting material that 
reforms during the analysis. The yields of the ds-isomers of the [2]-rotaxanes 7.6 and 7.7 
were too low for their isolation and analysis to be practical.
The DQCOSY NMR contour plot of the CD region of the [2]-rotaxane 7.1(Z) is 
shown in Figure 7.26. From the signal of the CD-H1 protons at 4.76 ppm, DQCOSY 
interactions were able to be used to assign the remaining signals as shown.
The signals of the axle of the [2]-rotaxane 7.1(Z) were able to be assigned from 
the ROESY 2D NMR contour plots in Figures 7.27 and 7.28. From the contour plot in 
Figure 7.27 the signals of the olefinic protons E and F are identifiable by their interaction 
with the signals of the aromatic protons D and G. The olefinic bond is cis as the signals of 
the olefinic protons E and F show a coupling constant of 12.5 Hz. The signals of the 
protons D and G show interactions with the C and H proton signals to complete the 
assignment of the stilbene signals. There is also an observable interaction between the 
signals of the protons K and L. The complete assignment of the axle, however, could not 
be determined from the contour plot in Figure 7.27. The assignment was able to be 
completed using the contour plot in Figure 7.28. The signals of the aromatic protons C 
and L both show NOE interactions with the signals of the methoxy protons A and N. This 
enables the signals of the axle of the [2]-rotaxane 7.1(Z) to be assigned as shown in 
Figure 7.29.
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Figure 7.26. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 7.1(Z) in 
d(j-DMSO at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals.
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Figure 7.27. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 7.1(Z) in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
In the assignment of the CD location on the axle of the [2]-rotaxane 7.1(Z), it 
appeared from the ROESY contour plot in Figure 7.28 that there are two different 
conformations. These structures are illustrated in Figure 7.29. From the contour plot in 
Figure 7.28 the signals of the protons K show NOE interactions with both the signals of 
the protons CD-H3 and CD-H5 while the signal of the stilbene protons H shows a slight 
interaction with one of the signals of the CD-H6 protons. These interactions place the CD 
as shown in the upper structure of Figure 7.29 where it is situated over the secondary CD 
binding unit. The NOE interaction that points to the formation of a second conformation 
is that of the strong NOE crosspeak between the signal of the stilbene protons D and that
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of the CD-H3 protons. There is also a possible interaction between the signal of the 
aromatic protons C and the signals of the CD-H3 and CD-H5 protons. These interactions 
place the CD as shown in the lower structure in Figure 7.29. It is clear though that the CD 
is distant from the olefinic bond as there are no observable interactions between the E and 
F proton signals and the CD annular proton signals. The isomerisation of the stilbene unit 
of the [2]-rotaxane 7.1 to its cis-isomer 7.1(Z) has caused the CD to move to two separate 
parts of the axle. From the HPLC separation, only one ds-product was identified and 
separated. It is likely that the two states are in equilibrium with each other. The exchange 
between the two states must be fast on the NMR timescale and therefore results in only 
one set of ’H NMR signals.
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Figure 7.28. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 7.1(Z) in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
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In the assignment of conformation of the [2]-rotaxane 7.2(Z) the DQCOSY NMR 
contour plot of the CD region, shown in Figure 7.30, was used to decipher the CD 
signals. From the characteristic downfield CD-H1 signal at 4.74 ppm, DQCOSY 
interactions were used to assign the remaining signals.
The signals of the axle of the [2]-rotaxane 7.2(Z) were assigned using the ROESY 
2D contour plots shown in Figures 7.31 and 7.32. NOE interactions are apparent between 
the signals of the olefinic protons E and F and those of the aromatic protons D and G. The 
signals of the protons D and G show interactions with the C and H proton signals to allow 
complete assignment of the stilbene signals. The signals of the phenyl protons K and L 
were also able to be determined from this spectrum. The assignment of the axle signals 
was completed using the contour plot shown in Figure 7.32. The stilbene protons C were 
determined to be near the triazine blocking group due to the NOE interaction of the 
latter’s signals with the signal of the methoxy protons A. The aromatic protons K were
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determined to be closer than protons L to the stilbene unit due to their NOE interaction 
with the signal of the alkyl protons J. The axle assignment can therefore be represented as 
shown in Figure 7.32.
Unlike the previous assignment of the CD position in the [2]-rotaxane 7.1(Z), the 
investigation into the CD positioning of the [2]-rotaxane 7.2(Z) was much simpler with 
the CD only residing in one position on the axle. The ROESY contour plot used to 
determine this positioning is shown in Figure 7.32. From the contour plot it is clear that 
the CD does not reside over the olefinic bond as there is no NOE interaction between the 
signals of the olefinic protons E and F with the signals of the CD protons. The signal of 
the phenyl protons K shows an interaction with the signal of the protons CD-H3 while it 
is likely the signal of the protons L shows an interaction with both the signals of the 
protons CD-H5 and CD-H3. The interactions between these signals places the CD as 
shown in Figure 7.32 and this assignment is supported by the absence of any NOE 
interactions of the signals between the axle protons and that of the protons CD-H6 which 
resides near the triazine ring. The isomerisation of the stilbene unit of the [2]-rotaxane 7.2 
to the c/s-isomer 7.2(Z) has therefore caused the CD to move to the second CD binding 
unit of the axle. It is possible that the CD of the [2J-rotaxane 7.2(Z) also dynamically 
shuttles across the stilbene unit just as was the case for the [2]-rotaxane 7.1(Z). However, 
the structure shown in Figure 7.32 must be relatively more stable increasing its 
population to leave it as the only one observable through NOE interactions.
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Figure 7.30. A section of the 500 MHz DQCOSY spectrum of the [2]-rotaxane 7.2(Z) in 
c/tf-DMSO at 25 °C of the region where crosspeaks are observed between cyclodextrin 
proton signals.
152
Isomeric Dimethoxytriazine Blocked [2]-Rotaxanes that Act as Molecular Shuttles
6 . 7 -
7 . 0 -
7 . 7~i
7 . 8 -
Figure 7.31. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 7.2(Z) in 
DMSO at 25 °C of the region where crosspeaks are observed between axle proton 
signals.
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Figure 7.32. A section of the 500 MHz ROESY spectrum of the [2]-rotaxane 7.2(Z) in d6- 
DMSO at 25 °C of the region where crosspeaks are observed between axle and 
cyclodextrin proton signals.
In summary, the [2]-rotaxanes 7.1, 7.2, 7.6 and 7.7 were synthesised and their 
conformations determined by 2D NMR spectroscopy. Each of the isomers was 
established to isomerise to its corresponding c/s-isomer, using HPLC and UV/visible
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spectroscopy. The use of the higher wavelength of light of 370 nm proved to be far more 
effective than the 350 nm light source in each of the [2]-rotaxane isomerisations. This is 
thought to be due to smaller amounts of the cis-isomer undergoing the reverse reaction. 
When comparing the pairs of the isomeric [2]-rotaxanes 7.1 and 7.2, and 7.6 and 7.7, it 
appears that the isomers 7.2 and 7.6 with the primary face of the CD facing towards the 
second CD binding unit isomerise more effectively than the isomers 7.1 and 7.7 having 
the CD facing the opposite direction. The reason for this bias may be explained by the 
structures determined by 2D NMR spectroscopy for the cis-isomers 7.1(Z) and 7.2(Z). In 
each case isomerisation of the stilbene unit causes the CD to shift to another part of the 
axle. The isomerisation of the [2]-rotaxane 7.1, which is less favoured, causes the CD to 
be in a dynamic equilibrium between two different positions on the axle. Neither of these 
is apparently particularly favoured. The isomerisation of the [2]-rotaxane 7.2, which is 
more favoured, produces only one conformation as determined by 2D NMR 
spectroscopy. Presumably this is more stable. In the case of the [2]-rotaxane 7.1, the 
isomerisation is likely to be disfavoured favoured due to the steric hindrance of the 
dimethoxytriazine blocking group near the more restricted primary face of the CD.
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Chapter 8: A Dimethoxytriazine Blocked Hermaphroditic [2]- 
Rotaxane that Acts as a Molecular Muscle
As the [2]-rotaxanes 7. 1, 7.2, 7.6 and 7.7 were observed to have the ability to 
undergo reversible photochemical isomerisation, a further objective was to use the 
dimethoxytriazine blocking reagent 6.9 in the formation of an hermaphroditic [2]- 
rotaxane as shown in Scheme 8.1. Upon irradiation it was hoped the trans,trans- 
hermaphroditic [2]-rotaxane 8.1 would form the cis,cis-isomer 8.2 . The isomerisation to 
the cis,cis-isomer 8.2 would reduce the length of the molecule in what can be seen as a 
molecular muscle. The hermaphroditic [2]-rotaxane 3.4 had been previously synthesised 
by Cieslinski80 using the trinitrophenyl blocking reagent 1.31 . The hermaphroditic [2]- 
rotaxane 3.4 proved ineffective for the reversible isomerisation of the stilbene units 
presumably due to the interference of the trinitrophenyl group. It was thought that the use
encapsulated trans-stilbene
frans, frans-hermaphroditic
second binding unit
blocking group
cis, c/s-hermaphroditic 
[2]-rotaxane 
8.2
------ v-------
c/s-stilbene
Scheme 8.1. Expected photochemical isomerisation of the stilbene unit of the trans,trans- 
hermaphroditic [2]-rotaxane 8.1 to produce a aXc/s-hermaphroditic [2]-rotaxane 8.2 that 
would cause the cyclodextin to shuttle to the second cyclodextrin binding unit
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of the alternative blocking reagent 6.9 would allow an hermaphroditic [2]-rotaxane to be 
prepared and allow this to isomerise and act as a molecular muscle.
The synthesis of the hermaphroditic [2]-rotaxane 8.5(E,E) is summarised in 
Scheme 8.2. The amine 8.3 is a known compound after its synthesis by Cieslinski and 
was stirred in MQ FTO presumably to form the dimeric included species 8.4. The 
hermaphroditic [2]-rotaxane 8.5(E,E) was formed after the addition of the blocking 
reagent 6.9 with its formation monitored by TLC. The hermaphroditic [2]-rotaxane 
8.5(E,E) was isolated using HPLC in 12% yield as a colourless powder and its ESI mass 
spectrum showed an M+H+ ion of mJz 2836.3.
Scheme 8.2. Formation of the hermaphroditic [2]-rotaxane 8.5(E,E).
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ID and 2D NMR spectroscopy was used to determine that the product isolated 
was the hermaphroditic [2]-rotaxane 8.5(E,E). The experiments were performed in d4- 
methanol to prove that the product 8.5(E,E) is a [2]-rotaxane. Because this solvent does 
not favour CD inclusion complexes, only the ROESY 2D NMR experiment of a 
mechanically interlocked [2]-rotaxane shows NOE interactions between the signals of 
CD and axle protons. Otherwise complexes dissociate under these conditions.
The ROESY contour plot of the hermaphroditic [2]-rotaxane 8.5(E,E) is shown in 
Figure 8.1. The aromatic signals of the stilbene unit are shown on the x-axis of the 
contour plot while the signals of the CD protons are shown on the y-axis. The contour 
plot shows NOE interactions between the signals of the CD and aromatic protons. The 'H 
NMR spectrum of the hermaphroditic [2]-rotaxane 8.5(E,E) shows six sharp stilbene 
proton signals meaning the molecule is symmetrical. An acyclic hermaphroditic [2]- 
rotaxane would result in twice the number of stilbene proton signals due to the protons of 
the two stilbenes being inequivalent. The mass spectrum of the hermaphroditic [2]- 
rotaxane 8.5(E,E) showed an ion of m/z 2836.3 which indicates the formation of a dimer. 
The hermaphroditic [2]-rotaxane 8.5(E,E) is therefore a mechanically interlocked cyclic 
dimer.
Although it was shown that the hermaphroditic [2]-rotaxane is a cyclic dimer, the 
full assignment of the NMR signals was not practical as solubility limitations in methanol 
limited their intensity. A 2D NMR study of the hermaphroditic [2]-rotaxane 8.5(E,E) was 
therefore conducted in D2 O which improved the solubility and the signal strength 
enabling the assignment to be undertaken. Since the formation of the mechanically 
interlocked cyclic dimer 8.5(E,E) was shown in ^-methanol, D2 O could be used as an 
alternative solvent to complete the 2D NMR assignment.
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Figure 8.1. A section of the 500 MHz ROESY spectrum of the hermaphroditic [2]- 
rotaxane 8.5(E,E) in ^-methanol at 25 °C of the region where crosspeaks are observed 
between aromatic and cyclodextrin proton signals.
The ]H NMR spectrum of the hermaphroditic [2]-rotaxane 8.5(E,E) in D2O is 
complex, but by using a combination of TOCSY, HMQC and ROESY 2D NMR 
spectroscopy, in a procedure similar to the literature,77 most of the signals can be 
assigned. The signals are labelled as in the previous chapters with the addition that the 
glucopyranose unit to which the signals of the protons belong can also be assigned. The
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glucopyranose units lose their symmetrical nature due to the substitution of one of the 
primary hydroxyl groups. The unit that incurred a substitution is labelled as 
glucopyranose unit A while the remaining units are labelled B to F in a clockwise 
direction looking at the primary face of the CD.
Each of the signals for the CD protons was assigned with their chemical shifts 
shown in Table 8.1.
Glucopyranose Unit
CD-H A B C D E F
1 5.11 5.15 5.04 4.94 5.17 5.16
2 3.64 3.67 3.63 3.52 3.65 3.71
3 3.59 3.89 3.92 3.50 3.84 3.99
4 3.47 3.74 3.78 3.53 3.61 3.90
5 3.70 3.96 3.98 3.48 3.84 4.12
6 3.06 - - - - -
6’ 4.52 - - - - -
Table 8.1. Chemical shifts (ppm) of the CD of the hermaphroditic [2]-rotaxane 8.5(E,E).
For the assignment of the signals of the hermaphroditic [2]-rotaxane 8.5(E,E), the 
signals of the CD-H1 protons can be identified from the ’H NMR spectrum as they 
characteristically appear further upfield. Using TOCSY NMR spectroscopy, through 
bond interactions arise as crosspeaks between the signals of nearby protons. Using this 
method the signals of the protons that belong to each individual glucopyranose unit can 
be determined. By increasing the mixing time for the TOCSY experiment, interacting 
protons located through greater numbers of bonds can be detected.
The TOCSY NMR spectrum of the hermaphroditic [2]-rotaxane 8.5(E,E) with a 
mixing time of 30 ms is shown in Figure 8.2. The signals of the CD-H1 protons that 
characteristically appear furthest downfield are found in the region of 4.9-5.2 ppm. At 
this short mixing time, observable crosspeaks can only be seen with the signals of the 
CD-H2 protons.
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Figure 8.2. A section of the 500 MHz TOCSY spectrum of the hermaphroditic [2]- 
rotaxane 8.5(E,E) in D20  at 25 °C with a mixing time of 30 ms of the region where 
crosspeaks are observed between cyclodextrin proton signals.
The TOCSY contour plot of the hermaphroditic [2]-rotaxane 8.5(E,E) with a 
mixing time of 55 ms is shown in Figure 8.3. By increasing the mixing time, TOCSY 
interactions between the signals of the CD-H1 protons and those of the CD-H2 and CD- 
H3 protons can be observed.
The TOCSY contour plot of the hermaphroditic [2]-rotaxane 8.5(E,E) with a 
mixing time of 80 ms is shown in Figure 8.4. From the contour plot, through bond 
interactions between the signals of the CD-H1 and CD-H4 protons are observable. 
Although the contour plot in Figure 8.4 labels the glucopyranose unit to which each set of 
signals belongs, at this point in the assignment the information obtained is insufficient to
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distinguish between the glucopyranose units. Instead this was established later but is 
illustrated here for clarity. Since the mixing time of 80 ms is the longest mixing time 
allowed for use on the NMR spectrometer, the signals of the CD-H5 and CD-H6 protons 
could not be identified from their interactions with the CD-H1 protons. The use of a 
TOCSY contour plot with an increased mixing time was not essential, however, for the 
complete assignment of the signals of the CD.
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Figure 8.3. A section of the 500 MHz TOCSY spectrum of the hermaphroditic [2]- 
rotaxane 8.5(E,E) in D2O at 25 °C with a mixing time of 55 ms of the region where 
crosspeaks are observed between cyclodextrin proton signals.
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Figure 8.4. A section of the 500 MHz TOCSY spectrum of the hermaphroditic [2]- 
rotaxane 8.5(E,E) in D2O at 25 °C with a mixing time of 80 ms of the region where 
crosspeaks are observed between cyclodextrin proton signals.
To enable the signals of the CD to be assigned to their respective glucopyranose 
units, the signals of one of the units first had to be identified. Using a g-HMQC 
experiment, the signals of the protons CD-H6a-A and CD-H6B-A are able to be 
determined. The contour plot of the g-HMQC spectrum is shown in Figure 8.5. Because 
the primary hydroxyl of the A glucopyranose unit has been substituted with an amino 
group and allowed to react to form an amide, the signal of the nearby carbon CD-C6 is
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moved upfield to around 43.8 ppm. The contour plot of the heteronuclear experiment 
shows the signals of the coupled protons CD-H6a-A and CD-H6b-B at 3.06 and 4.52
ppm.
I 11i
Figure 8.5. A section of the 600 MHz g-HMQC spectrum of the hermaphroditic [2]- 
rotaxane 8.5(E,E) in D2O at 25 °C of the region where crosspeaks are observed between 
cyclodextrin proton and carbon signals.
With the identification of the signals of the protons CD-H6a-A and CD-H6B-A, 
short range TOCSY interactions were used to identify the CD-H4-A signal. As the CD-
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HI to CD-H4 signals of each of the glucopyranose units were determined above, the 
entire assignment of the signals of the A glucopyranose unit was therefore possible. A 
section of the TOCSY contour plot with a mixing time of 30 ms of the hermaphroditic 
[2]-rotaxane 8.5(E,E) is shown in Figure 8.6. The plot shows interactions between the 
signals of the CD-H6a-A and CD-H6B-A protons and that of the proton CD-H5-A. The 
signal of the proton CD-H5-A also shows an interaction with that of the CD-H4-A 
proton. The signals of the protons CD-H1-A to CD-H3-A were then assigned using the 
TOCSY spectrum as shown in Figure 8.4.
CD-H5-A
CD-H6-A
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Figure 8.6. A section of the 500 MHz TOCSY spectrum of the hermaphroditic [2]- 
rotaxane 8.5(E,E) in D2O at 25 °C with a mixing time of 30 ms of the region where 
crosspeaks are observed between cyclodextrin proton signals.
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From the complete assignment of the signals of the A glucopyranose unit, the 
ROESY contour plot of the CD region can be used to identify each of the signals for the 
remaining glucopyranose units. The assignment of the signals of the glucopyranose units 
is possible because the signal of the proton CD-H1 of one glucopyranose unit should 
show interactions with the signal of the proton CD-H4 of its neighbouring glucopyranose 
unit. A section of the ROESY contour plot of the hermaphroditic [2]-rotaxane 8.5(E,E) is 
shown in Figure 8.7. The signal of the proton CD-H1-A shows an NOE interaction with 
that of the proton CD-H4-B enabling the signals of the CD-H1 to CD-H4 protons of the B 
glucopyranose unit to be assigned using the TOCSY contour plot shown in Figure 8.4. 
Further ROESY interactions between the signals of the protons CD-H1 and CD-H4 of the 
remaining glucopyranose units enable each of the glucopyranose signals to be assigned as 
shown in Figure 8.4.
At this point in the assignment, the signals of the protons CD-H1 to CD-H4 were 
assigned to the glucopyranose unit to which they belong. To identify the signals of the 
protons CD-H5, the TOCSY contour plot was again used. A section of the TOCSY 
contour plot which used a mixing time of 30 ms is shown in Figure 8.8. The signals of the 
CD-H4 protons of the A to F glucopyranose units show interactions with the signals of 
the protons CD-H5. The assignment is limited to the signals of the CD-H5 protons as 
interactions were not observed with the signals of the CD-H6 protons. The assignment of 
the CD-H6 protons is not important, however, as the ROESY interactions with the signals 
of the annular protons CD-H3 and CD-H5 are sufficient to determine where the CDs are 
located with respect to the axles of the hermaphroditic [2]-rotaxane 8.5(E,E).
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Figure 8.7. A section of the 500 MHz ROESY spectrum of the hermaphroditic [2]- 
rotaxane 8.5(E,E) in D2O at 25 °C of the region where crosspeaks are observed between 
cyclodextrin proton signals.
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Figure 8.8. A section of the 500 MHz TOCSY spectrum of the hermaphroditic [2]- 
rotaxane 8.5(E,E) in D2O at 25 °C with a mixing time of 30 ms of the region where 
crosspeaks are observed between cyclodextrin proton signals.
The ROESY contour plot of the aromatic region of the hermaphroditic [2]- 
rotaxane 8.5(E,E) is shown in Figure 8.9. The assignment of the signals of the stilbene 
unit of the axle was carried out as explained in Chapter 2. Interactions with the signals of 
the olefinic protons D and E allow the stilbene resonances to be assigned as shown in 
Figure 8.9.
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Figure 8.9. A section of the 500 MHz ROESY spectrum of the hermaphroditic [2]- 
rotaxane 8.5(E,E) in D2O at 25 °C of the region where crosspeaks are observed between 
aromatic proton signals.
In the ROESY contour plot in Figure 8.10, interactions between the signals of the 
CD and stilbene protons are observed. Interpreting these interactions allows the location 
of the CDs with respect to the axles of the hermaphroditic [2]-rotaxane 8.5(E,E) to be
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Figure 8.10. A section of the 500 MHz ROESY spectrum of the hermaphroditic [2]- 
rotaxane 8.5(E,E) in D2O at 25 °C of the region where crosspeaks are observed between 
aromatic and cyclodextrin proton signals.
determined. The signals of the stilbene protons C, D and E show interactions with each of 
the six signals of the CD-H5 protons placing the C, D and E protons centrally within the
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CD. The signals of the F and G protons show strong NOE interactions with each of the 
six CD-H3 protons placing the F and G protons at the secondary face of the CD. The 
signal of the B aromatic protons shows some minor interactions with what are most likely 
the signals of the protons CD-H6 thus placing the B protons at the primary face of the 
CD.
The structure of the hermaphroditic [2]-rotaxane 8.5(E,E) as a result of the 2D 
NMR assignment is therefore shown in Figure 8.10. As in the case of the similar
on
hermaphroditic [2]-rotaxane 3.4 synthesised by Cieslinski, the stilbenes of the 
hermaphroditic [2]-rotaxane 8.5(E,E) are included within the CDs. The next step was to 
test the ability for the trans-stilbenes of the hermaphroditic [2]-rotaxane 8.5(E,E) to 
isomerise upon irradiation with light of a particular wavelength.
Before commencing the photolysis on the hermaphroditic [2]-rotaxane 8.5(E,E), 
the required irradiation wavelength was determined from its UV/visible spectrum. The 
UV/visible spectrum of a 9.88 x 10'6 M solution of the hermaphroditic [2]-rotaxane 
8.5(E,E) in MQ H20  was recorded and is shown as the black line in Figure 8.11. From 
the spectrum the A,max at 333 nm can be attributed to the rrans-stilbenes of the 
hermaphroditic [2]-rotaxane 8.5(E,E). In the earlier isomerisation of the [2]-rotaxanes 
7.1, 7.2, 7.6 and 7.7, the c/s-stilbene appeared to have an absorbance near 265 nm. Light 
of wavelength 350 nm was chosen for the photolysis study as at this wavelength the 
absorption of light by the c/s-stilbene units and their isomerisation was expected to be 
less than that for the trans-isomers. Light of wavelength 254 nm was used to reverse the 
isomerisation. At 254 nm, the absorption of light by the mms-stilbenes and their 
isomerisation was expected to be less than that for the c/s-isomers.
For the isomerisations, irradiation with 350 nm light before irradiation with 254 
nm light was designated to be one cycle. The cycle was repeated another two times to 
establish a trend for the reversibility of the isomerisation using the percentage amount of 
the hermaphroditic [2]-rotaxanes 8.5(E,E) determined using HPLC.
As a result of the irradiation of the hermaphroditic [2]-rotaxane 8.5(E,E) with 
light of wavelength 350 nm for one minute, the trans,cis-isomer 8.5(E,Z) is apparently 
formed. The expected structure of the trans,cis-isomer 8.5(E,Z) is shown in Scheme 8.3. 
The trans,trans-isomer 8.5(E,E) was reformed following the irradiation with light of
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wavelength 254 nm for one minute. From the HPLC analysis the new product 8.5(E,Z) 
has a maximum absorbance at 333 nm and is therefore likely to contain a trans-stilbene 
unit. There is also an increase in the absorbance of the new product 8.5(E,Z) below 290 
nm resulting from the formation of the ds-stilbene unit. These changes in the UV/visible 
spectral profile are consistent with those observed in the UV/visible spectra shown in 
Figure 8.11 upon 350 nm irradiation. The change in the spectral profile therefore 
indicates that the product formed is the trans,cis-isomer 8.5(E,Z) and must be an 
intermediate in the complete isomerisation of the hermaphroditic [2]-rotaxane 8.5(E,E).
The reversibility of the isomerisation was then determined from the graph of the 
percentage amount of the hermaphroditic [2]-rotaxane 8.5(E,E) before and after 
irradiation. This graph is shown in Figure 8.12 and depicts the consumption of the 
hermaphroditic [2]-rotaxane 8.5(E,E) upon irradiation with 350 nm. It also shows the 
reformation of the hermaphroditic [2]-rotaxane 8.5(E,E) after 254 nm irradiation. At a 
glance it could be thought that a substantial portion of the trans,trans-isomer 8.5(E,E) 
decomposed during the first cycle. After the second and third cycles, however, the 
amount of material further lost is very minor. The initial drop in the amount of the 
recovered trans,trans-isomer 8.5(E,E) can therefore be attributed to the establishment of 
an equilibrium with the trans,cis-isomer 8.5(E,Z). Thus it was established that the 
interconversion between the trans,trans-isomer 8.5(E,E) and the trans,cis-isomer 
8.5(E,Z) is reversible.
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Figure 8.11. UV/visible spectra of a solution of the hermaphroditic [2]-rotaxane 8.5(E,E) 
[9.88 x 10'6 M] in MQ FFO and after exposure to 350 nm and 254 nm light.
1 rn 350 nm, 1 m 254 nm
Cycles
Figure 8.12. Percentage remaining of the hermaphroditic [2]-rotaxane 8.5(E,E) [9.88 x 
10‘6 M] in MQ FFO after various irradiations. One cycle as indicated on the graph 
denotes irradiation with 350 nm light before irradiation with 254 nm light.
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Scheme 8.3. Proposed behaviour of the hermaphroditic [2]-rotaxane 8.5(E,E).
Each of the stilbene units of the hermaphroditic [2]-rotaxane 8.5(E,E) was 
assumed not to isomerise at the same time. The time length for the 350 nm irradiation
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was therefore increased to ten minutes to isomerise both stilbene units to form the c/s,c/s- 
isomer 8.5(Z,Z). The 254 nm irradiation time length was retained and the reaction was 
monitored again by HPLC and UV/visible spectroscopy.
Increasing the time length of the 350 nm irradiation of the hermaphroditic [2]- 
rotaxane 8.5(E,E) was successful in the formation of the cis,cis-isomer 8.5(Z,Z). From 
the HPLC analysis, a new product is formed that shows an absorbance below 270 nm 
corresponding to the formation of a c/s-stilbene. The new product also does not show any 
absorbance at 333 nm indicating the absence of any trans-stilbene. These changes in the 
UV/visible profile are consistent with those observed in the UV/visible spectra of the 
isomerisation shown in Figure 8.13. Also evident from the HPLC traces was the 
formation of the intermediate 8.5(E,Z) determined above. The UV/visible profile of the 
new product therefore indicates that the c/s,c/s-isomer 8.5(Z,Z) was formed via the 
trans,cis intermediate 8.5(E,Z) from the isomerisation of the hermaphroditic [2]-rotaxane 
8.5(E,E).
The reversibility of the isomerisation was then determined from the graph of the 
percentage amount of the hermaphroditic [2]-rotaxane 8.5(E,E) before and after 
irradiation. This graph is shown in Figure 8.14 and depicts the consumption of the 
hermaphroditic [2]-rotaxane 8.5(E,E) upon irradiation with 350 nm light. It also shows 
the reformation of the hermaphroditic [2]-rotaxane 8.5(E,E) after 254 nm irradiation. 
Again there was a significant amount of the trans,trans-isomer 8.5(E,E) not reformed 
after the initial irradiation with 254 nm light. After the second and third irradiation cycles 
the amount of the trans,trans-isomer 8.5(E,E) material lost is a lot less. The initial drop 
in the amount of the recovered trans,trans-isomer 8.5(E,E) can therefore be attributed to 
the establishment of a equilibrium between the isomers. Thus it was established that the 
interconversion between the trans,trans-isomer 8.5(E,E), the trans,cis-isomer 8.5(E,Z) 
and the ccs,c/s-isomer 8.5(Z,Z) is reversible.
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Figure 8.13. UV/visible spectra o f a solution o f the hermaphroditic [2]-rotaxane 8.5(E,E) 
[9.88 x 106 M ] in MQ H 2 O and after exposure to 350 nm and 254 nm light.
10 m 350 nm, 1 m 254 nm
Figure 8.14. Percentage remaining of the hermaphroditic [2]-rotaxane 8.5(E,E) [9.88 x 
106 M ] in MQ H 2 O after various irradiations. One cycle as indicated on the graph 
denotes irradiation with 350 nm light before irradiation with 254 nm light.
177
Chapter 8
It was anticipated that isomerisation to the cis,cis-isomer 8.5(E,E) and the 
trans,cis-isomer 8.5(E,Z) would cause the CDs to shuttle over the stilbenes. 2D NMR 
spectroscopy was therefore sought to determine the location of the CDs in the cis,cis- 
isomer 8.5(E,E) and the trans,cis-isomer 8.5(E,Z). Due to the low yield of the formation 
of the hermaphroditic [2]-rotaxane 8.5(E,E), it was impractical to isolate each of the 
isomers 8.5(E,Z) and 8.5(Z,Z) for individual characterisation. A mixture of the isomers 
were therefore analysed by 2D NMR spectroscopy. Monitoring by HPLC, a dilute 
solution of the hermaphroditic [2]-rotaxane 8.5(E,E) was irradiated with 350 nm light. 
After three minutes it was determined that a maximum amount of the trans,cis-isomer 
8.5(E,Z) was formed. The isomerisation mixture was then subjected to NMR 
spectroscopy.
The 'H NMR spectrum of the hermaphroditic [2]-rotaxane 8.5(E,E) and the 
spectrum of the solution after irradiation is shown in Figure 8.15. From the spectra of the 
irradiated sample, new signals arise in the aromatic region near the original signals of the 
trans,trans-isomer 8.5(E,E) protons. From the HPLC monitoring of the isomerisation, a 
peak believed to correspond to the /raws, m-isomer 8.5(E,Z) appeared. The 'H NMR 
spectrum of the trans,cis-isomer 8.5(E,Z) was anticipated to show double the number of 
signals due to the lack of symmetry related to the two different stilbenes. The number of 
signals observed in the spectrum also implies the formation of the trans,cis-isomer 
8.5(E,Z).
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Figure 8.15. 500 MHz 'H NMR spectra of the hermaphroditic [2]-rotaxane 8.5(E,E) and 
an isomerisation mixture of the transjrans-isomer 8.5(E,E) and the trans,cis-isomer 
8.5(E,Z) in D20  at 25 °C.
The signals of the trans,cis-isomer 8.5(E,Z) were assigned using the DQCOSY 
and ROESY contour plots shown in Figures 8.16 and 8.17. As shown in the figures the 
signals are differentiated according to which stilbene unit they belong to and whether 
they are olefinic or aromatic signals. The signals belonging to the protons of the 
previously assigned transjrans-isomer 8.5(E,E) are shown as the blue signals. The
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purple signals are identifiable as belonging to the protons of a m-stilbene. The two 
olefinic signals 2-0  at 6.79 ppm and 6.94 ppm were identified through their coupling 
constants. The two olefinic signals 2-0 have a coupling constant of 12 Hz which is 
characteristic of a c/s-alkene bond. The signals coloured green belong to a frazzs-stilbene 
and were identified by locating one of the signals of the olefinic protons 3-0. The signals 
of the olefinic protons 3-0 have a coupling constant of 16 Hz characteristic of a trans- 
alkene bond. The fourth stilbene unit in red was able to be assigned but its conformation 
was not determined. The signal of the protons 4-0  arises as a singlet and was identified as 
olefinic through its interactions with the signals of two sets of aromatic protons. The 
olefinic protons 4-0  are likely to be cis orientated as Cieslinski previously identified the 
signal of the olefinic protons of the hermaphroditic CD 5.2(Z) to be a singlet. From the 
'H NMR spectrum the signals of the green /razis-stilbene and the purple m-stilbene 
protons integrate 1:1 and must therefore belong to the trans,cis-isomer 8.5(E,Z). The full 
structure is of the czs-stilbene unit coloured red is unknown but is probably the cis,cis- 
isomer 8.5(Z,Z). The formation of the cis,cis-isomer 8.5(Z,Z) would account for the 
observation of only one set of stilbene proton signals due to the symmetry of that species.
After analysing the 2D NMR spectra of the isomerisation mixture of the 
hermaphroditic [2]-rotaxane 8.5(E,E), the signals were thus assigned for three sets of 
stilbenes. It was impractical, however, to determine the exact conformations of the 
isomers 8.5(E,Z) and 8.5(Z,Z) due to their low concentration in the mixture.
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Figure 8.16. A section of the 500 MHz DQCOSY spectrum of the isomerisation mixture 
of the trans,trans-isomer 8.5(E,E) in D2O at 25 °C of the region where crosspeaks are 
observed between aromatic proton signals.
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Figure 8.17. A section o f the 500 MHz ROESY spectrum of the isomerisation mixture of 
the trans,trans-isomer 8.5(E,E) in D2O at 25 °C of the region where crosspeaks are 
observed between aromatic proton signals.
In conclusion, the hermaphroditic [2]-rotaxane 8.5(E,E) was synthesised using the 
triazine-based blocking reagent 6.9. The CD resides over the stilbene unit o f each o f the 
monomers to form a cyclic dimer. The structure o f the hermaphroditic [2]-rotaxane 
8.5(E,E) after 2D NMR assignment is shown in Figure 8.10. After irradiation o f the
182
A Dimethoxytriazine Blocked Hermaphroditic [2]-Rotaxane that Acts as a Molecular Muscle
hermaphroditic [2]-rotaxane 8.5(E,E) with 350 nm light, the trans,cis-isomer 8.5(E,Z) 
formed. Irradiation for a longer period of time formed the cis,cis-isomer 8.5(Z,Z). In the 
isomerisation of the [2]-rotaxanes 7.1 and 7.2 to their cis-isomers 7.1(Z) and 7.2(Z), the 
CD shuttled from their stilbene units. It is therefore very likely that the formation of cis- 
stilbenes of the hermaphroditic [2]-rotaxane 8.5(Z,Z) causes the CDs to shuttle to the 
alkyl chain but this has not been unambiguously determined. The irradiation of the 
isomer mixture with 254 nm light reformed the hermaphroditic [2]-rotaxane 8.5(E,E). In 
viewing the structures of the isomers of the hermaphroditic [2]-rotaxanes 8.5(E,E), 
8.5(E,Z) and 8.5(Z,Z) shown in Scheme 8.3, the length of the molecule likely contracts 
upon the isomerisation of the stilbene units. This system could therefore be viewed as 
photochemically reversible molecular muscle.
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Conclusions and Future Directions
Chapter 9: Conclusions and Future Directions
From the work described in this thesis, various structures have been made using 
CDs and stilbene units. Through the isomerisation of these stilbene units these structures 
have been shown to introduce function in what can be seen as CD based molecular 
devices. The isomerisation of the stilbene of the hermaphroditic CD 5.5(E) was shown to 
alter its transport capabilities with the organic dye 5.8. Also, the ditopic CD [2]-rotaxanes
7.1, 7.2, 7.6 and 7.7 and the hermaphroditic CD [2]-rotaxane 8.5(E,E) were constructed. 
Upon the isomerisation of their stilbene units the CDs were propelled to other parts of the 
molecule. The [2]-rotaxanes 7.1, 7.2, 7.6 and 7.7 can be viewed as molecular shuttles 
while the hermaphroditic CD [2]-rotaxane 8.5(E,E) can be viewed as a molecular muscle. 
It can therefore be concluded that the use of CDs in conjunction with stilbene units can 
provide the basis of a variety of molecular devices.
As a result of the research conducted there are many future directions possible for 
the continuation of this project. In Chapter 6, the synthesis of the [2]-rotaxanes 6.7 and 
6.8 was described and entailed the use of triazine groups. The synthesis of the [2]- 
rotaxanes 6.7 and 6.8 was achieved in a two step procedure. The first step formed the [2]- 
rotaxane 6.7 before reaction with the amine 6.4 to form the [2]-rotaxane 6.8. A different 
reactive group could be attached to the [2]-rotaxane 6.7 in the formation of CD [2]- 
rotaxane polymers.
In Chapter 5, the acetamides 5.5(E) and 5.5(Z) were able to transport the dye 5.8 
along an HPLC column. The ds-isomer 5.5(Z), however, was more efficient in the 
transport of the dye 5.8. The isomerisation of the isomer 5.5(E) to the ds-isomer 
5.5(Z) had fulfilled the purpose of a machine to do work for the transport of the dye 5.8 
through a HPLC column. From Chapter 7, the isomerisation of the stilbenes of the [2]- 
rotaxanes 7.1, 7.2, 7.6 and 7.7 caused the CD to shuttle from the stilbene unit. By 
attaching the CD and one of the blocking groups to external objects as shown in Scheme
9.1, the energy of the movement may be harnessed.
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trans-[ 2]-rotaxane 
9.1(E)
encapsulated trans-stilbene
• • C M i
second binding unit
c/s-[2]-rotaxane
9-1 (Z)
i [
hv hv'
external objects
) r
cis-stilbene
blocking group
Scheme 9.1. Expected photochemical isomerisation of the stilbene unit of a /rans-stilbene 
based [2]-rotaxane 9.1(E) to produce its c/s-isomer 9.1(Z) that would cause the 
cyclodextrin to shuttle to the second cyclodextrin binding unit. The CD and one of the 
blocking groups are attached to external objects.
In Chapter 8, the stilbenes of the hermaphroditic CD [2]-rotaxane 8.5(E,E) were 
isomerised to form the cis,cis-isomer 8.5(Z,Z). The change in conformation of the 
stilbene units would cause the overall length of the molecule to contract in what can be 
seen as a molecular muscle. If each of the blocking groups was attached to an external 
object as shown in Scheme 9.2, the energy of the movement may be harnessed. If the two 
step triazine blocking strategy was used as it was done in the formation of the [2]- 
rotaxane 6.8, hermaphroditic [2]-rotaxane polymers may be formed. These polymers 
would be photochemically contractable and extendable.
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trans, frans-hermaphroditic 
[2]-rotaxane
9.2(E,E) encapsulated trans-stilbene b|ocking group
second binding unit
external objects
hv'
cis,cis-hermaphroditic [2]- 
rotaxane 
9.2(Z,Z)
c/s-stilbene
_A_
Scheme 9.2. Expected photochemical isomerisation of the stilbene units of the 
/rans,/ratts-hermaphroditic [2]-rotaxane 9.2(E,E) to produce its cfs,c«-isomer 9.2(Z,Z) 
that would cause the cyclodextrins to shuttle to the second cyclodextrin binding units. 
The CD and one of the blocking groups are attached to external objects.
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Chapter 10: Experimental 
General
'Hi NMR spectroscopy and 2D NMR spectroscopy were conducted using a Varian 
Mercury 300 spectrometer operating at 300 MHz, a Varian Inova 300 spectrometer 
operating at 300 MHz, a Varian Inova 500 spectrometer operating at 500 MHz, or a 
Varian Inova 600 spectrometer operating at 600 MHz. I3C NMR was conducted on either 
a Varian Mercury 300 spectrometer operating at 75 MHz, a Varian Inova 300 
spectrometer operating at 75 MHz, or a Varian Inova 500 spectrometer operating at 125 
MHz. The & and Sc values are reported in parts per million (ppm), while the J values are 
given in hertz (Hz). c/4-MethanoI with an isotopic purity of 99.8% was purchased from 
Apollo Scientific LTD. D2 O with an isotopic purity of 99.75% and d^-DMSO with an 
isotopic purity of 99.8% was purchased from Cambridge Isotope Laboratories Inc. d4- 
Methanol was referenced at S = 3.31 for !H and 39.5 for l3C NMR spectroscopy, d6- 
DMSO was referenced at S= 2.50 for 'H and 49.5 for l3C NMR spectroscopy. When D2 O 
was used, 3-(trimethylsilyl)-3,3,2,2-tetradeuteropropionic acid sodium salt (d4-TSP) was 
used as an external standard.
Low and high resolution electron impact (El) mass spectra were determined using 
a Micromass VG AutoSpec M mass spectrometer. Low resolution electrospray ionisation 
(ESI) mass spectrometry was conducted using a Micromass-Waters LC-ZMD single 
quadrupole liquid chromatograph mass spectrometer. High resolution ESI mass 
spectrometry was carried out on a Bruker Apex 4.7T FTICR mass spectrometer. Matrix- 
assisted laser desorption-ionisation time-of-flight (MALDI-TOF) mass spectrometry was 
conducted on a Bruker OmniFlex instrument. Mass spectral data are reported as a mass- 
to-charge ratio (tn/z).
Elemental analyses were performed by the Australian National University 
microanalytical service based at the Research School of Chemistry.
Thin layer chromatography (TLC) was carried out using aluminium backed 0.2 
mm thick silica gel 60 F254 plates purchased from Merck. The mobile phases used
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included n-butanol-ethanol-water (5:4:3 v/v/v) or /-propanol-ethanol-water-acetic acid 
(5:4:3:2 v/v/v/v). TLC plates were visualised with a 254 nm UV lamp and by treatment 
with a naphthalene-1,3-diol solution (0.1% w/v) in ethanol:water:H2S0 4  (200:157:43 
v/v/v). The R{ values are reported relative to the solvent front, aCD (1.15) or the starting 
material.
Analytical and semi-preparative high performance liquid chromatography (HPLC) 
was performed with a Waters 2695 Separation Module with a Waters 2996 Photodiode 
Array Detector running with Empower Pro Empower 2 software. Semi-preparative and 
preparative HPLC was performed with a Waters 600 Controller with a Waters 717 plus 
Autosampler and a Waters 2996 Photodiode Array Detector running with Empower Pro 
Empower 2 software. All separations were collected with a Waters Fraction Collector III.
UV/visible studies were conducted using a Shimadzu UV-2450 UV/visible 
spectrophotometer with a Shimadzu CPS-temperature controller running with UV Probe 
Version 2.10 software.
A Luzchem photoreactor was used to irradiate samples in conjunction with UV-A 
fluorescent lamps (for 350 nm irradiation) and UV-C fluorescent lamps (for 254 nm 
irradiation). A 400-1000W Oriel Research Arc Lamp with a 1000W Hg(Xe) OF source 
and a 370 nm Oriel filter was also used to irradiate samples.
Melting points were determined using a Reichert hot-stage microscope and were 
not corrected.
aCD (1.15) was acquired from the Nihon Shokuhin Kako Co. Japan in 99.1% 
purity and was dried over P2O5 under reduced pressure to constant weight. The Diaion 
HP-20 resin was purchased from Supelco, PA. All other starting materials, solvents and 
reagents were purchased from Aldrich, Ajax, Auspep, BDH, Fluka, Labscan, Lancaster, 
Merck or Unilab. HPLC solvents were purchased from J. T. Baker and MilliQ H2O was 
purified using either a MilliQ reagent system or an ELGA system.
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Experimental for Chapter 2
4-(A-(tert-Butoxycarbonyl)amino)phenylacetic acid (2.9)
N 
H
2.9
Method: From the amino acid 2.8 (1.000 g, 6.62 mmol), the carbamate 2.9 was produced 
according to the reaction conditions stated by Gibbs et al.,69 and worked up according to 
the procedure of Jacobson et al.,10 to produce a colourless powder. The crude material 
was used in the following reaction without further purification. For characterisation 
purposes a small portion of the crude material was recrystallised from EtOH/O.1% aq. 
citric acid to form colourless needles.
Yield: 1.102 g, 66%.
Melting point: 155-158 °C, lit.69'72 141.5-142.5, 153-154, 197-198 °C.
Mass spectrum: m/z (El) 251.1 (M+').
JH NMR: &(300 MHz; J 6-DMSO) 12.25 (1 H, s, COOH), 9.29 (1 H, s, ArNHCO), 7.37 
(2 H, d, J 8.4, CH=CH), 7.12 (2 H, d, J 8.4, CH=CH), 3.46 (2 H, s, COCH2Ar), 1.47 (9 
H, s, C(CH3)3).
(Zs)-(4-(A-(tert-Butoxycarbonyl)amino)phenylacetamido)-4’-aminostilbene (2.10)
Method: Under an atmosphere of nitrogen, the carbamate 2.9 (0.500 g, 1.99 mmol), the 
stilbene 1.30 (1.255 g, 5.97 mmol) and BOP (1.319 g, 2.58 mmol) were dissolved in
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anhydrous DMF (10 cm3). TEA (1 cm3, 7.17 mmol) was then added and the mixture was 
stirred for two days. The reaction mixture was then subjected to preparative HPLC with 
the desired fractions combined and concentrated under reduced pressure. The residue was 
then recrystallised from aqueous ethanol to give the carbamate 2.10 as a light brown 
powder.
Yield: 0.385 g, 44%.
Melting point: 203-205 °C.
Mass spectrum: m/z (ESI) 444.0 (M+ + H).
lH  NMR: 500 MHz; d4-methanol) 7.51 (2 H, d, J  8.0, CH=CH), 7.42 (2 H, d, J  8.0,
CH=CH), 7.36 (2 H, d, J  8.0, CH=CH), 7.29 (2 H, d, J  8.0, CH=CH), 7.26 (2 H, d, J  8.0, 
CH=CH), 6.98 (1 H, d, J  16.0, CH=CH), 6.87 (1 H, d, J  16.0, CH=CH), 6.69 (2 H, d, J  
8.0, CH=CH), 3.61 (2 H, s, COCH2Ar), 1.51 (9 H, s, C(CH3)3).
13C NMR: *(125 MHz; J4-methanol) 173.3, 156.2, 149.6, 140.3, 139.3, 136.6, 131.8, 
131.3, 130.2, 129.8, 129.4, 128.2, 125.7, 122.2, 120.8, 117.3,44.9 and 29.6.
Elemental analysis: Found: C, 72.87; H, 6.20; N, 9.57. C27H29N3O3 requires C, 73.11; H, 
6.59; N, 9.47%.
HPLC: ?r  14.2 min (column: YMC-PACK ODS-AQ, 250 x 20 mm with YMC- 
Guardpack ODS-AQ, 50 x 20 mm; H20/MeCN gradient).
Time
(min)
Flow
(cm3m in 1)
h 2o
(%)
MeCN
(%)
0 10 50 50
15 10 0 100
17 10 0 100
18 10 50 50
20 10 50 50
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(Zs)-4-(4-Aminophenylacetamido)-4’-aminostilbene (2.11)
2.11
Method: To a stirring suspension of the carbamate 2.10 (0.300 g, 0.68 mmol) in DCM 
(50 cm3), TFA (2 cm3, 25.9 mmol) was added drop wise to produce a dark red solution. 
After 4 hours the solvent was removed and the residue suspended in water (100 cm3). The 
suspension was washed with diethyl ether (30 cm3) before being adjusted to pH 12 with 5 
M NaOH to produce a yellow precipitate. The mixture was extracted with EtOAc (4 x 
100 cm3), dried over anhydrous MgSCri and concentrated under reduced pressure to 
afford the diamine 2.11 as a yellow powder which was carried over into the next 
procedure without further purification.
Yield: 0.203 g, 87%.
Melting Point: 189-191 °C.
Mass spectrum: m/z (HI-RES El) Found: 343.1687 (M+\ C22H21N3O). Calculated: 
343.1685.
JH NMR: &(300 MHz; db-DMSO) 7.55 (2 H, d, J 8.4, CH=CH), 7.41 (2 H, d, J 8.4, 
CH=CH), 7.24 (2 H, d, J 8.4, CH=CH), 6.97 (2 H, d, J 8.4, CH=CH), 6.90 (1 H, d, J 16.5, 
CH=CH), 6.81 (1 H, d, J 16.5, CH=CH), 6.54 (2 H, d, J 8.4, CH=CH), 6.50 (2 H, d, J 8.4, 
CH=CH), 5.26 (2 H, s, ArNH2), 4.93 (2 H, s, ArNH2), 3.40 (2 H, s, COCH2Ar).
13C NMR: £(125 MHz; ^-DMSO) 169.8, 148.5, 147.2, 137.9, 132.9, 129.5, 127.7, 
127.4, 126.0, 124.9, 122.8, 122.4, 119.1, 113.9, 42.7 and 28.1.
[(£)-4-(4-(2,4,6-trinitrophenylamino)phenylacetamido)-4’-(2,4,6- 
trinitrophenylamino)stilbene]-[a-cyclodextrin]-[2]-[rotaxanes] (2.12 and 2.13)
were
Method: The diamine 2.11 and aCD (1.15) was suspended in a 0.2 M carbonate buffer 
(pH 10.0, 200 cm3) and stirred at room temperature for 24 hours. The trinitrophenyl
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blocking reagent 1.31 was added and the reaction mixture was stirred for three days. The 
reaction mixture was then washed with diethyl ether (100 cm ) and filtered. The filtrate 
was applied to a Diaion HP-20 column (300 mm x 20 mm). The column was flushed with 
MQ H2O until no unreacted ocCD (1.15) was detected by TLC. The column was then 
flushed with methanol until all of the reacted aCD (1.15) was removed as detected by 
TLC. The solvent was removed under pressure and the crude product was dissolved in 
DMF and subjected to preparative reverse-phase HPLC. Fractions containing the [2]- 
rotaxanes 2.12 and 2.13 were isolated and lyophilised as red powders.
Yield: 0.023 g, 2.2%.
TLC: (5:4:3 v/v/v «-butanol-ethanol-water) R\ 0.72 (relative to the solvent front), 1.64 
(relative to aCD (1.15)).
Melting point: 296 °C (dec.).
Mass spectrum: m/z (ESI) 1736.4 (M‘).
*H NMR: &(500 MHz; </6-DMSO) 10.22 (1 H, s, I), 8.88 (4 H, s, A and N), 7.73 (2 H, d, 
J 8.0, G), 7.61 (2 H, d, J 8.0, H), 7.30 (2 H, d, J 8.0, K), 7.12-7.04 (6 H, m, C, D and L), 
7.01 (1 H, d, J 16.0, F), 6.81 (1 H, d, J 16.0, E), 5.47-5.42 (6 H, m, CD-OH2), 5.27 (6 H, 
s, CD-OH3), 4.76-4.72 (6 H, m, CD-H1), 4.37-4.33 (6 H, m, CD-OH6), 3.69 (2 H, s, J), 
3.68-3.60 (12 H, m, CD-H5 and CD-H3), 3.60-3.54 (6 H, m, CD-H6A B), 3.48-3.42 (6 H, 
m, CD-H4), 3.40-3.30 (6 H, m, CD-H6A B), 3.24-3.18 (6 H, m, CD-H2).
13C NMR: *(125 MHz; J 6-DMSO) 168.9, 137.0-139.0 (br), 130.2, 127.6, 126.5-127.5 
(br), 126.0, 120.0-121.0 (br), 119.1, 111.4, 102.1,81.7,73.2, 72.1,71.8,59.1 and 42.5. 
Elemental analysis: (Found: C, 42.64; H, 5.45; N, 6.55. C70H83N9O43.I3H2O requires C, 
42.62; H, 5.57; N, 6.39%).
HPLC: tR 45.9 min (column: YMC-PACK ODS-AQ, 250 x 20 mm; 25% aq. MeCN; 
flow rate: 10.0 cm'min' ).
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UV/visible spectrum: ^max = 230 nm, £230 = 38660.5 M 'cm"1; 7*max = 337.5 nm, £337.5 =  
34769.7 M 'W 1; = 392.5 nm, £392.5 = 32286.1 M 'W 1.
G H
Yield: 0.021 g, 2.1%.
TLC: (5:4:3 v/v/v n-butanol-ethanol-water) Rf 0.71 (relative to the solvent front), 1.61 
(relative to aCD (1.15)).
Melting point: 294 °C (dec.).
Mass spectrum: m/z (HI-RES ESI) Found: 1760.4464 (M+ + Na. C70H83N9O35). 
Calculated: 1760.4482.
lH NMR: 4(500  MHz; d6-DMSO) 10.24 (1 H, s, I), 8.94 (4 H, m, A and N), 7.76-7.68 
(2 H, m, D), 7.60 (2 H, d, J 7.5, H), 7.27 (2 H, d, J  7.5, K), 7.20-7.12 (4 H, m, C and G), 
7.10-7.04 (2 H, m, L), 6.97 (1 H, d, J 16.0, E), 6.88 (1 H, d, J 16.0, F), 5.22-5.18 (6 H, m, 
CD-OH2), 5.18-5.14 (6 H, m, CD-OH3), 4.77-4.74 (6 H, m, CD-H1), 4.44-4.38 (6 H, m, 
CD-OH6), 3.70-3.64 (14 H, m, J, CD-H3 and CD-H5), 3.58-3.52 (6 H, m, CD-H6AB), 
3.47-3.42 (6 H, m, CD-H4), 3.28-3.18 (6 H, m, CD-H6AB and CD-H2).
13C NMR: 4(125 MHz; d6-DMSO) 138.0-139.0 (br), 130.2, 126.0-128.0 (br), 120.0- 
121.0 (br), 118.5, 111.4, 102.1, 81.5, 73.2, 72.3, 71.7, 59.2 and 42.3.
Elemental analysis: (Found: C, 43.69; H, 5.26; N, 6.32. C70H83N9O35.IOH2O requires C, 
43.82; H, 5.41; N, 6.57%).
HPLC: tR 48.8 min (column: YMC-PACK ODS-AQ, 250 x 20 mm; 25% aq. MeCN; 
flow rate; 10.0 cnr'min'1).
UV/visible spectrum; 7,max = 231 nm, £231 =26056.3 M ' e m '; Xmax = 337.5 nm, 
£337.5 = 13782.6 M 'cm"1; Xmax = 394 nm, £394 = 23151.4 M 'em"1.
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Experimental for Chapter 3
Attempted Photochemical Isomerisation of the [2]-rotaxanes 2.12 and 2.13
The [2]-rotaxane 2.12 (0.0021 g, 0.0012 mmol) was made up to a concentration of 2.42 x
10'5 M in MQ tTO (50 cm3). The [2]-rotaxane 2.13 (0.00079 g, 0.00045 mmol) was
made up to a concentration of 2.27 x 10’5 M in MQ fTO (20 cm3). The [2]-rotaxanes 2.12
and 2.13 were analysed for their molar responses using analytical reverse-phase HPLC
for a 10 pi injection. Their absorbance was analysed using a UV/visible
spectrophotometer. 3 cm3 aliquots of the solutions were then sealed in a 10 mm i.d.
quartz tube and irradiated with ten 350 nm UV-A lamps for 24 hours in a photolysis
WAS
reactor. At time periods during the irradiation, an aliquot of the solutions were subjected
to HPLC while the UV/visible spectra were once again recorded. The solution was then
sealed and irradiated with ten 254 nm UV-C lamps for 15 minutes. The UV/visible
was
spectra of the solutions were recorded and an aliquot of the solutions w#re subjected to 
HPLC.
Attempted Acid-Base Controlled Shuttling of the [2]-rotaxane 2.12
The [2]-rotaxane 2.12 (0.0055 g, 0.0032 mmol) was made up to a concentration of 6.33 x 
10' M in ^-methanol (0.5 cm ) in an NMR spectroscopy tube. The solution was then 
adjusted to a pD of 3.6 with 0.5 M DC1 as determined using a micro combination pH 
electrode. A 'H NMR experiment was then performed on the solution. The pD of the 
solution was then elevated by the addition of 0.5 M NaOD. At pDs of 5.5, 6.6, 7.2, 8.1, 
9.9, 10.3, 10.9 and 11.3 the 'H NMR spectrum was recorded for the solution.
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(Zs)-AK6A-Deoxy-a-cyclodextrin-6A-yl)aminocarbonyl-4-(3-propionamido)-4’- 
aminostilbene (3.7)
Method: Under an atmosphere of nitrogen, the succinic acid 3.6 (0.300 g, 0.279 mmol), 
the stilbene 1.30 (0.177 g, 0.839 mmol) and DMT-MM (0.232 g, 0.839 mmol) were 
dissolved in anhydrous DMF (5 cm3). TEA (0.8 cm3, 5.59 mmol) was then added and the 
mixture was stirred for two days. The reaction mixture was precipitated with acetone (20 
cm3). The precipitate was collected by centrifugation and resuspended in acetone (3 x 20 
cm ). The precipitate was recollected by centrifugation, dissolved in MQ H2 O (200 cm ) 
and subjected to a Diaion HP-20 column (300 mm x 20 mm). The column was then 
flushed with MQ H2 O (1 dm3). The column was then eluted with MQ H20-methanol 
gradient. The fractions (35-65% methanol) containing the hermaphroditic CD 3.7 were 
combined, concentrated under reduced pressure and lyophilised.
Yield: 0.181 g, 51%.
Mass spectrum: m/z (ESI) 1264.2 (M+ -1- H).
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Attempted synthesis of the [(Zs)-A-(6A-Deoxy-a-cyclodextrin-6A-yl)aminocarbonyl-4- 
(3-propionamido)-4’-(2,4,6-trinitrophenylamino)stilbene]-[c2]-[daisy chain] (3.9)
Method: The hermaphroditic CD 3.7 (0.181 g, 0.143 mmol) was suspended in a 0.2 M 
carbonate buffer (pH 10.0, 20 cm3) and stirred at room temperature for 24 hours. The 
trinitrophenyl blocking reagent 1.31 was added and the reaction mixture was stirred for 
four days. The reaction mixture was then washed with diethyl ether (200 cm ) and the 
aqueous layer was concentrated under reduced pressure. The red residue was dissolved in 
DMF and a trace amount of the hermaphroditic [2]-rotaxane 3.9 was obtained through 
semi-preparative reverse-phase HPLC.
Mass spectrum: m/z (MALDI) 2972.8 (M+ + Na).
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(E)-4,4 ’ -Diacrylamidostilbene (4.2)
Method: To a stirring solution of the stilbene 1.30 (0.100 g, 0.476 mmol) in DMF (5 
cm3) and TEA (1 cm3, 7.17 mmol), the acid chloride 4.1 (0.430 g, 4.751 mmol) was 
added. The reaction mixture was stirred for three days before being precipitated with 
acetone (100 cm3). The resultant suspension was centrifuged and the supernatant was 
decanted and precipitated with fTO (100 cm ). The resultant suspension was subjected to 
centrifugation and the supernatant was discarded. The precipitation with I-bO and 
centrifugation was repeated a further two times. The residual solvent was removed in 
vacuo to give the title compound as a yellow powder.
Yield: 0.107 g, 71%.
Melting point: >300 °C.
Mass spectrum: m/z (HI-RES ESI) Found: 317.1296 ((M - H)\ C2 0H 18N2O2 ). 
Calculated: 317.1290.
!H NMR: &(300 MHz ; d6-DMSO) 10.23 (2 H, s, CONHAr), 7.68 (4 H, d, J 8.4, 
CH=CH), 7.54 (4 H, d, J 8.4, CH=CH), 7.12 (2 H, CH=CH), 6.45 (2 H, dd, J 17.1 and 
9.9, CH=CH2), 6.27 (2 H, dd, J 17.1 and 2.1, CH=CH2), 5.76 (2 H, dd, J 9.9 and 2.1, 
CH=CH2).
199
Chapter 10
Attempted synthesis of the [(£)-4,4’-Bis(3-mesitylisoxazolin-5-ylamido)stilbene]-[a- 
cyclodextrin]-[2]-[rotaxane] (4.4)
r Q HN
NH O
Method: The stilbene 4.2 (0.100 g, 0.314 mmol) was suspended in a solution of aCD 
(1.15) (1.527 g, 1.570 mmol) and MQ H20  (100 cm3) and stirred for 24 hours. The nitrile 
oxide 4.3 (0.111 g, 0.690 mmol) was then added to the suspension and the stirring was 
continued. After three days the precipitate was filtered and the filtrate was applied to a 
Diaion HP-20 column (300 mm x 20 mm). The column was flushed with MQ H20  until 
no unreacted aCD (1.15) was detected by TLC. The column was then flushed with 
methanol until all of the remaining products on the column had been removed. The 
solvent was removed under pressure and the crude product was dissolved in DMF and 
subjected to preparative reverse-phase HPLC.
(£')-4-Amino-4’-(a‘CycIodextrin-6A-yl)stilbene (4.6)
B D
Method: The tosylate 1.19 (1.000 g, 0.877 mmol), 4 4 -aminohydroxystilbene (0.563 g,
A
2.662 mmol) and potassium carbonate (1.226 g, 8.773 mmol) were dissolved in 
anhydrous DMF (30 cm3) under an atmosphere of nitrogen. The reaction mixture was 
heated at 80 °C and stirred for 2 days. The reaction mixture was allowed to cool to room 
temperature and was precipitated with acetone (100 cm ). The precipitate was collected
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by centrifugation and resuspended in acetone (3 x 100 cm3). The precipitate was 
recollected by centrifugation, dissolved in MQ H2O and subjected to a Diaion HP-20 
column (300 mm x 20 mm). The column was then flushed with MQ H2O (1 dm3). The 
column was then eluted with MQ H20-methanol gradient. The fractions (20-65% 
methanol) containing the hermaphroditic CD 4.6 were combined, concentrated under 
reduced pressure and lyophilised. The solid was dissolved in MQ H2O/DMF and 
subjected to preparative reverse-phase HPLC. Fractions containing the title product 4.6 
were isolated and lyophilised to give a light brown coloured powder.
Yield: 0.267 g, 26%.
TLC: (5:4:3 v/v/v n-butanol-ethanol-water) Rf 0.51 (relative to the solvent front), 1.00 
(relative to ocCD tosylate (1.19)).
Melting point: 267 °C (dec.).
Mass spectrum: m/z (HI-RES ESI) Found: 1166.4168 (M+ + H. C50H71NO30). 
Calculated: 1166.4139
*H NMR: Sn(500 MHz; D20) 7.67 (2 H, d, J  8.0, E), 7.19 (2 H, d, J 8.0, B), 7.01 (2 H, d, 
J 8.0, F), 6.91 (1 H, d, J 16.5, D), 6.74 (1 H, d, J 16.5, C), 6.68 (2 H, d, J 8.0, A), 4.91- 
5.15 (6 H, m, CD-H1), 3.25-4.35 (36 H, m, CD-H2, CD-H3, CD-H4, CD-H5, CD-H6A B). 
HPLC: tR 12.6 min (column: YMC-PACK ODS-AQ, 250 x 20 mm; 25% aq. MeCN; 
flow rate: 10.0 cnrm in '1).
(E)-4-Acrylamido-4’-(a-cyclodextrin-6A-yl)stilbene (4.7)
J
C E F Q
Method: To a stirring solution of the hermaphroditic CD 4.6 (0.267 g, 0.229 mmol) and 
TEA (0.717 g, 7.085 mmol) in MQ H2O (25 cm3), the acid chloride 4.1 (0.207 g, 2.285 
mmol) was added. The reaction mixture was stirred for 16 hours then subjected to
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preparative reverse-phase HPLC. Fractions containing the hermaphroditic CD 4.7 were 
isolated and lyophilised to give a colourless powder.
Yield: 0.232 g, 83%.
TLC: (5:4:3 v/v/v «-butanol-ethanol-water) R{ 0.61 (relative to the solvent front), 1.15 
(relative to the hermaphroditic CD 4 .6).
Melting point: 232 °C (dec.).
Mass spectrum: m/z (HI-RES ESI) Found: 1242.4003 (M+ + Na. C53H73NO31). 
Calculated: 1242.4064.
’H NMR: &(500 MHz; D20 ) 7.69 (2 H, d, J  8.0, E or F), 7.62 (2 H, d, J  8.0, E or F), 
7.08 (2 H, d, J  8.0, B), 6.84 (2 H, d, J  16.0, C or D), 6.77 (2 H, d, J  16.0, C or D), 6.56 (2 
H, s, J  8.0, A), 6.34 (1 H, dd, J  10.0 and 17.0, H), 6.24 (1 H, apparent d, J  17.0, J), 5.76 
(1 H, apparent d, J  10.0, I), 5.00-4.75 (6  H, CD-H1), 4.20-3.04 (36 H, CD-H2, CD-H3, 
CD-H4, CD-H5 and CD-H6 A B).
13C NMR: £(125 MHz; d6-DMSO) 163.0, 158.1, 138.1, 132.8, 131.9, 129.8, 127.5, 
126.9, 126.6, 125.7, 119.4, 114.7, 102.2, 102.0, 101.8, 82.3, 82.1, 73.3, 72.1, 69.6, 66.7 
and 60.0.
Elemental analysis: (Found: C, 47.64; H, 6.32; N, 0.92. C53H73NO31.6 H2O requires C, 
47.93; H, 6.45; N, 1.05%).
HPLC: tR 10.4 min (column: YMC-PACK ODS-AQ, 250 x 20 mm; 30% aq. MeCN; 
flow rate: 1 0 .0  cm3min'1).
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Attempted synthesis of the [(Zs)-4-(3-Mesitylisoxazolin-5-ylamido)-4’-(a- 
cyclodextrin-6A-yl)stilbene]-[c2]-[daisy chain] (4.9)
O HN NH p^i
Method: The acrylamide 4.7 (0.100 g, 0.082 mmol) was dissolved in MQ H2O (10 cm3) 
and stirred for 24 hours. A solution of the nitrile oxide 4.3 (0.017 g, 0.172 mmol) in DMF 
(0.1 cm3) was then added dropwise over several minutes to produce a white suspension 
and the stirring was continued. After six days the nitrile oxide 4.3 appeared by TLC to be 
completely consumed. A further amount of the nitrile oxide 4.3 (0.012 g, 0.074 mmol) 
dissolved in DMF (0.1 cm ) was added dropwise to the reaction vessel and the suspension 
was stirred for another three days. After this time period there was none of the acrylamide 
4.7 present in the suspension by TLC. DMF (5 cm3) was added to the reaction to dissolve 
the white suspension and it was subjected to preparative reverse-phase HPLC.
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Experimental for Chapter 5
(£')-4-Acetamido-4’-(a-cyclodextrin-6A-yl)stilbene (5.5(E))
A B
Method: To a stirring solution of the hermaphroditic CD 4.6 (0.145 g, 0.124 mmol) and 
TEA (0.013 g, 0.248 mmol) in MQ H2O (20 cm3), the anhydride 5.4 (0.013 g, 0.248 
mmol) was added. The reaction mixture was stirred for 3 days then subjected to semi-
preparative reverse-phase HPLC. Fractions containing the hermaphroditic CD 5.5(E) 
were combined and lyophilised to give a colourless powder.
Yield: 0.079 g, 53%.
TLC: (5:4:3 v/v/v n-butanol-ethanol-water) R{ 0.53 (relative to the solvent front), 1.50 
(relative to ocCD (1.15)).
Melting point: 245 °C (dec.).
Mass spectrum: m/z (ESI) 1208.1 (M+ + H).
!H NMR: &(500 MHz ; D20) 7.82 (2 H, d, J 8.0, E), 7.67 (2 H, d, J 8.0, F), 7.23 (2 H, d, 
J 8.0, B), 7.00 (1 H, d, J 16.0, C or D), 6.92 (1 H, d, J  16.0, C or D), 6.71 (2 H, d, J 8.0, 
A), 5.16-4.91 (6 H, CD-H1), 4.34-3.18 (36 H, CD-H2, CD-H3, CD-H4, CD-H5 and CD- 
H6a  b), 2.22 (3 H, s, H).
13C NMR: <5fc(125 MHz; D20 ) 175.7, 160.8, 140.2, 135.7, 131.3, 130.2, 129.8, 128.5, 
124.0, 117.6, 105.3, 105.1, 104.5, 104.2, 85.3, 84.4, 84.3, 83.8, 83.4, 76.6, 76.5, 76.3, 
76.2, 76.1, 75.8, 74.6, 72.7, 69.3, 63.1, 63.0, 62.5, 62.0 and 25.9.
Elemental analysis: (Found: C, 47.72; H, 6.37; N, 0.97. C52H73N03i.6H20  requires C, 
47.45; H, 6.51;N, 1.06%).
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HPLC: rR 22.8 min (column: YMC-PACK ODS-AQ, 250 x 10 mm; H20/MeCN 
gradient).
Time
(min)
Flow
(cm3 min'1)
H20
(%)
MeCN
(%)
0 3 90 10
25 3 65 35
26 3 90 10
30 3 90 10
UV/visible spectrum: Xmax = 233.5 nm, 8 2 3 3 .5  =9000 M ’cm'1; 7.max = 338 nm, 
8338 = 27160 M’W .
(Z)-4-Acetamido-4’-(a-cyclodextrin-6A-yl)stilbene (5.5(Z))
A B
Method: The acetamide 5.5(E) was dissolved in MQ H20  (660 cm ) and placed in a 1 
dnr quartz round bottom flask. The mixture was then irradiated with light of wavelength 
350 nm (10 lamps) for five minutes. The reaction mixture was then lyophilised, dissolved 
in 25% aqueous MeCN and subjected to semi-preparative reverse-phase HPLC. Fractions 
containing the acetamide 5.5(Z) were combined and lyophilised to give a colourless 
powder.
Yield: 0.008 g, 40%.
TLC: (5:4:3 v/v/v n-butanol-ethanol-water) Rf  0.59 (relative to the solvent front), 1.69 
(relative to aCD (1.15)).
Melting point: 244 °C (dec.).
Mass spectrum: m/z (HI-RES ESI) Found: 1208.4195 (M+ + H, C52H73NO31). 
Calculated: 1208.4244
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*H NMR: &(500 MHz; D20) 7.28 (2 H, d, J 7.5, E or F), 7.24 (2 H, d, J 7.5, E or F), 
7.20 (2 H, d, J 7.5, B), 6.83 (2 H, d, J 7.5, C or D), 6.59 (1 H, d, J 12.0, C or D), 6.55 (1 
H, d, J 12.0, C or D), 5.10-5.00 (6 H, CD-H1), 4.38-3.55 (36 H, CD-H2, CD-H3, CD-H4, 
CD-H5 and CD-H6A B), 2.14 (3 H, s, H).
13C NMR: <£(125 MHz; J4-methanol/D20) 173.3, 159.1, 138.2, 135.4, 131.9, 130.8, 
129.9, 121.8, 115.8, 103.7, 103.5, 103.3, 83.5, 83.2, 82.9, 82.6, 75.4, 75.3, 75.2, 73.8, 
73.6, 73.5, 72.0, 68.7, 61.8, 61.6 and 24.4.
Elemental analysis: (Found: C, 43.87; H, 6.56; N, 0.98. C52H73NO31.I2H2O requires C, 
43.85; H, 6.86; N, 0.98%).
HPLC: tR 25.9 min (column: YMC-PACK ODS-AQ, 250 x 10 mm; H20/MeCN 
gradient).
Time
(min)
Flow
(cm3m in ')
h 2o
(%)
MeCN
(%)
0 3 90 10
25 3 65 35
26 3 90 10
30 3 90 10
UV/visible spectrum: Xmäx = 192 nm, 8192 =38269.2 M 'em '1; 7.max = 236 nm, 
8338 = 15384.6 M‘'cm ', ?imax = 297.5 nm, 8297.5 = 12756.4 M 'em '.
Photochemical interconversion between the acetamides 5.5(E) and 5.5(Z)
5.5(E)
The acetamide 5.5(E) (0.0015 g, 0.0012 mmol) was made up to a concentration of 2.50 x 
105 M in MQ H20  (50 cm3). The acetamide 5.5(E) solution was analysed for its molar 
response using analytical reverse-phase HPLC for a 10 jul injection and its absorbance 
using UV/visible spectrophotometer. A 1 cm aliquot of the solution was then sealed in a 
quartz UV/visible cell and irradiated with ten 350 nm UV-A lamps for two minutes in a 
photolysis reactor. An aliquot of the solution was then subjected to HPLC while the 
absorbance was once again recorded. The solution was again resealed and irradiated with
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ten 254 nm UV-C lamps for two minutes. The UV/visible spectrum of the solution was 
recorded and an aliquot of the solution was subjected to HPLC.
5.5(Z)
The acetamide 5.5(Z) (0.001 g, 0.00083 mmol) was made up to a concentration of 1.56 x 
10" M in MQ H2 O (50 cm ). The solution was analysed before and after each irradiation 
using UV/visible spectroscopy and analytical reverse-phase HPLC as for the acetamide 
5.5(E). The only difference was that the solution was irradiated with ten 254 nm UV-C 
lamps for one minute in a photolysis reactor before being irradiated with ten 350 nm UV- 
A lamps for one minute.
HPLC: 5.5(Z) tR 17.7 min, 5.5(E) tR 20.5 min, (column: YMC-PACK ODS-AQ, 250 x 
4.6 mm; H20/MeCN gradient).
Time Flow h 2o MeCN
(min) (cm3min ') (%) (%)
0 1 90 10
25 1 65 35
26 1 90 10
30 1 90 10
T ransport Assay
0.05 mol dm'3 Borax Buffer -  pH 9.0
Sodium tetraborate (76.284 g, 200 mmol) was dissolved in Milli-Q H2 O (4 dm3) and 
concentrated hydrochloric acid was added dropwise to adjust the solution to pH 9.
Methyl Orange Solutions
To 0.05 mol dm"3 borax buffer (1 dm3), methyl orange (5.8) (0.0164 g, 0.501 mmol) was 
added and the mixture sonicated until dissolved. Aliquots of 250, 100, 20, and 4 cm3 of 
the stock solution were removed and made up to 500 cm3 with 0.05 mol dm"3 borax 
buffer to produce concentrations of 2.5 x 10'5, 1 x 10"5, 2 x 10 6, and 4 x 10"7 M 
respectively.
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CD Solutions
Each of the CDs 1.15, 5.5(E) and 5.5(Z) (0.001 mmol) were made up to 1 cm3 with 0.05 
mol dm borax buffer to produce a solution of concentration 1 x 10' M.
HPLC Procedure
The transport coefficients for the CDs 1.15, 5.5(E) and 5.5(Z) were obtained using the 
Hummel and Dryer method,88 as adapted by Croft et al.*9 The 4 x 107 M methyl orange 
(5.8) solution was pumped through a Waters carbohydrate analysis HPLC column (25 °C) 
operating at a flow rate of 0.9 cm3 min'1, monitoring at an absorbance of 450 nm. The CD 
1.15, 5.5(E) or 5.5(Z) (20 |il) was then injected. The molar amount of the dye 5.8 
transported by the CD was then determined by comparing the areas of the negative peaks 
with a blank injection of borate buffer. The injection of the CDs 1.15, 5.5(E) and 5.5(Z) 
were then repeated for each of the methyl orange (5.8) solutions described above. Plotting 
the molar ratio (F) of guest bound to host injected against F/[guest] in a Scatchard plot90 
enabled the transport coefficient (K) for each of the CDs 1.15, 5.5(E) and 5.5(Z) for the 
dye 5.8 to be determined.
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Experimental for Chapter 6
[(Zs)-4,4’-Bis(3-chloro-5-methoxy-2,4,6-triazinylamino)stilbene]-[a-cyclodextrin]-[2]- 
[rotaxane] (6.7)
Method: To a stirred solution of aCD (1.15) (0.694 g, 0.713 mmol) in MQ-H2O (80 
cm3), TEA was added unit the pH of the solution reached 9. The stilbene 1.30 (0.050 g, 
0.238 mmol) was then added and the resultant suspension was stirred for two hours. The 
triazine 6.6 was added and the stirring was continued for another 17 hours. The reaction 
mixture was washed with EtOAc (3 x 50 cm ) and lyophilsed. The crude material was 
dissolved in 25% aqueous MeCN and subjected to preparative HPLC. The [2]-rotaxane 
6.7 was obtained after lyophilisation as a colourless powder.
Yield: 0.069 g, 19.8%.
TLC: (5:4:3 v/v/v n-butanol-ethanol-water) Rf 0.69 (relative to the solvent front), 1.79 
(relative to aCD (1.15)).
Melting point: 265 °C (dec.).
Mass spectrum: m/z (ESI) 1491.5 (M+ + Na).
NMR: 4(500  MHz; db-DMSO) 10.81 (1 H, s, B), 10.62 (1 H, s, I), 7.80 (2 H, d, J 
7.5, G), 7.76 (2 H, d, J 7.5, H), 7.71 (2 H, d, J 7.5, C), 7.27 (2 H, d, J 7.5, D), 7.02 (1 H, 
d, J 16.5, F), 6.83 (1 H, d, J  16.5, E), 4.75 (6 H, d, J  2.5, CD-H1), 4.04 (3 H, s, J), 4.00 (3 
H, s, A), 3.56-3.69 (18 H, m, CD-H6A B, CD-H3, CD-H5), 3.43 (6 H, apparent t, J 4.0, 
CD-H4), 3.29 (6 H, apparent d, J 6.0, CD-H6A B), 3.23 (6 H, dd, J 3.0 and 12.5, CD-H2). 
Elemental analysis: (Found: C, 42.87; H, 5.69; N, 6.61. C58H78CI2N8O32.9H2O requires 
C, 42.68; H, 5.93; N, 6.86%).
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HPLC: Tr  10.8 min (column: YMC-PACK ODS-AQ, 250 x 20 mm; 13% aq. MeCN; 
flowrate: 10.0 cm3 min'1).
[(Zs)-4,4’-Bis(3-anilino-5-methoxy-2,4,6-triazinylamino)stilbene]-[a-cyclodextrin]- 
[2]-[rotaxane] (6.8)
N
E
Method: To a stirring solution of the [2]-rotaxane 6.7 (0.030 g, 0.020 mmol) in MQ- 
ITO/MeCN (50:50, 10 cm3), TEA was added unit the pH of the solution reached 9. The 
amine 1.30 (0.019 g, 0.204 mmol) was then added and the reaction mixture was stirred at 
50 °C for three hours. The reaction mixture was then subjected to preparative HPLC. The 
[2]-rotaxane 6.8 was obtained after lyophilisation as a colourless powder.
Yield: 0.011 g, 33.4%.
TLC: (5:4:3 v/v/v n-butanol-ethanol-water) Rf 0.74 (relative to the solvent front), 2.08 
(relative to ocCD (1.15)).
Mass spectrum: m/z (HI-RES ESI) Found: 1583.5780 (M+ + H, C70H90N10O32). 
Calculated: 1583.5800.
*H NMR: &(500 MHz; db-DMSO) 9.81 (1 H, s, F), 9.71 (1 H, s, M), 9.47 (2 H, s, D and 
O), 7.83 (4 H, d, J 7.5, C and P), 7.75-7.80 (6 H, m, G, K and L), 7.31 (4 H, t, J  7.5, B 
and Q), 7.16 (2 H, unresolved, H), 7.00 (2 H, t, J  7.5, A and R), 6.88 (2 H, unresolved, I 
and J), 5.44 (6 H, s, CD-OH2), 5.31 (6 H, s, CD-OH3), 4.77 (6 H, d, J 3.0, CD-H1), 4.45 
(6H, apparent t, J 5.0, CD-OH6), 3.94 (6 H, s, E and N), 3.70-3.73 (12 H, m, CD-H3 and 
CD-H5), 3.61 (6 H, unresolved, CD-H6AB), 3.47 (6 H, apparent t, J 4.0, CD-H4), 3.32 (6 
H, unresolved, CD-H6A B), 3.26 (6 H, unresolved, CD-H2).
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13C NMR: 4(500  MHz; db-DMSO) 170.8, 164.9, 128.5, 125.7, 120.1, 102.1, 81.6, 73.2, 
72.2, 71.8, 59.2 and 54.0. (not all signals resolved due to broadness)
Elemental analysis: (Found: C, 46.74; H, 6.45; N, 7.52. C7oH9oN]o032.12H20 requires C, 
46.72; H, 6.38; N, 7.78%).
HPLC: tR 18.9 min (column: YMC-PACK ODS-AQ, 250 x 20 mm; 23% aq. MeCN; 
flow rate: 10.0 cm3min'').
[(£)-4,4’-Bis(3,5-dimethoxy-2,4,6-triazinylamino)stilbene]-[cx-cyclodextrin]-[2]- 
[rotaxane] (6.10)
V o M e  J
Method: To a stirred solution of aCD (1.15) (0.694 g, 0.713 mmol) in MQ-H2O (80 
cm ), TEA was added until the pH of the solution reached 9. The stilbene 1.30 (0.050 g, 
0.238 mmol) was then added and the resultant suspension was stirred for two hours. The 
triazine 6.9 was added and the stirring was continued for another 17 hours. The reaction 
mixture was washed with EtOAc (3 x 50 cm ) and lyophilised. The crude material was 
dissolved in 25% aqueous MeCN and subjected to preparative HPLC. The [2]-rotaxane 
6.10 was obtained after lyophilisation as a colourless powder.
Yield: 0.017 g, 4.8%.
TLC: (5:4:3 v/v/v ^-butanol-ethanol-water) Rf 0.55 (relative to the solvent front), 1.15 
(relative to ocCD (1.15)).
Melting point: 264 °C (dec.).
Mass spectrum: m/z (ESI) 1462.2 (M+ + H).
NMR: 4(500  MHz; 4-DM SO) 10.23 (1 H, s, B), 9.94 (1 H, s, I), 7.75-7.78 (4 H, m, 
G and H), 7.74 (2 H, d, J 8.0, C), 7.22 (2 H, d, J 8.0, D), 6.98 (1 H, d, J 16.0, F), 6.79 (1 
H, d, J 16.0, E), 5.42 (6 H, s, CD-OH2), 5.28 (6 H, s, CD-OH3), 4.75 (6 H, d, J 2.5, CD-
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Hl), 4.41 (6 H, apparent t, J 5.5, CD-OH6), 3.88-3.98 (12 H, m, A and J), 3.70 (6 H, 
apparent d, J 9.5, CD-H5), 3.65 (6 H, apparent t, J 9.0, CD-H3), 3.59 (6 H, unresolved, 
CD-H6a  b), 3.43 (6 H, apparent t, J  9.0, CD-H4), 3.30 (6 H, unresolved, CD-H6AB), 3.24 
(6 H, unresolved, CD-H2).
13C NMR: <5fc(125 MHz; ^-DM SO) 54.2-55.8 (br), 61.0, 71.8, 72.1, 73.2, 81.7, 102.1, 
119.7, 120.1, 125.2, 125.8, 127.3, 127.5, 131.0, 131.4, 133.5, 137.7, 138.0, 165.7, 165.8 
and 171.8-173.0 (br)
Elemental analysis: (Found: C, 43.70; H, 6.13; N, 6.60. C60H84NSO34.IOH2O requires C, 
43.90; H, 6.39; N, 6.83%).
HPLC: tR 13.6 min (column: YMC-PACK ODS-AQ, 250 x 20 mm; 10% aq. MeCN; 
flow rate: 10.0 cm3min'1).
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Experimental for Chapter 7
[(£)-4-(4-(3,5-dimethoxy-2,4,6-triazinylamino)phenylacetamido)-4’-(3,5-diinethoxy- 
2,4,6-triazinylamino)stilbene]-[a-cyclodextrin]-[2]-[rotaxanes] (7.1 and 7.2)
Method: To a stirred solution of aCD (1.15) (4.250 g, 4.370 mmol) in MQ H2 O (300 
cm ), the diamine 2.11 (0.300 g, 0.874 mmol) was added and the resultant suspension 
was stirred for 24 hours. The triazine 6.9 was added and the stirring was continued for 
another 3 days. The precipitate was filtered and the residue was extracted with MQ H2 O 
(3 x 100 cm ). The combined filrate was then subjected to Diaion HP-20 column (300 
mm x 20 mm). The column was flushed with MQ H2 O until no unreacted aCD (1.15) 
was detected by TLC. The column was then flushed with methanol until all of the reacted 
aCD (1.15) was removed as detected by TLC. The solvent was reduced under pressure 
and the crude product was dissolved in MeOH and subjected to preparative reverse-phase 
HPLC. Fractions containing the [2]-rotaxanes 7.1 and 7.2 were isolated and lyophilised as 
colourless powders.
G H
Yield: 0.047 g, 3.4%.
TLC: (5:4:3 v/v/v «-butanol-ethanol-water) R{ 0.64 (relative to the solvent front), 1.56 
(relative to aCD (1.15)).
Melting point: 255 °C (dec.).
Mass spectrum: m/z (ESI) 1594.5 (M+ + H).
NMR: <5k(500 MHz; d6-DMSO) 10.26-10.22 (2 H, m, B and I), 10.07 (1 H, s, M), 
7.73 (4 H, m, C and G), 7.65 (2 H, d, J  8.0, L), 7.62 (2 H, d, J  8.0, H), 7.32 (2 H, d, J  8.0, 
K), 7.18 (2 H, d, J 8.0, D), 7.01 (1 H, d, J 16.0, F), 6.85 (1 H, d, J 16.0, E), 5.44 (6 H,
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unresolved, CD-OH2), 5.27 (6 H, unresolved, CD-OH3), 4.75 (6 H, unresolved, CD-H1), 
4.40 (6 H, unresolved, CD-OH6), 3.95-3.90 (12 H, m, A and N), 3.70-3.62 (14 H, m, CO-
M3, CD-H5 and J), 3.43 (6 H, unresolved, CD-H6A B), 3.43 (6 H, t, J  8.5, CD-H4), 3.28- 
3.20 (12 H, m, CD-H2 and CD-H6AB).
13C NMR: £(125 MHz; ^-DM SO) 171.8, 169.2, 166.0, 165.8, 138.0, 137.3, 132.0, 
130.9, 130.7, 129.5, 127.4, 125.8, 125.2, 120.6, 119.6, 119.2, 102.1, 81.7, 73.3, 72.1, 
71.6, 59.2, 54.5 and 42.6.
Elemental analysis: (Found: C, 47.56; H, 5.99; N, 7.44. C68H91N9O35.7H2O requires C, 
47.47; H, 6.15; N, 7.33%).
HPLC: fR 13.1 min (column: YMC-PACK ODS-AQ, 250 x 20 mm with YMC- 
Guardpack ODS-AQ, 50 x 20 mm; 20% aq. MeCN; flow rate: 10.0 cm3min ‘).
UV/visible spectrum: Xmax = 196 nm, £ i 96 = 63348.3 M 'em '; X mdx = 235 nm, £235 = 
21452.4 M ' c m ' ;  ^max = 266 nm, £266 = 22726.8 M ''cm '';X max = 345.5 nm, £345.5 =  
42108.3 M 'cm '1.
C D
Yield: 0.018 g, 1.3%.
TLC: (5:4:3 v/v/v n-butanol-ethanol-water) R f 0.63 (relative to the solvent front), 1.54 
(relative to aCD (1.15)).
Melting point: 276 °C (dec.).
Mass spectrum: m/z (ESI) 1594.5 (M+ + H).
lH  NMR: <^(500 MHz; d6-DMSO) 10.23 (1 H, s, I), 10.08 (1H, s, M), 9.94 (1 H, s, B), 
7.79-7.73 (4 H, m, C and D), 7.66 (2 H, d, J  8.0, L), 7.59 (2 H, d, J  8.0, H), 7.30 (2 H, d, 
J  8.0, K), 7.18 (2 H, d, J  8.0, G), 6.96 (1 H, d, J  16.0, E), 6.77 (1 H, d, J  16.0, F), 5.40 (6 
H, unresolved, CD-OH2), 5.27 (6 H, unresolved, CD-OH3), 4.74 (6 H, unresolved, CD- 
Hl), 4.41 (6 H, t, J  5.0, CD-OH6), 3.98 (3 H, s, A), 3.90 (9 H, s, A and N), 3.68 (6 H, d, J
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9.5, CD-H5), 3.66-3.61 (8 H, m, CD-H3 and J), 3.57 (6 H, unresolved, CD-H6AB), 3.42 
(6 H, t, J 9.0, CD-H4), 3.27 (6 H, unresolved, CD-H6AB), 3.22 (6 H, unresolved, CD- 
H2).
13C NMR: &(125 MHz; </6-DMSO) 171.8, 169.2, 166.0, 165.7, 138.4, 137.7, 137.4, 
131.4, 131.2, 130.5, 129.4, 127.5, 127.2, 125.9, 125.2, 120.5, 120.0, 118.5, 102.1, 81.7, 
73.2, 72.1,71.7, 59.2, 54.5 and 42.7.
Elemental analysis: (Found: C, 46.56; H, 6.04; N, 6.98. C68H91N9O35.9H2O requires C, 
46.49; H, 6.25; N, 7.18%).
HPLC: tR 19.3 min (column: YMC-PACK ODS-AQ, 250 x 20 mm with YMC- 
Guardpack ODS-AQ, 50 x 20 mm; 20% aq. MeCN; flow rate: 10.0 cnr min ').
UV/visible spectrum: Xmax =  198 nm, £ i98 = 57029.4 M"’cm ‘; 7. m ax = 237 nm, £ 2 3 7  = 
19062.9 M ’cm '1; ^ max = 267 nm, £207 = 20549.7 M 'c irf1; X msix =  346 nm, £346 = 36692.1 
M '!cm '\
(£>4-(3-(A-(tert-Butoxycarbonyl)amino)propionamido)-4’-aminostilbene (7.4)
Method: Under an atmosphere of nitrogen, the carbamate 7.3 (0.500 g, 2.64 mmol), the 
stilbene 1.30 (1.667 g, 5.97 mmol) and BOP (1.753 g, 3.96 mmol) were dissolved in 
anhydrous DMF (10 cm3). TEA (2 cm3, 14.34 mmol) was then added and the mixture 
was stirred for three days. The reaction mixture was then subjected to preparative HPLC 
with the desired fractions combined and concentrated under reduced pressure. The 
residue was then recrystallised from aqueous ethanol to give the carbamate 7.4 as a light 
brown powder.
Yield: 0.708 g, 70%.
Melting point: 193-195 °C.
Mass spectrum: m/z (El) 381.2 (M+ ).
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*H NMR: 4(300 MHz; 4-DMSO) 9.94 (1 H, s, CONHAr), 7.55 (2 H, d, J  8.4, 
CH=CH), 7.41 (2 H, d, J  8.4, CH=CH), 7.24 (2 H, d, J  8.4, CH=CH), 6.96 (1 H, d, J  16.2, 
CH=CH), 6.88 (1 H, t, J  5.1, CONHCH2), 6.82 (1 H, d, J  16.2, CH=CH), 6.54 (2 H, d, J  
8.4, CH=CH), 5.27 (2 H, s, NH2Ar), 3.21 (2 H, dd, J  13.2 and 6.9, CH2CH2NH), 2.47 (2 
H, unresolved, COCH2CH2), 1.38 (9 H, s, C(CH3)3),
13C NMR: 4(75 MHz; 4-DMSO) 169.2, 155.6, 148.5, 137.7, 132.9, 127.7, 127.4, 
126.0, 124.9, 122.5, 119.2, 113.9, 77.6, 36.8, 36.5 and 28.3.
Elemental analysis: Found: C, 68.95; H, 7.25; N, 10.82. C22H27N30 3 requires C, 69.27; 
H, 7.13; N, 11.02%.
HPLC: /r  14.5 min (column: YMC-PACK ODS-AQ, 250 x 20 mm with YMC- 
Guardpack ODS-AQ, 50 x 20 mm; 45% aq. MeCN; flow rate: 10.0 cm^rnin1).
(£)-4-(3-Aminopropionamido)-4’-aminostilbene (7.5)
Method: To a stirring suspension of the carbamate 7.4 (0.700 g, 1.94 mmol) in DCM 
(250 cm3), TFA (5 cm3, 64.8 mmol) was added drop wise to produce a dark red solution. 
After 4 hours the solvent was removed and the residue was suspended in water (250 cm3). 
The suspension was washed with diethyl ether (50 cm3) before being adjusted to pH 12 
with 5 M NaOH to produce a yellow precipitate. The mixture was extracted with EtOAc 
(5 x 100 cm3), dried over anhydrous MgSC>4 and concentrated under reduced pressure to 
afford the diamine 7.5 as a yellow powder which was carried over into the next procedure 
without further purification.
Yield: 0.445 g, 88%.
Melting Point: 179-181 °C.
Mass spectrum: m/z (HI-RES El) Found: 281.1526 (M+‘. CnHi9N30). Calculated: 
281.1528.
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*H NMR: &(500 MHz; 76-DMSO) 10.07 (1 H, s, CONHAr), 7.55 (2 H, d, 7 8.5, 
CH=CH), 7.42 (2 H, d, 7 8.5, CH=CH), 7.24 (2 H, d, 7 8.5, CH=CH), 6.95 (2 H, d, 7 16.0, 
CH=CH), 6.82 (2 H, d, 7 16.0, CH=CH), 6.54 (2 H, d, 7 8.5, CH=CH), 5.27 (2 H, s, 
NH2Ar), 2.87 (2 H, t, 7 6.5, CH2CH2NH2), 2.42 (2 H, t, 7 6.5, COCH2CH2), (NH2 signal 
hidden under H20  peak at 3.33).
13C NMR: *(125 MHz; <76-DMSO) 170.1, 148.5, 137.7, 132.8, 127.7, 127.3, 126.0, 
124.9, 122.4, 119.2, 113.9 and 37.7.
[(£')-4-(3-(3,5-dimethoxy-2,4,6-triazinylamino)propionamido)-4’-(3,5-dimethoxy- 
2,4,6-triazinylamino)stilbene]-[a-cyclodextrin]-[2]-[rotaxanes] (7.6 and 7.7)
Method: To a stirred solution of aCD (1.15) (3.720 g, 3.826 mmol) in 0.012 M NaHCCfj 
(250 cm ), the diamine 7.5 (0.200 g, 0.765 mmol) was added and the resultant suspension 
was stirred for 24 hours. The triazine 6.9 was added and the stirring was continued for 
another 3 days. The precipitate was filtered and the residue was extracted with MQ H20  
(3 x 100 cm3). The combined filtrate was then subjected to Diaion HP-20 column (300 
mm x 20 mm). The column was flushed with MQ H20  until no unreacted aCD (1.15) 
was detected by TLC. The column was then flushed with methanol until all of the reacted 
aCD (1.15) was removed as detected by TLC. The solvent was reduced under pressure 
and the crude product was dissolved in MeOH and subjected to preparative reverse-phase 
HPLC. Fractions containing the [2]-rotaxanes 7.6 and 7.7 were isolated and lyophilised as 
colourless powders.
G H
Yield: 0.0047 g, 0.4%.
TLC: (5:4:3 v/v/v n-butanol-ethanol-water) Rf  0.49 (relative to the solvent front), 1.48 
(relative to aCD (1.15)).
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Mass spectrum: m/z (HI-RES ESI) Found: 1532.5528 (M+ + H, C63H90N9O35). 
Calculated: 1532.5539.
'H NMR: <^(500 MHz; </6-DMSO) 10.07 (1 H, s, I), 9.97 (1 H, s, B), 7.96 (1 H, 
unresolved, L), 7.75 (4 H, apparent s, C and D), 7.60 (2 H, d, J  8.0, H), 7.19 (2 H, d, J  
8.0, G), 6.96 (1 H, d, J  16.5, E), 6.77 (1 H, d, J  16.5, F), 5.60-5.30 (12 H, m, CD-OH2 
and CD-OH3), 4.74 (6 H, d, J  3.0, CD-H1), 4.43 (6 H, unresolved, CD-OH6), 3.98 (3 H, 
s, A or M), 3.89 (3 H, s, A or M), 3.86 (3 H, s, A or M), 3.81 (3 H, s, A or M), 3.69 (6 H, 
unresolved, CD-H5), 3.65 (6 H, unresolved, CD-H3), 3.60-3.55 (8 H, m, CD-H6AB and 
K), 3.42 (unresolved, CD-H4), 3.27 (6 H, unresolved, CD-H6A B), 3.22 (6 H, unresolved, 
CD-H2), 2.64 (2 H, t, J  6.5, J).
HPLC: t R 32.1 min (column: YMC-PACK ODS-AQ, 250 x 20 mm with YMC- 
Guardpack ODS-AQ, 50 x 20 mm; 10% aq. MeCN; flow rate: 10.0 cm3min'1).
UV/visible spectrum: ^ max = 348 nm, £348 = 9909.9 M ' c m 1.
Note: insufficient material for microanalysis or C NMR.
Yield: 0.020 g, 1.7%.
TLC: (5:4:3 v/v/v n-butanol-ethanol-water) R f  0.50 (relative to the solvent front), 1.51 
(relative to aCD (1.15)).
Melting point: 288 °C (dec.).
Mass spectrum: m/z (ESI) 1532.6 (M+ + H).
lH  NMR: &(500 MHz; J 6-DMSO) 10.24 (1 H, s, B), 10.07 (1 H, s, I), 8.03 (1 H, t, J  5.0, 
L), 7.76-7.70 (4 H, m, C and G), 7.63 (2 H, d, J  8.0, H), 7.18 (2 H, d, J  8.0, D), 7.00 (1 
H, d, J  16.5, E), 6.84 (1 H, d, J  16.5, F), 5.47 (6 H, unresolved, CD-OH2), 5.26 (6 H, 
unresolved, CD-OH3), 4.75 (6 H, d, J  3.0, CD-H1), 4.41 (6 H, unresolved, CD-OH6), 
3.98-3.89 (6 H, m, A or M), 3.87 (3 H, s, A or M), 3.81 (3 H, s, A or M), 3.71-3.62 (12
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H, m, CD-H5 and CD-H3), 3.60-3.52 (8 H, m, CD-H6A B and K), 3.43 (6 H, t, J  9.0, CD- 
H4), 3.28-3.21 (12 H, m, CD-H6A B and CD-H2), 2.67 (2 H, t, J 6.5, J).
,3C NMR: £(125 MHz; ^-methanol) 173.7, 173.2, 172.4, 169.3, 167.7, 139.9, 139.2, 
134.4, 132.8, 129.2, 129.0, 128.3, 127.8, 122.2, 122.0, 104.0, 83.2, 75.1, 73.9, 73.7, 61.5, 
55.2, 38.4 and 37.5.
Elemental analysis: (Found: C, 44.04; H, 6.36; N, 7.09. C63H89N9O35.IOH2O requires C, 
44.18; H, 6.42; N, 7.36%).
HPLC: tR 37.6 min (column: YMC-PACK ODS-AQ, 250 x 20 mm with YMC- 
Guardpack ODS-AQ, 50 x 20 mm; 10% aq. MeCN; flow rate: 10.0 en tm in '1).
UV/visible spectrum: kmax = 346 nm, £340 = 14132.7 M ’cm '1.
Photochemical isomerisation of the [2]-rotaxanes 7.1, 7.2,7.6 and 7.7
Solutions
The [2]-rotaxane 7.1 (0.0006 g, 0.00038 mmol) was made up to a concentration of 1.51 x 
10° M in MQ H2O (25 cm3). The [2]-rotaxane 7.2 (0.0015 g, 0.00094 mmol) was made 
up to a concentration of 1.88 x 10 s M in MQ H2O (50 cm3). The [2]-rotaxane 7.6 (0.0034 
g, 0.0022 mmol) was made up to a concentration of 2.22 x 103 M in MQ H20  (100 cm3). 
The [2]-rotaxane 7.7 (0.0015 g, 0.00098 mmol) was made up to a concentration of 1.96 x 
10'5 M in MQ H20  (50 cm3).
350 nm and 254 nm irradiation
Each of the solutions of the [2]-rotaxanes 7.1, 7.2, 7.6 and 7.7 were analysed for their 
molar responses using analytical reverse-phase HPLC for a 10 pi injection and its 
absorbance using UV/visible spectrophotometer. A 1 cm aliquot of the solutions were 
then sealed in quartz UV/visible cells and irradiated with ten 350 nm UV-A lamps for 30 
seconds in a photolysis reactor. Aliquots of the irradiated solutions were then subjected to 
HPLC while the absorbances were once again recorded. The solutions were again 
resealed and irradiated with ten 254 nm UV-C lamps for 30 seconds. The UV/visible 
spectra of the solutions were recorded and aliquots of the solutions were subjected to
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HPLC. The cycle of irradiation with 350nm and 254 nm light was then repeated a further 
two times.
370 nm and 254 nm irradiation
A 1 cm aliquot of the solutions of the were sealed in 13 mm pyrex tubes and irradiated 
with light of wavelength 370 nm. The [2]-rotaxane 7.1 was irradiated for 45 minutes 
while its orientational isomer 7.2 was irradiated for 20 minutes. The [2]-rotaxanes 7.6 and 
7.7 were irradiated for 30 minutes. Aliquots of the irradiated solutions were then 
subjected to HPLC while the absorbances were once again recorded. The solutions were 
again resealed and irradiated with four 254 nm UV-C lamps. The [2]-rotaxane 7.1 was 
irradiated for two minutes while the [2]-rotaxanes 7.2, 7.6 and 7.7 were irradiated for one 
minute. The UV/visible spectra of the solutions were recorded and aliquots of the 
solutions were subjected to HPLC. The cycle of irradiation with 370nm and 254 nm light 
was then repeated a further two times.
HPLC: 7.1 tR 6.5 min, (column: YMC-PACK ODS-AQ, 250 x 4.6 mm; H20/MeCN 
gradient).
Time
(min)
Flow
(cm3 m in 1)
h 2o
(%)
MeCN
(%)
0 1 95 5
10 1 0 100
11 1 95 5
15 1 95 5
HPLC: 7.2 tR 3.5 min, (column: YMC-PACK ODS-AQ, 250 x 4.6 mm; 25% aq. MeCN; 
flowrate: 1.0cm3min'1).
HPLC: 7.6 tR 2.6 min, 7.7 tR 2.6 min, (column: YMC-PACK ODS-AQ, 250 x 4.6 mm; 
30% aq. MeCN; flow rate; 1.0 cm3min ’).
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[(Z)-4-(4-(3,5-dimethoxy-2,4,6-triazinylamino)phenylacetamido)-4’-(3,5-dimethoxy-
2,4,6-triazinylamino)stilbene]-[oc-cyclodextrin]-[2]-[rotaxane] (7.1(Z))
} —OMe N
Method: The [2]-rotaxane 7.1 (0.040 g, 0.025 mmol) was dissolved in MQ H2O (500 
cm ) and placed in a 1 dm quartz round bottom flask. The mixture was then irradiated 
with light of wavelength 350 nm (10 lamps) for three minutes. The reaction mixture was 
then lyophilised, dissolved in 25% aqueous MeCN and subjected to semi-preparative 
reverse-phase HPLC. Fractions containing the [2]-rotaxane 7.1(Z) were combined and 
lyophilised to give a colourless powder.
Yield: 0.0043 g, 11%.
TLC: (5:4:3 v/v/v «-butanol-ethanol-water) R{ 0.65 (relative to the solvent front), 1.67 
(relative to aCD (1.15)).
l H  NMR: 4(500 MHz; d6-DMSO) 7.64 (2 H, d, J 8.0, L), 7.62 (2 H, d, J 8.0, C), 7.48- 
7.42 (4 H, m, H and K), 7.29 (2 H, d, J 8.0, D), 7.22 (2 H, d, J 8.0, G), 6.52 (1 H, d, J 
12.5, E or F), 6.48 (1 H, d, J  12.5, E or F), 4.76 (6 H, d, J 2.5, CD-H1), 3.92 (6 H, s, N), 
3.89 (6 H, s, A), 3.79 (6 H, d, J 9.5, CD-H5), 3.74-3.66 (8 H, m, J and CD-H5), 3.60 (6 
H, d, J 11.0, CD-H6a  b), 3.44 (unresolved, CD-H4), 3.35 (unresolved, CD-H6A B), 3.24 (6 
H, d, J 9.5, CD-H2).
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HPLC: tR 8.4 min (column: YMC-PACK ODS-AQ, 250 x 10 mm; H20/MeCN 
gradient).
Time
(min)
Flow
(cm3 min'1)
H20
(%)
MeCN
(%)
0 3 70 30
10 3 70 30
15 3 0 100
16 3 70 30
20 3 70 30
[(Z)-4-(4-(3,5-dimethoxy-2,4,6-triazinylamino)phenylacetamido)-4’-(3,5-dimethoxy- 
2,4,6-triazinylamino)stilbene]-[a-cyclodextrin]-[2]-[rotaxane] (7.2(Z))
E F
^—OMe N
Method: The [2]-rotaxane 7.2 (0.015 g, 0.0094 mmol) was dissolved in MQ H20  (500 
cm ) and placed in a 1 dm quartz round bottom flask. The mixture was then irradiated 
with light of wavelength 350 nm (10 lamps) for three minutes. The reaction mixture was 
then lyophilised, dissolved in 25% aqueous MeCN and subjected to semi-preparative 
reverse-phase HPLC. Fractions containing the [2]-rotaxane 7.2(Z) were combined and 
lyophilised to give a colourless powder.
Yield: 0.0055 g, 37%.
TLC: (5:4:3 v/v/v n-butanol-ethanol-water) Rf 0.63 (relative to the solvent front), 1.61 
(relative to otCD (1.15)).
lH NMR: 4(500 MHz; d6-DMSO) 7.68-7.56 (6 H, m, C, H and L), 7.37 (2 H, d, J 8.0, 
K), 7.26-7.16 (4 H, m, D and G), 6.52-6.44 (2 H, m, E and F), 4.74 (6 H, d, J 3.0, CD- 
Hl), 3.89 (9 H, s, A and N), 3.84 (3 H, s, A or N), 3.82-3.76 (8 H, m, J and CD-H5), 3.66
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(6 H, t, J 9.0, CD-H5), 3.59 (6 H, d, J 11.5, CD-H6AB), 3.42 (unresolved, CD-H4), 3.35 
(unresolved, CD-H6A B), 3.21 (6 H, dd, J 9.5 and 3.0, CD-H2).
HPLC: tR 12.6 min (column: YMC-PACK ODS-AQ, 250 x 10 mm; H20/MeCN 
gradient).
Time
(min)
Flow
(cm3m in ')
H20
(%)
MeCN
(%)
0 3 70 30
10 3 70 30
15 3 0 100
16 3 70 30
20 3 70 30
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Experimental for Chapter 8
[(£)-Af-(6A-Deoxy-a-cyclodextrin-6A-yl)-4-aminocarbonyl-4’-(3-(3,5-dimethoxy- 
2,4,6-triazinylamino)propionamido)stilbene]-[c2]-[daisy chain] (8.5(E,E))
C BL HN
M MeO
Method: The hermaphroditic CD 8.3 (0.100 g, 0.078 mmol) was dissolved in MQ H2O 
(10 cm ) and stirred for 24 hours. The triazine 6.9 (0.015 g, 0.086 mmol) was added and 
the resulting suspension was stirred. After two days the reaction was deemed incomplete 
by TLC. A further equivalent of the triazine 6.9 (0.014 g, 0.0078 mmol) was added and 
the suspension was stirred for a further three days. The solvent was then removed by 
lyophilisation. The resultant colourless powder was dissolved in MQ FDO/MeCN and 
subjected to semi-preparative reverse-phase HPLC. Fractions containing the 
hermaphroditic [2]-rotaxane 8.5(E,E) were isolated and lyophilised as a colourless 
powder.
Yield: 0.014 g, 12%.
TLC: (5:4:3:2 v/v/v /-propanol-ethanol-water-acetic acid) Rf  0.41 (relative to the solvent 
front), 0.76 (relative to aCD (1.15)).
Melting point: 239 °C (dec.).
Mass spectrum: m/z (ESI) 2836.3 (M+ + H).
]H NMR: 4(500  MHz; D20 ) 8.02-7.97 (8 H, m, F and G), 7.58 (4 H, d, 7 8.0, B), 7.32 
(4 H, d, 7 8.0, C), 7.29 (2 H, d, 7 16.5, D or E), 7.19 (2 H, d, 7 16.5, D or E), 5.18-4.92 
(12 H, m, CD-H1), 4.53-3.01 (92 H, m, CD-H2, CD-H3, CD-H4, CD-H5, CD-H6A B, I, 
K, M), 1.97 (4 H, p, 7 6.5, J).
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Detailed 'H NMR assignment is shown in Chapter 8.
13C NMR: £(125 MHz; d6-DMSO) 174.9, 174.3, 172.6, 171.0, 170.2, 141.5, 141.1, 
137.4, 135.7, 132.6, 131.7, 131.3, 130.4, 130.1, 128.6, 105.3, 105.0, 104.9, 104.7, 87.2,
84.2, 84.0, 83.9, 83.7, 76.6, 76.5, 76.4, 76.3, 75.5, 75.3, 75.1, 74.6, 74.5, 74.4, 62.9, 62.6,
62.3, 62.1,57.7, 57.6, 43.7, 40.9, 40.2, 33.1 and 31.0.
Elemental analysis: (Found: C, 47.07; H, 6.26; N, 5.15. C 120H 168N 12O66.I3 H2O requires 
C, 46.96; H, 6.37; N, 5.48%).
HPLC: tR 10.3 min (column: YMC-PACK ODS-AQ, 250 x 10 mm; H20/MeCN 
gradient).
Time
(min)
Flow
(cm3m in 1)
H20
(%)
MeCN
(%)
0 3 85 15
15 3 85 15
25 3 0 100
30 3 0 100
31 3 85 15
40 3 85 15
UV/visible spectrum: Xmax = 222.5 nm, £222.5 = 64979.8 M ’cm'1; ^max = 333.5 nm, £333.5 
= 105161.9 M 'W .
Photochemical isomerisation of the hermaphroditic [2]-rotaxane 
8.5(E,E)
The hermaphroditic [2]-rotaxane 8.5(E,E) (0.0007 g, 0.00025 mmol) was made up to a 
concentration of 9.88 x 106 M in MQ H2O (25 cm3). The molar response for the 
hermaphroditic [2]-rotaxane 8.5(E,E) was analysed using analytical reverse-phase HPLC 
for a 10 |il injection and its absorbance using UV/visible spectrophotometer. A 1 cm 
aliquot of the solution was then sealed in a quartz UV/visible cell and irradiated with ten 
350 nm UV-A lamps for one minute in a photolysis reactor. An aliquot of the irradiated 
solution was then subjected to HPLC while the absorbance was once again recorded. The 
solution was again resealed and irradiated with ten 254 nm UV-C lamps for one minute.
225
Chapter 10
The UV/visible spectrum of the solution was recorded and an aliquot of the solution was 
subjected to HPLC. The cycle of irradiation with 350nm and 254 nm light was then 
repeated a further two times. The photochemical isomerisation was then repeated as 
described above. The only change was the time length of the 350 nm irradiation which 
was increased to ten minutes.
HPLC: 8.5(E,E) / r  6.2 min, (column: YMC-PACK ODS-AQ, 250 x 4.6 mm; 15% aq. 
MeCN; flow rate: 1.0 cm3min'').
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